<?xml version='1.0' encoding='UTF-8'?>
<!-- Created by Xince -->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:cardifflexington.com="http://cardifflexington.com/20251231" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025">
  <link:schemaRef xlink:href="./CDIF_taxonomy_FY_2023_2025.zip/CDIF_taxonomy_FY_2023_2025/CDIF-20251231.xsd" xlink:type="simple"/>
  <xbrli:context id="c">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote103Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesXSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesXSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c4">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote404Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c5">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c6">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c7">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c8">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c9">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote102Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c10">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote101Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c11">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cardifflexington.com:RedRockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c13">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote371Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c15">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c16">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cardifflexington.com:PreviousOwnersOfEdgeViewMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c17">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c18">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote409Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c19">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cardifflexington.com:PreviousOwnersOfEdgeViewMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c21">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c22">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cardifflexington.com:RedRockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c23">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote103Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c24">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2024Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c25">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c26">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c27">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote102Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c28">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c29">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote102Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote101Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c32">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cardifflexington.com:ChairmanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c33">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cardifflexington.com:RedRockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c34">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c35">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c36">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c37">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c38">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c39">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c40">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cardifflexington.com:ChairmanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c41">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote39Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c42">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cardifflexington.com:RedRockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c43">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote371Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c44">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c45">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c46">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote409Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c47">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c48">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c49">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c50">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-08</xbrli:startDate>
      <xbrli:endDate>2024-01-09</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c51">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c52">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c53">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c54">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c55">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c56">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote404Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c57">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c58">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c59">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote371Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c60">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c61">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c62">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c63">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c64">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c65">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote4010Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c66">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote39Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c67">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c68">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c69">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c70">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote373Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c71">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote101Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c72">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-05-15</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c73">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c74">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesBEF1JAndLMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c75">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote404Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c76">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cardifflexington.com:MedicalEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c77">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c78">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote401Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c79">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote405Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c80">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c81">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cardifflexington.com:FirstDoctorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-05-02</xbrli:startDate>
      <xbrli:endDate>2021-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c82">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c83">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesBEF1JAndLMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c84">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote403Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c85">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:ManagersOfAHIMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-10-30</xbrli:startDate>
      <xbrli:endDate>2022-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c86">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">cardifflexington.com:SettlementOfEmploymentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-10-09</xbrli:startDate>
      <xbrli:endDate>2022-10-10</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c87">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cardifflexington.com:SecondDoctorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-05-02</xbrli:startDate>
      <xbrli:endDate>2021-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c88">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c89">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c90">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cardifflexington.com:ThirdDoctorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-05-02</xbrli:startDate>
      <xbrli:endDate>2021-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c91">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote372Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c92">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote103Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c93">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesAIKMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c94">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c95">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote39Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c96">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:ManagersOfAHIMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-10-30</xbrli:startDate>
      <xbrli:endDate>2022-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c97">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote4010Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c98">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2023Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c99">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:HealthcareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c100">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cardifflexington.com:ChiefAccountingOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-05-24</xbrli:startDate>
      <xbrli:endDate>2023-05-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c101">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c102">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:ManagersOfAHIMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-10-30</xbrli:startDate>
      <xbrli:endDate>2022-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c103">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesBEF1JAndLMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c104">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:HealthcareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c105">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote372Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c106">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:RealEstatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c107">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:PropertyManagerOfEdgeViewMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-23</xbrli:startDate>
      <xbrli:endDate>2023-07-24</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c108">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote373Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c109">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote4010Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c110">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c111">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote405Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c112">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:RealEstatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c113">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesNSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c114">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote38Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c115">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote10Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c116">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote41Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c117">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c118">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2021Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c119">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote31Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c120">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c121">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesNSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c122">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:AHIMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cardifflexington.com:BuyBackAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-10-01</xbrli:startDate>
      <xbrli:endDate>2022-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c123">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote407Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c124">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c125">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:AHIMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-10-01</xbrli:startDate>
      <xbrli:endDate>2022-10-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c126">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c127">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote38Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c128">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c129">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote10Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c130">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c131">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote31Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c132">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote41Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c134">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-09-28</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c135">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote409Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c136">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c137">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c138">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c139">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNotesPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c140">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote10Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c141">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote41Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c142">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c143">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2021Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c144">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2022Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c145">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c146">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c147">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote408Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c148">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesRSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c149">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote408Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c150">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesRSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c151">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote31Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c152">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c153">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote71Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c154">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:SubsidiaryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c155">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c156">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesNSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c157">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:SubsidiaryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c158">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c159">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesAIKMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c160">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c161">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote38Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c162">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:LoansAndNotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c163">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:LoansAndNotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c164">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNotesPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c165">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c166">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote408Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c167">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesBEF1JAndLMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c168">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:SBALoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-06-01</xbrli:startDate>
      <xbrli:endDate>2020-06-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c169">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesRPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c170">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:CardiffLexingtonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c171">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:SBALoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c172">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:SBALoanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c173">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:CardiffLexingtonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c174">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2023Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c175">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesAIKMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c176">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c177">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesAIKMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c178">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote9Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c179">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c180">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote407Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c181">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote402Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c182">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesLPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c183">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote292Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c184">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c185">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote71Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c186">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote401Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c187">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote407Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c188">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c189">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote71Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c190">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote402Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c191">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c192">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:ThirdPartyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-12-14</xbrli:startDate>
      <xbrli:endDate>2022-12-15</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c193">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote292Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c194">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesBEF1JAndLMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c195">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c196">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote401Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c197">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote373Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c198">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesXPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c199">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote9Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c200">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">cardifflexington.com:RestatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c201">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote403Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c202">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote402Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c203">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c204">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c205">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c206">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesAIKMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c207">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cardifflexington.com:PreferredStockSeriesCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c208">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote9Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c209">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c210">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:RedRockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c211">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote403Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c212">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c213">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2022Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c214">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c215">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-10-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c216">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote406Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c217">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c218">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:NewPromissoryNoteMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-09-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c219">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2024Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c220">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c221">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c222">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:NewPromissoryNoteMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesXSeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-09-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c223">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c224">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote372Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c225">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesIPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c226">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesIPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c227">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:AllPromissoryNotesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-09-20</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c228">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote406Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c229">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:AllPromissoryNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cardifflexington.com:PrincipalAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-09-20</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c230">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2025Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c232">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cardifflexington.com:AccruedInterestAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:AllPromissoryNotesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-09-20</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c233">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">cardifflexington.com:SeriesDIntoSeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-07-01</xbrli:startDate>
      <xbrli:endDate>2022-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c234">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:AllPromissoryNotesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-09-21</xbrli:startDate>
      <xbrli:endDate>2022-09-22</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c235">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">cardifflexington.com:SeriesDIntoSeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-07-01</xbrli:startDate>
      <xbrli:endDate>2022-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c236">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c237">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote292Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c238">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">cardifflexington.com:SeriesHIntoSeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-07-01</xbrli:startDate>
      <xbrli:endDate>2022-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c239">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">cardifflexington.com:SeriesHIntoSeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-07-01</xbrli:startDate>
      <xbrli:endDate>2022-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c240">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EffectOfFourthQuarterEventsByTypeAxis">cardifflexington.com:YearEnd2025Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c241">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c242">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote405Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c243">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c244">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c245">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c246">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c247">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cardifflexington.com:ConvertibleNote406Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c248">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesF1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c249">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesJPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cardifflexington.com:NovaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-09-06</xbrli:startDate>
      <xbrli:endDate>2022-09-07</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c250">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesF1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c251">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:HealthcareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c252">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c253">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:HealthcareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c254">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesRPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c255">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesXPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c256">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesXPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-09-11</xbrli:startDate>
      <xbrli:endDate>2022-09-12</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c257">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:RealEstatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c258">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c259">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:OthersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c260">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c261">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:RealEstatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c262">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c263">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cardifflexington.com:SeriesLPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c264">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c265">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cardifflexington.com:OthersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c266">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000811222</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cardifflexington.com:ThirdPartyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-11-01</xbrli:startDate>
      <xbrli:endDate>2022-11-11</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="usd">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="usd1">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f" decimals="0" contextRef="c" unitRef="usd">-47520.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:DebtCurrent id="f1" decimals="0" contextRef="c1" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:PreferredStockSharesOutstanding id="f2" decimals="INF" contextRef="c2" unitRef="shares">375000.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesIssued id="f3" decimals="INF" contextRef="c3" unitRef="shares">375000.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f4" decimals="INF" contextRef="c4" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:StockholdersEquity id="f5" decimals="0" contextRef="c5" unitRef="usd">488.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f6" decimals="0" contextRef="c6" unitRef="usd">-24681.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:LiabilitiesCurrent1 id="f7" decimals="0" contextRef="c7" unitRef="usd">11439675.0</cardifflexington.com:LiabilitiesCurrent1>
  <cardifflexington.com:AccruedExpenseDividendPayable id="f8" decimals="0" contextRef="c8" unitRef="usd">0.0</cardifflexington.com:AccruedExpenseDividendPayable>
  <us-gaap:PreferredStockSharesOutstanding id="f9" decimals="INF" contextRef="c3" unitRef="shares">375000.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:DebtInstrumentMaturityDate id="f10" contextRef="c9">2024-03-30</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f11" decimals="0" contextRef="c10" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet id="f12" decimals="0" contextRef="c11" unitRef="usd">860.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
  <us-gaap:ErrorCorrectionTextBlock id="f13" contextRef="c12">&lt;p id="xdx_803_eus-gaap--ErrorCorrectionTextBlock_zAmfDxZVnAg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82C_zgLXQtNI0Kqb"&gt;RESTATEMENT AND REVISION OF FINANCIAL STATEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="text-decoration: underline"&gt;Restatement of Previously Issued Financial Statements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the preparation of the year ended December
31, 2023 financial statements, the Company identified and corrected its classification and accounting treatment for its series R convertible
preferred stock and the related dividend accrual in its balance sheet as of December 31, 2022 and 2021. Pursuant to ASC 250, Accounting
changes and error corrections issued by FASB and SAB 99 Materiality issued by Securities and Exchange Commission,
the Company determined the impact of the error was immaterial. The impact of the error correction is reflected in a $198,000 increase
to the mezzanine equity and offsetting decrease to the series R convertible preferred stock and subject to possible redemption mezzanine
equity line item on the consolidated balance sheet as of December 31, 2021. In addition, the impact of the unpaid dividend accrual is
reflected in $29,462 and $47,520 increase to mezzanine equity and offsetting decrease to the accumulated deficits as of December 31, 2022
and 2021, respectively. The impact of the error correction is also reflected in $29,462 and $47,520 increase of preferred share dividends
and $28 and $5 decrease of earnings (loss) per share on the consolidated statement of operations for the years ended December 31, 2022
and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes the impacts of
the error corrections on the Company's financial statements for each of the periods presented below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;i. Consolidated balance sheet&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zCWHnW27IUu1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RESTATEMENT AND REVISION OF FINANCIAL STATEMENTS (Details - Financical Statements)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B7_zZI1E8cmkmtd" style="display: none"&gt;Schedule of restated financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 25%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsED3V0iKNZi" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;15,297,039&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_iI_pp0p0_d0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z8BKXFX7urMl" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_zLNcX2FgX0ec" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;15,297,039&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zge5aI3TCc4f" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,439,675&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zRrE0TWHEsP2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_z7pwrQF8fGgb" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,439,675&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--MezzanineEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxzcdROXdt6" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;3,125,004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--MezzanineEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvon5NUppmq1" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;245,520&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MezzanineEquity_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_zDod0Ocgy2i4" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;3,370,524&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVVngQI9dTi6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;732,360&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z3OQ2Af9VOpi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(245,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_zC7TSppfx6rh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;486,840&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf03b9XT2Ki8" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;13,344,780&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_pp0p0_d0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zh2a43imrHf7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Assets_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zjJOCwDlcZH1" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;13,344,780&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvQHLxq1hCm2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,189,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z5eS9CIezdQ7" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zhixvwxQl93d" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,189,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--MezzanineEquity_iI_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHhPdHGPO5I8" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;4,625,002&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--MezzanineEquity_pp0p0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIWF1blafnEf" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;274,982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--MezzanineEquity_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zfLZPCgmlHB4" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;4,899,984&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockholdersEquity_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbBgEVqgBSfg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,469,809&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquity_pp0p0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIL8eTWcCtg2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(274,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zyJnK8PNqhZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,744,791&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;March 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3Wa8D6CQSVe" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;14,284,585&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_pp0p0_d0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_znhdu0bo4Az8" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Assets_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_z4y9sl1iX4R6" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;14,284,585&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOhlpfaUKIx2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,745,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvUnEwOFV1m2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_zY9OCGUhdtA5" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,745,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--MezzanineEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaPZc01R0cNk" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,171,861&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--MezzanineEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9hJ3W6zm3nl" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;283,118&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--MezzanineEquity_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_zkF4aVQIfmm7" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,454,979&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYiVUgmuoup1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,632,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zoJ1p50GKJVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(283,118&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_zJKTk4ccvgc3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,915,491&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Assets_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDeZinqYNNk9" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;16,053,519&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_iI_pp0p0_d0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zU5vZpB6xtae" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_z1UfLJ6yMvq3" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;16,053,519&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9DpK4abK8V6" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,672,952&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zxu0kMaMaEPi" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_zxzsAe0BZNxk" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,672,952&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--MezzanineEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z2xutyBA7dpc" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,297,605&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MezzanineEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsZ5QRJtAsU3" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;291,345&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--MezzanineEquity_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_zLYSUHdjpqm" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,588,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zQuTh8n5vUY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(917,038&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zuXrGawJdUKl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(291,345&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquity_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_zpAtMxIH9a56" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,208,383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjpoDR2Y6aId" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;18,518,727&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_pp0p0_d0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zNAxJOMv2sY9" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_z2F9F5lEAzh8" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;18,518,727&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcjYqeJRtf52" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;12,102,942&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zBnnJbepuCQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_zO2d7INlqLi9" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;12,102,942&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MezzanineEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjlvsUKVnp8" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,440,434&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--MezzanineEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvM43uQhh6al" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;299,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--MezzanineEquity_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_zUi5FklEn0o5" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,740,096&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA5rWcEVEwl4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;975,351&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2rAUNM6C9Wh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(299,662&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_zZxyePGVY5ae" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;675,689&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ii. Consolidated statement of operations&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the year&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXm4akmYFl9b" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;666,293&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_d0_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSXNY8tXN3il" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zDxIGxZ9O9se" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;666,293&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSXDaN8sNqdc" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(201,782&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z07Fi355OfU9" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(47,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zsc5CL1Y7cq1" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(249,302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0Om7dx994a7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;464,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_za4k3uG57vYb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(47,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zORbGaFuEc5j" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;416,991&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zV1J4N8usyz1" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5WIOThzCngb" title="Diluted earnings per share, continued operations"&gt;272&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTS3V5R4Eiae" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPaIEW9L4F0b" title="Diluted earnings per share, continued operations"&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_z59CxL5NsfFb" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zTipFdqCElpf" title="Diluted earnings per share, continued operations"&gt;244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss for the year&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVGnbe57PYo4" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(5,429,521&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pp0p0_d0_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zcek9uzZB2Z9" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zgtfMEGEYbP3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(5,429,521&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4m2DGIl7Ec8" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(307,188&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zLZE8aE4OKHl" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(76,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zQuHeu2BDR2b" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(384,170&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYnEtxFBtFY1" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(5,736,709&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZGEsxoikSSl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(76,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zTVCYoQ44E0f" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(5,813,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsyLcE2osET1" title="Diluted earnings per share, continued operations"&gt;(994&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" title="Diluted earnings per share, continued operations"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_z7RcX91K8Tni" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zmTClOpQ54t4" title="Diluted earnings per share, continued operations"&gt;(999&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Three months ended March 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8ZZ4jSHQFJ3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(15,991&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9k7pyT9fyw2" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zRVkUtV5zbNh" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(15,991&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6xATN3s7S51" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(336,811&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zi1U1wEwHqB1" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(8,136&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zB2p7rCH1Sl5" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(344,947&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zD4NSrbmuOmk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(352,802&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z3nt3j93UgE3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(8,136&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_z7EkZ1jZlAi" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(360,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zY6OeQVcPhp5" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyepbM3zKoP2" title="Diluted earnings per share, continued operations"&gt;(30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zVy5nYHQSgdj" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zxrClIL2iYb7" title="Diluted earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zbq2YAsnxjXl" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zP7Xsw87Q28d" title="Diluted earnings per share, continued operations"&gt;(31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Three months ended June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_pp0p0_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zhZNlMsCHish" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;816,078&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGUoYkuyqBW7" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zR5OUnBcGcZj" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;816,078&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zal4pFqADfGf" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(125,744&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_znk6gZVM3E9c" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(8,227&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zI2BXYX1osg6" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(133,971&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsqzb7SiGF0d" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;690,334&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zVhY7Vt8APxj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(8,227&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zFbbEgqJoxgf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;682,107&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zO0DZY6DJ8y5" title="Basic earnings per share, continued operations"&gt;56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQAstmoLSR33" title="Basic earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zQKLiEWaQ6Ph" title="Basic earnings per share, continued operations"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM0aDP2Kpe1a" title="Diluted earnings per share, continued operations"&gt;(21&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAZrxaLQY0we" title="Diluted earnings per share, continued operations"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_z0dN77DcY1ef" title="Diluted earnings per share, continued operations"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Six months ended June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zclEgbf6jOgl" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;800,087&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMQXP8JQJTc9" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zqNUwtRxculc" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;800,087&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zClAQqQ4J0s2" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(462,555&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zynEqd8Z8Fm5" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(16,363&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zVPmo2SKVF2k" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(478,918&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqUgd4CcY167" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;337,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpOj9lUgUO6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(16,363&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zixyHC3M2fE7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;321,169&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHhDg4HMfPpd" title="Basic earnings per share, continued operations"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zDbEgXiLTrGi" title="Basic earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_z8d5niw8Uk19" title="Basic earnings per share, continued operations"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z14Z2Akq7n7d" title="Diluted earnings per share, continued operations"&gt;(16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCyk0gyhYf3c" title="Diluted earnings per share, continued operations"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zWPbwthPgV9g" title="Diluted earnings per share, continued operations"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Three months ended September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ziLlobifr5C3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;1,981,520&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zDDyyVl1dTH" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_zDYIX5Etq9Wl" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;1,981,520&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcH43c2KTkcl" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(142,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMZAOY2lSdTf" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(8,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_zhaMYZ0sNGIl" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(151,146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM8VGcLKgkwa" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;1,838,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zp3HrFYXVgOg" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(8,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_z8UIX6ov9NK2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;1,830,374&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcgqJPLLMNOj" title="Basic earnings per share, continued operations"&gt;137&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zb9fDu07cJoa" title="Basic earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_z8Pt0SvcNJMh" title="Basic earnings per share, continued operations"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ztVTJLRUyppf" title="Diluted earnings per share, continued operations"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOWUpTfDMhnf" title="Diluted earnings per share, continued operations"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_zBx5MQ8jRDr4" title="Diluted earnings per share, continued operations"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Nine months ended September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the year&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwVSiHOxca2g" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;2,781,608&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zA7NnoAXOafc" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_zACpT12tNVO3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;2,781,608&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqNwTQmSYNMd" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(605,384&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9pAvw1GTldk" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(24,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_z9FFKGf8B0el" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(630,065&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrF0xlnWAc41" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;2,176,224&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwFTReh9Z7vi" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(24,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_z6deMxdJldMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;2,151,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZeZn88CUpnc" title="Basic earnings per share, continued operations"&gt;167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zfBoNQWRMfC6" title="Basic earnings per share, continued operations"&gt;(2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_zFSc1yT1KFXd" title="Basic earnings per share, continued operations"&gt;165&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zU6tlKYUvWn" title="Diluted earnings per share, continued operations"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgNG5hYmJXae" title="Diluted earnings per share, continued operations"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_zPFbTZJFPAy1" title="Diluted earnings per share, continued operations"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zrcCmmRom4F9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Revision of Financial Statements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the preparation of the financial statements
for the year ended December 31, 2023, the Company found that the results of the settlement agreement with Red Rock Travel Group (Red
Rock) were incorrectly reflected on the consolidated statement of stockholders equity (deficiency) as of December 31, 2022.
The Company determined that these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement
was necessary. The revisions discussed below were made to the December 31, 2022 balance sheet and statement of stockholders equity
(deficiency).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of the settlement agreement with Red
Rock on July 29, 2022, the Company reduced 35,000,000 shares of common shares on the consolidated financial statements as of December
31, 2022. The certificate of the common stock for 35,000,000 shares (0.047 shares after 10,000:1 and 75,000:1 reverse split) which were
originally issued on February 24, 2020 was returned as part of the 2022 agreement with Red Rock and 0.047 common shares were cancelled,
which were equivalent to 35,000,000 shares before the 10,000:1 and 75,000:1 reverse split on May 12, 2020 and January 9, 2024, respectively.
Consequently, the December 31, 2022 financial statements as originally reported were understated by 34,996,500 common shares. The impact
of the correction is reflected in the $35,097 increase to common stock and decrease the same amount to additional paid-in-capital on the
consolidated statement of stockholders equity. The adjustment had no impact on earnings per share for any 2022 period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On July 31, 2018, the Company issued 8,200,562
shares of series K preferred stock to the prior owners of Red Rock for the consideration of the acquisition of Red Rock. The acquisition
was not completed, and Red Rock returned the 8,200,562 shares of series K preferred stock during the year ended December 31, 2018. A total
of 8,200,562 shares of series K preferred stock were cancelled. The impact of the correction is reflected in the $8,201 decrease to series
K preferred stock and increase the same amount to additional paid-in-capital on the consolidated statement of stockholders equity
(deficiency).&lt;/p&gt;

</us-gaap:ErrorCorrectionTextBlock>
  <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent id="f14" decimals="INF" contextRef="c8" unitRef="pure">0.0473</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
  <cardifflexington.com:AccruedInterest id="f15" decimals="0" contextRef="c13" unitRef="usd">28756.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:AccruedProfessionalFees id="f16" decimals="0" contextRef="c8" unitRef="usd">29122.0</cardifflexington.com:AccruedProfessionalFees>
  <us-gaap:EarningsPerShareBasic id="f17" decimals="INF" contextRef="c14" unitRef="usd1">-1.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="f18" decimals="INF" contextRef="c15" unitRef="usd1">28.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:NotesAndLoansPayable id="f19" decimals="0" contextRef="c16" unitRef="usd">4979.0</us-gaap:NotesAndLoansPayable>
  <us-gaap:StockholdersEquity id="f20" decimals="0" contextRef="c17" unitRef="usd">167421.0</us-gaap:StockholdersEquity>
  <us-gaap:InterestExpenseDebt id="f21" decimals="0" contextRef="c18" unitRef="usd">1605.0</us-gaap:InterestExpenseDebt>
  <us-gaap:EarningsPerShareBasic id="f22" decimals="INF" contextRef="c19" unitRef="usd1">-31.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:NotesAndLoansPayable id="f23" decimals="0" contextRef="c20" unitRef="usd">4979.0</us-gaap:NotesAndLoansPayable>
  <us-gaap:LiabilitiesCurrent id="f24" decimals="0" contextRef="c21" unitRef="usd">9964927.0</us-gaap:LiabilitiesCurrent>
  <us-gaap:GoodwillImpairmentLossNetOfTax id="f25" decimals="0" contextRef="c22" unitRef="usd">-0.0</us-gaap:GoodwillImpairmentLossNetOfTax>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f26" decimals="INF" contextRef="c1" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:InterestExpenseDebt id="f27" decimals="0" contextRef="c23" unitRef="usd">1469.0</us-gaap:InterestExpenseDebt>
  <cardifflexington.com:MinimumAnnualAmount id="f28" decimals="-5" contextRef="c24" unitRef="usd">5500000.0</cardifflexington.com:MinimumAnnualAmount>
  <us-gaap:PreferredStockValue id="f29" decimals="0" contextRef="c25" unitRef="usd">8525312.0</us-gaap:PreferredStockValue>
  <us-gaap:EarningsPerShareDiluted id="f30" decimals="INF" contextRef="c19" unitRef="usd1">-31.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f31" decimals="0" contextRef="c12" unitRef="usd">5195045.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f32" decimals="0" contextRef="c26" unitRef="usd">416991.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount id="f33" decimals="0" contextRef="c2" unitRef="usd">1690685.0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
  <cardifflexington.com:AccruedInterest id="f34" decimals="0" contextRef="c27" unitRef="usd">2836.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:ConversionAndNoteIssuanceCost id="f35" decimals="0" contextRef="c12" unitRef="usd">11250.0</cardifflexington.com:ConversionAndNoteIssuanceCost>
  <cardifflexington.com:ReverseStockSplitPolicyTextBlock id="f36" contextRef="c12">&lt;p id="xdx_84F_ecustom--ReverseStockSplitPolicyTextBlock_zbXKqSZAHDbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zwsZ02TZenr"&gt;Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 9, 2024, the Company effected a &lt;span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240108__20240109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkTJpYVjVRib" title="Reverse stock split"&gt;1-for-75,000
reverse split&lt;/span&gt; of its outstanding common stock. All outstanding shares of common stock and warrant to purchase common stock were adjusted
to reflect the 1-for-75,000 reverse split, with respective exercise prices of the warrants proportionately increased. The conversion prices
of the outstanding convertible notes and certain series of preferred stock were adjusted to reflect a proportional decrease in the number
of shares of common stock to be issued upon conversion.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All share and per share data throughout these
consolidated financial statements have been retroactively adjusted to reflect the reverse stock split. The total number of authorized
shares of common stock did not change. As a result of the reverse stock split, an amount equal to the decreased value of the common stock
was reclassified from common stock to additional paid-in capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















</cardifflexington.com:ReverseStockSplitPolicyTextBlock>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f37" decimals="0" contextRef="c28" unitRef="usd">2151543.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:LiabilitiesCurrent1 id="f38" decimals="0" contextRef="c29" unitRef="usd">0.0</cardifflexington.com:LiabilitiesCurrent1>
  <cardifflexington.com:AccruedExpenseDividendPayable id="f39" decimals="0" contextRef="c21" unitRef="usd">210046.0</cardifflexington.com:AccruedExpenseDividendPayable>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="f40" decimals="0" contextRef="c12" unitRef="usd">0.0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:RepaymentsOfConvertibleDebt id="f41" decimals="0" contextRef="c12" unitRef="usd">175000.0</us-gaap:RepaymentsOfConvertibleDebt>
  <us-gaap:CostOfRevenue id="f42" decimals="0" contextRef="c12" unitRef="usd">3560624.0</us-gaap:CostOfRevenue>
  <us-gaap:ConvertibleDebt id="f43" decimals="0" contextRef="c30" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f44" decimals="INF" contextRef="c31" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:OperatingIncomeLoss id="f45" decimals="0" contextRef="c12" unitRef="usd">5195045.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:ShortTermBorrowings id="f46" decimals="0" contextRef="c32" unitRef="usd">120997.0</us-gaap:ShortTermBorrowings>
  <us-gaap:Revenues id="f47" decimals="0" contextRef="c33" unitRef="usd">1438294.0</us-gaap:Revenues>
  <us-gaap:DividendsPreferredStock id="f48" decimals="0" contextRef="c34" unitRef="usd">8227.0</us-gaap:DividendsPreferredStock>
  <us-gaap:StockholdersEquity id="f49" decimals="0" contextRef="c35" unitRef="usd">-3479128.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertibleDebt id="f50" decimals="0" contextRef="c4" unitRef="usd">68667.0</us-gaap:ConvertibleDebt>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="f51" contextRef="c12">&lt;p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z69rx47LiPt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zkqlXPIzHFN4"&gt;Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment are carried at cost. Expenditures
for renewals and betterments that extend the useful lives of property, equipment or leasehold improvements are capitalized. Expenditures
for maintenance and repairs are charged to expense as incurred. Depreciation is calculated using the straight-line method for financial
reporting purposes based on the following estimated useful lives:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--PropertyPlantAndEquipmentUsefulLifeTextBlock_zmNeau8MZivk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zOA5hmjon6t9" style="display: none"&gt;Schedule of estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 35%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Classification&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 65%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #EEEEEE"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z8elNfWLgwZe" title="Property and equipment, useful live"&gt;5 - 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MedicalEquipmentMember_zNVhPkdecQtb" title="Property and equipment, useful live"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #EEEEEE"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z6OXlvIpluw7" title="Property and equipment, useful live"&gt;10 years or lease term, if shorter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <cardifflexington.com:MezzanineEquity id="f52" decimals="0" contextRef="c36" unitRef="usd">4625002.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:EarningsPerShareBasic id="f53" decimals="INF" contextRef="c37" unitRef="usd1">136.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised id="f54" decimals="INF" contextRef="c38" unitRef="shares">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
  <us-gaap:GoodwillImpairmentLossNetOfTax id="f55" decimals="0" contextRef="c33" unitRef="usd">2092048.0</us-gaap:GoodwillImpairmentLossNetOfTax>
  <us-gaap:EarningsPerShareBasic id="f56" decimals="INF" contextRef="c39" unitRef="usd1">-1.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:ShortTermBorrowings id="f57" decimals="0" contextRef="c40" unitRef="usd">123192.0</us-gaap:ShortTermBorrowings>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f58" contextRef="c41">2021-04-26</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities id="f59" decimals="0" contextRef="c42" unitRef="usd">238285.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
  <us-gaap:InterestExpenseDebt id="f60" decimals="0" contextRef="c43" unitRef="usd">19507.0</us-gaap:InterestExpenseDebt>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f61" decimals="0" contextRef="c44" unitRef="usd">3906889.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount id="f62" decimals="0" contextRef="c3" unitRef="usd">1500000.0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
  <cardifflexington.com:RepaymentsToDirectorsAndOfficers id="f63" decimals="0" contextRef="c12" unitRef="usd">2195.0</cardifflexington.com:RepaymentsToDirectorsAndOfficers>
  <us-gaap:AccruedBonusesCurrent id="f64" decimals="0" contextRef="c45" unitRef="usd">2365500.0</us-gaap:AccruedBonusesCurrent>
  <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax id="f65" decimals="0" contextRef="c12" unitRef="usd">-86520.0</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
  <cardifflexington.com:ConversionAndNoteIssuanceCost id="f66" decimals="0" contextRef="c44" unitRef="usd">0.0</cardifflexington.com:ConversionAndNoteIssuanceCost>
  <cardifflexington.com:AccruedInterest id="f67" decimals="0" contextRef="c46" unitRef="usd">1605.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:LiabilitiesCurrent1 id="f68" decimals="0" contextRef="c47" unitRef="usd">11439675.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:RepaymentsOfConvertibleDebt id="f69" decimals="0" contextRef="c44" unitRef="usd">5908.0</us-gaap:RepaymentsOfConvertibleDebt>
  <us-gaap:OperatingIncomeLoss id="f70" decimals="0" contextRef="c44" unitRef="usd">3906889.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:AccruedBonusesCurrent id="f71" decimals="0" contextRef="c48" unitRef="usd">1870500.0</us-gaap:AccruedBonusesCurrent>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f72" decimals="0" contextRef="c27" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:StockholdersEquity id="f73" decimals="0" contextRef="c49" unitRef="usd">-65166264.0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityReverseStockSplit id="f74" contextRef="c50">1-for-75,000
reverse split</us-gaap:StockholdersEquityReverseStockSplit>
  <us-gaap:StockholdersEquity id="f75" decimals="0" contextRef="c7" unitRef="usd">732360.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:MezzanineEquity id="f76" decimals="0" contextRef="c51" unitRef="usd">274982.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:DividendsPreferredStock id="f77" decimals="0" contextRef="c52" unitRef="usd">125744.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromConvertibleDebt id="f78" decimals="0" contextRef="c9" unitRef="usd">25000.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:DebtDisclosureTextBlock id="f79" contextRef="c12">&lt;p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zluOco3w8hPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_825_zj7CpW1QN5A"&gt;NOTES AND LOANS PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Notes payable at December 31, 2023 and 2022,
respectively, are summarized as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDebtTableTextBlock_zeF8pjqFNBw6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES AND LOANS PAYABLE (Details - Notes Payable)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B5_zCdZej4qx5V" style="display: none"&gt;Schedule of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_490_20231231_zAokPpERJEVg" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49C_20221231_zuBpNHTTJ5a7" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Notes and loans payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,280,743&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;155,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NotesAndLoansPayableCurrent_iNI_pp0p0_di_zObZYjNZ0GSd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,136,077&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(15,809&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermNotesAndLoans_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long-term portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;144,666&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;139,789&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Long-term debt matures as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z5gYPfcvmrB9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES AND LOANS PAYABLE (Details - Long term debt maturity)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BD_z0P4v9VUBir6" style="display: none"&gt;Schedule of maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49B_20231231_z0K9Q7H2ZMja" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_z6CNyV1yjgPg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,136,077&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_zgH9ThDBJvHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_zJZv8F7jrCP7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_zFBy7iPT7tFd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_zkV0g5hdnpkg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_zfadzjwexIG6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;124,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebt_iI_pp0p0_zmQgOXdQuUZ2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,280,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Loans and Notes Payable  Unrelated Party&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 12, 2009, the Company issued a debenture
in the principal amount of $20,000. The debenture bore interest at 12% per year and matured on September 12, 2009. The balance of the
debenture was $&lt;span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--LoansAndNotesPayableMember_zM4UP7uIo0Qf" title="Notes payable outstanding"&gt;&lt;span id="xdx_90B_eus-gaap--NotesPayable_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansAndNotesPayableMember_zNJFh7XLMj68" title="Notes payable outstanding"&gt;10,989&lt;/span&gt;&lt;/span&gt; at December 31, 2023 and 2022. The accrued interest of the debenture was $&lt;span id="xdx_905_ecustom--AccruedInterests_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--LoansAndNotesPayableMember_z8zQGyDw0R08" title="Accrued interest"&gt;7,547&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--AccruedInterests_c20221231__us-gaap--LongtermDebtTypeAxis__custom--LoansAndNotesPayableMember_pp0p0" title="Accrued interest"&gt;6,229&lt;/span&gt; at December 31, 2023
and 2022, respectively. The Company assigned all of its receivables from consumer activations of the rewards program as collateral on
this debenture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Small Business Administration (SBA)
Loans&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 2, 2020, the Company obtained an SBA loan
in the principal amount of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromLoans_pp0p0_c20200601__20200602__us-gaap--LongtermDebtTypeAxis__custom--SBALoanMember_zQyYLkn16Ch5" title="Proceeds from loans"&gt;150,000&lt;/span&gt; with an interest rate of &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20200601__20200602__us-gaap--LongtermDebtTypeAxis__custom--SBALoanMember_zx6oV0nEJIni" title="Interest rate"&gt;3.75&lt;/span&gt;% and a maturity date of June 2, 2050. The principal balance and accrued
interest at December 31, 2023 was $&lt;span id="xdx_90D_eus-gaap--LoansPayable_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--SBALoanMember_z4PO8TQPR95g" title="Loan payable"&gt;149,655&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--AccruedInterests_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--SBALoanMember_z239yn0qCWY8" title="Accrued interest"&gt;956&lt;/span&gt;, respectively, and principal and accrued interest at December 31, 2022 was $&lt;span id="xdx_905_eus-gaap--LoansPayable_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SBALoanMember_pp0p0" title="Loan payable"&gt;144,609&lt;/span&gt;
and $&lt;span id="xdx_90A_ecustom--AccruedInterests_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SBALoanMember_pp0p0" title="Accrued interest"&gt;5,723&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Line of Credit&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 29, 2023, the Company and Nova
entered into a two-year revolving purchase and security agreement with DML HC Series, LLC to sell, with recourse, Novas
accounts receivables for a revolving financing up to a maximum advance amount of $&lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20230929_zv3uAB2sweSf" title="Line of credit maximum borrowing capacity"&gt;4.5&lt;/span&gt;
million. As of December 31, 2023, the Company had $&lt;span id="xdx_90A_eus-gaap--LineOfCredit_iI_pp0p0_c20231231_zSChLFakvPRd" title="Line of credit outstanding balance"&gt;2,120,100&lt;/span&gt;
outstanding balance against the revolving receivable line of credit. The revolving purchase and security agreement includes
discounts recorded as interest expense on each funding and matures on &lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityExpirationDate1_pp0p0_dd_c20230928__20231231_zXtXQ8vgE7g9" title="Line of credit maturity date"&gt;September
29, 2025&lt;/span&gt;.&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:ConvertibleDebt id="f80" decimals="0" contextRef="c31" unitRef="usd">50000.0</us-gaap:ConvertibleDebt>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities id="f81" decimals="0" contextRef="c11" unitRef="usd">159700.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f82" decimals="0" contextRef="c53" unitRef="usd">2176224.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasic id="f83" decimals="INF" contextRef="c54" unitRef="usd1">272.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="f84" decimals="INF" contextRef="c53" unitRef="usd1">167.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:DebtInstrumentMaturityDate id="f85" contextRef="c41">2022-04-26</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:EarningsPerShareDiluted id="f86" decimals="INF" contextRef="c54" unitRef="usd1">272.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:StockholdersEquity id="f87" decimals="0" contextRef="c55" unitRef="usd">-299662.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:AccruedInterest id="f88" decimals="0" contextRef="c56" unitRef="usd">187.0</cardifflexington.com:AccruedInterest>
  <us-gaap:DepreciationAndAmortization id="f89" decimals="0" contextRef="c12" unitRef="usd">20777.0</us-gaap:DepreciationAndAmortization>
  <cardifflexington.com:LiabilitiesCurrent1 id="f90" decimals="0" contextRef="c57" unitRef="usd">10745097.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:AccruedBonusesCurrent id="f91" decimals="0" contextRef="c58" unitRef="usd">2350500.0</us-gaap:AccruedBonusesCurrent>
  <cardifflexington.com:LossOnDivestitureOfSubsidiary id="f92" decimals="0" contextRef="c22" unitRef="usd">-0.0</cardifflexington.com:LossOnDivestitureOfSubsidiary>
  <cardifflexington.com:AccruedInterest id="f93" decimals="0" contextRef="c59" unitRef="usd">64929.0</cardifflexington.com:AccruedInterest>
  <us-gaap:EarningsPerShareDiluted id="f94" decimals="INF" contextRef="c60" unitRef="usd1">1.0</us-gaap:EarningsPerShareDiluted>
  <dei:AuditorName id="f95" contextRef="c12">GRASSI &amp; CO., CPAs, PC</dei:AuditorName>
  <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital id="f96" decimals="0" contextRef="c8" unitRef="usd">5890104.0</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f97" decimals="0" contextRef="c44" unitRef="usd">300000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock>
  <us-gaap:AccruedBonusesCurrent id="f98" decimals="0" contextRef="c61" unitRef="usd">1863000.0</us-gaap:AccruedBonusesCurrent>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="f99" decimals="0" contextRef="c12" unitRef="usd">25000.0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f100" decimals="0" contextRef="c46" unitRef="usd">4863.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:StockholdersEquity id="f101" decimals="0" contextRef="c62" unitRef="usd">486840.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLoss id="f102" decimals="0" contextRef="c28" unitRef="usd">2781608.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:MezzanineEquity id="f103" decimals="0" contextRef="c63" unitRef="usd">4899984.0</cardifflexington.com:MezzanineEquity>
  <cardifflexington.com:DividendOnPreferredStock1 id="f104" decimals="0" contextRef="c12" unitRef="usd">0.0</cardifflexington.com:DividendOnPreferredStock1>
  <us-gaap:IncomeTaxPolicyTextBlock id="f105" contextRef="c12">&lt;p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zSBknmBorPi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zDu2EIpL31D9"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income taxes are determined in accordance with
ASC Topic 740, Income Taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax
basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years
in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 740 prescribes a comprehensive model for how
companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to
be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely
than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be
measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the
tax authority assuming full knowledge of the position and relevant facts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended December 31, 2023 and 2022,
the Company did not have any interest and penalties associated with tax positions and did &lt;span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zp7DrnNjADzd" title="Uncertain tax positions"&gt;&lt;span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zXewDvvHcI5f" title="Uncertain tax positions"&gt;no&lt;/span&gt;&lt;/span&gt;t have any significant unrecognized uncertain
tax positions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:PreferredStockSharesOutstanding id="f106" decimals="INF" contextRef="c64" unitRef="shares">2139478.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:InterestExpenseDebt id="f107" decimals="0" contextRef="c65" unitRef="usd">614.0</us-gaap:InterestExpenseDebt>
  <us-gaap:LongTermDebt id="f108" decimals="0" contextRef="c8" unitRef="usd">2280743.0</us-gaap:LongTermDebt>
  <us-gaap:ConvertibleDebt id="f109" decimals="0" contextRef="c66" unitRef="usd">168866.0</us-gaap:ConvertibleDebt>
  <us-gaap:Assets id="f110" decimals="0" contextRef="c67" unitRef="usd">14284585.0</us-gaap:Assets>
  <us-gaap:DividendsPreferredStock id="f111" decimals="0" contextRef="c68" unitRef="usd">384170.0</us-gaap:DividendsPreferredStock>
  <us-gaap:EarningsPerShareBasic id="f112" decimals="INF" contextRef="c6" unitRef="usd1">-2.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:DepreciationAndAmortization id="f113" decimals="0" contextRef="c44" unitRef="usd">23132.0</us-gaap:DepreciationAndAmortization>
  <cardifflexington.com:LiabilitiesCurrent1 id="f114" decimals="0" contextRef="c69" unitRef="usd">0.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:DebtCurrent id="f115" decimals="0" contextRef="c27" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f116" decimals="0" contextRef="c70" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:LossOnDivestitureOfSubsidiary id="f117" decimals="0" contextRef="c33" unitRef="usd">217769.0</cardifflexington.com:LossOnDivestitureOfSubsidiary>
  <cardifflexington.com:AccruedInterest id="f118" decimals="0" contextRef="c71" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:AccruedBonusesCurrent id="f119" decimals="0" contextRef="c72" unitRef="usd">156000.0</us-gaap:AccruedBonusesCurrent>
  <us-gaap:AccruedPayrollTaxesCurrent id="f120" decimals="0" contextRef="c21" unitRef="usd">0.0</us-gaap:AccruedPayrollTaxesCurrent>
  <us-gaap:EarningsPerShareBasic id="f121" decimals="INF" contextRef="c" unitRef="usd1">-28.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital id="f122" decimals="0" contextRef="c21" unitRef="usd">4899984.0</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
  <us-gaap:DividendsPreferredStock id="f123" decimals="0" contextRef="c73" unitRef="usd">133971.0</us-gaap:DividendsPreferredStock>
  <us-gaap:AccountsPayableCurrent id="f124" decimals="0" contextRef="c8" unitRef="usd">720774.0</us-gaap:AccountsPayableCurrent>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f125" contextRef="c23">2023-08-11</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStockShares id="f126" decimals="INF" contextRef="c74" unitRef="shares">818750.0</cardifflexington.com:IssuanceOfSeriesJPreferredStockShares>
  <us-gaap:InterestExpenseDebt id="f127" decimals="0" contextRef="c75" unitRef="usd">6867.0</us-gaap:InterestExpenseDebt>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="f128" decimals="0" contextRef="c44" unitRef="usd">0.0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:EarningsPerShareDiluted id="f129" decimals="INF" contextRef="c" unitRef="usd1">-28.0</us-gaap:EarningsPerShareDiluted>
  <cardifflexington.com:PropertyPlantAndEquipmentEstimatedUsefulLives1 id="f130" contextRef="c76">10 years</cardifflexington.com:PropertyPlantAndEquipmentEstimatedUsefulLives1>
  <us-gaap:EarningsPerShareDiluted id="f131" decimals="INF" contextRef="c14" unitRef="usd1">1.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:AccruedBonusesCurrent id="f132" decimals="0" contextRef="c77" unitRef="usd">17057.0</us-gaap:AccruedBonusesCurrent>
  <us-gaap:ConvertibleDebt id="f133" decimals="0" contextRef="c78" unitRef="usd">2600000.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:AccruedTaxesPenaltiesAndInterest id="f134" decimals="0" contextRef="c8" unitRef="usd">5346.0</cardifflexington.com:AccruedTaxesPenaltiesAndInterest>
  <cardifflexington.com:DividendOnPreferredStock1 id="f135" decimals="0" contextRef="c44" unitRef="usd">-102740.0</cardifflexington.com:DividendOnPreferredStock1>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f136" decimals="0" contextRef="c59" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:InterestExpenseDebt id="f137" decimals="0" contextRef="c79" unitRef="usd">8284.0</us-gaap:InterestExpenseDebt>
  <us-gaap:CostOfRevenue id="f138" decimals="0" contextRef="c22" unitRef="usd">59453.0</us-gaap:CostOfRevenue>
  <us-gaap:AccruedBonusesCurrent id="f139" decimals="0" contextRef="c80" unitRef="usd">17057.0</us-gaap:AccruedBonusesCurrent>
  <cardifflexington.com:AccruedTaxesPenaltiesAndInterest id="f140" decimals="0" contextRef="c21" unitRef="usd">6732.0</cardifflexington.com:AccruedTaxesPenaltiesAndInterest>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="f141" contextRef="c12">&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zgfiXiwtk898" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zNh80TzMl9A6"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The FASB issuedASU 2023-07 on November
27, 2023. The amendments improve reportable segment disclosure requirements, primarily through enhanced disclosures about
significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in
which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities
with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable
investors to better understand an entitys overall performance and assess potential future cash
flows. The Management is evaluating the impact of ASU 2023-07 on the consolidated financial statements and does not expect
there to be any changes or impact to the financial statements.&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <dei:AuditorLocation id="f142" contextRef="c12">Jericho, New York</dei:AuditorLocation>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f143" decimals="0" contextRef="c23" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:LiabilitiesCurrent1 id="f144" decimals="0" contextRef="c67" unitRef="usd">10745097.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="f145" contextRef="c12">&lt;p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zcdp3WEdol4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_821_zmue00uB8f4b"&gt;PLANT AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment as of December 31, 2023
and 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKvb71M0rNV8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PLANT AND EQUIPMENT, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B3_zxBQzY278aqk" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_499_20231231_znnZNyQ4emLj" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49E_20221231_ztvOQgixoqo2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--MedicalEquipment_iI_maCz0Bq_z4sAZgvkjv75" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Medical equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;96,532&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;96,532&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--MachineryAndEquipmentGross_iI_maCz0Bq_zqGDw9B30J56" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Computer Equipment&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FurnitureAndFixturesGross_iI_maCz0Bq_zbXXEmSdlDal" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Furniture, fixtures and equipment&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LeaseholdImprovementsGross_iI_maCz0Bq_zmRYLh1ai0Ec" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold Improvement&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;15,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;15,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iTI_mtCz0Bq_maCz0Z3_zHiQe7NmAmwg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;136,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;141,883&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msCz0Z3_zWr7HOjEkkz3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(102,089&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(86,444&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtCz0Z3_z51UIa4RP37j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;34,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;55,439&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended December 31, 2023 and 2022,
depreciation expense was $&lt;span id="xdx_90C_eus-gaap--Depreciation_c20230101__20231231_z4LmZcsrMBmk" title="Depreciation expense"&gt;20,777&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--Depreciation_c20220101__20221231_zAB7TPdsWXml" title="Depreciation expense"&gt;23,132&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:EarningsPerShareBasic id="f146" decimals="INF" contextRef="c28" unitRef="usd1">165.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:ScheduleOfDebtTableTextBlock id="f147" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfDebtTableTextBlock_zeF8pjqFNBw6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES AND LOANS PAYABLE (Details - Notes Payable)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B5_zCdZej4qx5V" style="display: none"&gt;Schedule of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_490_20231231_zAokPpERJEVg" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49C_20221231_zuBpNHTTJ5a7" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Notes and loans payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,280,743&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;155,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NotesAndLoansPayableCurrent_iNI_pp0p0_di_zObZYjNZ0GSd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,136,077&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(15,809&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermNotesAndLoans_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long-term portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;144,666&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;139,789&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:InterestExpenseDebt id="f148" decimals="0" contextRef="c41" unitRef="usd">27787.0</us-gaap:InterestExpenseDebt>
  <us-gaap:AccountsPayableCurrent id="f149" decimals="0" contextRef="c21" unitRef="usd">342331.0</us-gaap:AccountsPayableCurrent>
  <us-gaap:ProceedsFromConvertibleDebt id="f150" decimals="0" contextRef="c41" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f151" contextRef="c65">2023-07-24</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f152" decimals="0" contextRef="c74" unitRef="usd">3275000.0</cardifflexington.com:IssuanceOfSeriesJPreferredStock>
  <us-gaap:AllowanceForDoubtfulAccountsReceivable id="f153" decimals="0" contextRef="c21" unitRef="usd">0.0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="f154" decimals="0" contextRef="c12" unitRef="usd">3076820.0</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f155" decimals="0" contextRef="c9" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:GainOnChangeOfEstimate id="f156" decimals="0" contextRef="c22" unitRef="usd">0.0</cardifflexington.com:GainOnChangeOfEstimate>
  <us-gaap:InterestExpenseDebt id="f157" decimals="0" contextRef="c10" unitRef="usd">6658.0</us-gaap:InterestExpenseDebt>
  <us-gaap:DebtInstrumentMaturityDate id="f158" contextRef="c23">2024-08-11</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:SalariesWagesAndOfficersCompensation id="f159" decimals="0" contextRef="c81" unitRef="usd">372000.0</us-gaap:SalariesWagesAndOfficersCompensation>
  <cardifflexington.com:GainOnForgivenessOfDebt id="f160" decimals="0" contextRef="c12" unitRef="usd">115448.0</cardifflexington.com:GainOnForgivenessOfDebt>
  <us-gaap:CostOfRevenue id="f161" decimals="0" contextRef="c33" unitRef="usd">462556.0</us-gaap:CostOfRevenue>
  <cardifflexington.com:CancellationOfCommonStock id="f162" decimals="0" contextRef="c82" unitRef="usd">-35097.0</cardifflexington.com:CancellationOfCommonStock>
  <us-gaap:EarningsPerShareDiluted id="f163" decimals="INF" contextRef="c37" unitRef="usd1">2.0</us-gaap:EarningsPerShareDiluted>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockShares id="f164" decimals="INF" contextRef="c83" unitRef="shares">8150.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockShares>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f165" decimals="0" contextRef="c52" unitRef="usd">690334.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ConvertibleDebt id="f166" decimals="0" contextRef="c84" unitRef="usd">68667.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:GainLossOnDisposalOfStock id="f167" decimals="0" contextRef="c85" unitRef="usd">-217769.0</cardifflexington.com:GainLossOnDisposalOfStock>
  <cardifflexington.com:AccruedInterest id="f168" decimals="0" contextRef="c4" unitRef="usd">7054.0</cardifflexington.com:AccruedInterest>
  <us-gaap:EarningsPerShareBasic id="f169" decimals="INF" contextRef="c26" unitRef="usd1">244.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="f170" decimals="INF" contextRef="c86" unitRef="shares">18750.0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:SalariesWagesAndOfficersCompensation id="f171" decimals="0" contextRef="c87" unitRef="usd">450000.0</us-gaap:SalariesWagesAndOfficersCompensation>
  <us-gaap:EarningsPerShareDiluted id="f172" decimals="INF" contextRef="c26" unitRef="usd1">244.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="f173" decimals="0" contextRef="c12" unitRef="usd">0.0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:PreferredStockSharesAuthorized id="f174" decimals="INF" contextRef="c88" unitRef="shares">500.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ProceedsFromConvertibleDebt id="f175" decimals="0" contextRef="c23" unitRef="usd">25000.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:PreferredStockSharesAuthorized id="f176" decimals="INF" contextRef="c89" unitRef="shares">500.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:SalariesWagesAndOfficersCompensation id="f177" decimals="0" contextRef="c90" unitRef="usd">372000.0</us-gaap:SalariesWagesAndOfficersCompensation>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="f178" decimals="0" contextRef="c44" unitRef="usd">2703141.0</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeLossFromContinuingOperations id="f179" decimals="0" contextRef="c44" unitRef="usd">-5429521.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:AccruedIncomeTaxes id="f180" decimals="0" contextRef="c21" unitRef="usd">6732.0</us-gaap:AccruedIncomeTaxes>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f181" decimals="INF" contextRef="c27" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f182" contextRef="c91">2020-11-02</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:GainOnChangeOfEstimate id="f183" decimals="0" contextRef="c33" unitRef="usd">-4474.0</cardifflexington.com:GainOnChangeOfEstimate>
  <us-gaap:PropertyPlantAndEquipmentNet id="f184" decimals="0" contextRef="c21" unitRef="usd">55439.0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:DebtInstrumentMaturityDate id="f185" contextRef="c65">2024-07-24</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:ConvertibleDebt id="f186" decimals="0" contextRef="c92" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:ScheduleOfAnnualObjectiveOfFinancialPerformanceTableTextBlock id="f187" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfAnnualObjectiveOfFinancialPerformanceTableTextBlock_zd0QjV6s3Yik" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details - Financial performance goals)"&gt;
  &lt;tr&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B4_z66GagkW3ZZ" style="display: none"&gt;Schedule of annual objectives of financial performance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 35%"&gt;&lt;span style="font-size: 10pt"&gt;Minimum Annual Nova EBITDA&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 25%"&gt;&lt;span style="font-size: 10pt"&gt;Cash Annual Bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 25%; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series J Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_90A_ecustom--MinimumAnnualAmount_iI_pn6n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2021Member_z93cW7XP62Y2" title="Minimum Annual Nova EBITDA"&gt;2&lt;/span&gt;.0M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2021Member_zkxYrKWVejOf" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$120,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2021Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zk36Oh3kCBOf" title="Shares"&gt;120,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_901_ecustom--MinimumAnnualAmount_iI_pn5n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2022Member_zbPW2A56ilSi" title="Minimum Annual Nova EBITDA"&gt;2.4&lt;/span&gt;M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2022Member_zMmNxpCtlV68" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$150,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2022Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zLbD2ksxCoY" title="Shares"&gt;135,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--MinimumAnnualAmount_iI_pn5n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2023Member_zBmDLHtAgG44" title="Minimum Annual Nova EBITDA"&gt;3.7&lt;/span&gt;M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2023Member_zgJOx5ibjc87" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$210,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2023Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zwpavuyA5IAg" title="Shares"&gt;150,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--MinimumAnnualAmount_iI_pn5n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2024Member_zWSA0OHHBjJd" title="Minimum Annual Nova EBITDA"&gt;5.5&lt;/span&gt;M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2024Member_zULyBCDnr17h" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zPuRjBpK9Qud" title="Shares"&gt;180,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_906_ecustom--MinimumAnnualAmount_iI_pn6n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2025Member_zEqiOY2GguP3" title="Minimum Annual Nova EBITDA"&gt;8&lt;/span&gt;.0M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2025Member_zEkT3W3mqROc" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$420,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2025Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zDkugtaqgvye" title="Shares"&gt;210,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</cardifflexington.com:ScheduleOfAnnualObjectiveOfFinancialPerformanceTableTextBlock>
  <cardifflexington.com:GainOnForgivenessOfDebt id="f188" decimals="0" contextRef="c44" unitRef="usd">-0.0</cardifflexington.com:GainOnForgivenessOfDebt>
  <us-gaap:EarningsPerSharePolicyTextBlock id="f189" contextRef="c12">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zCZWYPQPJYzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zyIaYTsDZib7"&gt;Income (Loss) per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;FASB ASC Subtopic 260, &lt;i&gt;Earnings Per Share&lt;/i&gt;,
provides for the calculation of Basic and Diluted earnings per share. Basic earnings per common share is computed
by dividing income available to common stockholders by the weighted-average number of shares of common stock outstanding during the period.
Diluted earnings per common share is computed by dividing income available to common stockholders by the weighted-average number of shares
of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been
outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options,
warrants, and debts convertible into common stock. The dilutive effect of stock options and warrants are reflected in diluted earnings
per common share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of
the Companys common stock can result in a greater dilutive effect from potentially dilutive securities. The diluted effect of debt
convertibles is reflected utilizing the if converted method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:SharesOutstanding id="f190" decimals="INF" contextRef="c93" unitRef="shares">23085563.0</us-gaap:SharesOutstanding>
  <cardifflexington.com:CancellationOfCommonStock id="f191" decimals="0" contextRef="c94" unitRef="usd">35097.0</cardifflexington.com:CancellationOfCommonStock>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f192" decimals="0" contextRef="c83" unitRef="usd">12600.0</cardifflexington.com:IssuanceOfPreferredStockSeriesB>
  <us-gaap:AllowanceForDoubtfulAccountsReceivable id="f193" decimals="0" contextRef="c8" unitRef="usd">122190.0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f194" decimals="INF" contextRef="c88" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f195" decimals="0" contextRef="c34" unitRef="usd">-8227.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:AccruedCreditCards id="f196" decimals="0" contextRef="c8" unitRef="usd">26645.0</cardifflexington.com:AccruedCreditCards>
  <us-gaap:ConvertibleDebt id="f197" decimals="0" contextRef="c13" unitRef="usd">113667.0</us-gaap:ConvertibleDebt>
  <us-gaap:DebtCurrent id="f198" decimals="0" contextRef="c95" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:EarningsPerShareDiluted id="f199" decimals="INF" contextRef="c53" unitRef="usd1">2.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f200" decimals="INF" contextRef="c89" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f201" decimals="0" contextRef="c94" unitRef="usd">-75000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution>
  <cardifflexington.com:AccruedInterest id="f202" decimals="0" contextRef="c31" unitRef="usd">6658.0</cardifflexington.com:AccruedInterest>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="f203" decimals="0" contextRef="c44" unitRef="usd">25000.0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f204" decimals="INF" contextRef="c96" unitRef="shares">67500.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="f205" decimals="0" contextRef="c22" unitRef="usd">332005.0</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:CommonStockValue id="f206" decimals="0" contextRef="c21" unitRef="usd">824793.0</us-gaap:CommonStockValue>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f207" decimals="0" contextRef="c44" unitRef="usd">-3250638.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f208" decimals="0" contextRef="c4" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:NetIncomeLoss id="f209" decimals="0" contextRef="c6" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:DividendsPreferredStock id="f210" decimals="0" contextRef="c53" unitRef="usd">605384.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ConvertibleDebt id="f211" decimals="0" contextRef="c97" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:StockholdersEquity id="f212" decimals="0" contextRef="c93" unitRef="usd">59548201.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:BonusStockToBeIssuedShares id="f213" decimals="INF" contextRef="c98" unitRef="shares">150000.0</cardifflexington.com:BonusStockToBeIssuedShares>
  <us-gaap:IncomeLossFromContinuingOperations id="f214" decimals="0" contextRef="c99" unitRef="usd">5973233.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:DebtInstrumentMaturityDate id="f215" contextRef="c91">2021-08-31</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="f216" decimals="INF" contextRef="c100" unitRef="shares">3150.0</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f217" decimals="0" contextRef="c73" unitRef="usd">682107.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:AccruedCreditCards id="f218" decimals="0" contextRef="c21" unitRef="usd">6994.0</cardifflexington.com:AccruedCreditCards>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="f219" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKvb71M0rNV8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PLANT AND EQUIPMENT, NET (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B3_zxBQzY278aqk" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_499_20231231_znnZNyQ4emLj" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49E_20221231_ztvOQgixoqo2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--MedicalEquipment_iI_maCz0Bq_z4sAZgvkjv75" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Medical equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;96,532&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;96,532&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--MachineryAndEquipmentGross_iI_maCz0Bq_zqGDw9B30J56" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Computer Equipment&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FurnitureAndFixturesGross_iI_maCz0Bq_zbXXEmSdlDal" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Furniture, fixtures and equipment&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LeaseholdImprovementsGross_iI_maCz0Bq_zmRYLh1ai0Ec" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Leasehold Improvement&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;15,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;15,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iTI_mtCz0Bq_maCz0Z3_zHiQe7NmAmwg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;136,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;141,883&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msCz0Z3_zWr7HOjEkkz3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(102,089&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(86,444&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtCz0Z3_z51UIa4RP37j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;34,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;55,439&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:PreferredStockSharesIssued id="f220" decimals="INF" contextRef="c88" unitRef="shares">123.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:OperatingExpenses id="f221" decimals="0" contextRef="c12" unitRef="usd">3097597.0</us-gaap:OperatingExpenses>
  <us-gaap:ConvertibleDebt id="f222" decimals="0" contextRef="c27" unitRef="usd">25000.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:GainOnReversalOfRrtLiability id="f223" decimals="0" contextRef="c22" unitRef="usd">0.0</cardifflexington.com:GainOnReversalOfRrtLiability>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f224" contextRef="c43">2020-09-03</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:PreferredStockSharesOutstanding id="f225" decimals="INF" contextRef="c88" unitRef="shares">123.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:EarningsPerShareDiluted id="f226" decimals="INF" contextRef="c6" unitRef="usd1">1.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:StockIssuedDuringPeriodValueOther id="f227" decimals="0" contextRef="c100" unitRef="usd">25000.0</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="f228" decimals="0" contextRef="c33" unitRef="usd">1094121.0</us-gaap:SellingGeneralAndAdministrativeExpense>
  <cardifflexington.com:AccruedInterest id="f229" decimals="0" contextRef="c1" unitRef="usd">1469.0</cardifflexington.com:AccruedInterest>
  <us-gaap:StockholdersEquity id="f230" decimals="0" contextRef="c36" unitRef="usd">-1469809.0</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockSharesIssued id="f231" decimals="INF" contextRef="c89" unitRef="shares">123.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:OtherIncome id="f232" decimals="0" contextRef="c12" unitRef="usd">-49795.0</us-gaap:OtherIncome>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f233" decimals="0" contextRef="c41" unitRef="usd">-168866.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:PreferredStockSharesOutstanding id="f234" decimals="INF" contextRef="c89" unitRef="shares">123.0</us-gaap:PreferredStockSharesOutstanding>
  <cardifflexington.com:GoingConcernPolicyTextBlock id="f235" contextRef="c12">&lt;p id="xdx_84B_ecustom--GoingConcernPolicyTextBlock_zLvenyvwvAeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zEUKaBIiLKH1"&gt;Going Concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial statements
have been prepared using the going concern basis of accounting, which contemplates continuity of operations, realization of assets and
liabilities and commitments in the normal course of business. The Company had previously sustained operating losses since its inception,
has an accumulated deficit of $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20231231_zlX72OBegjPf" title="Accumulated deficit"&gt;68,684,115&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20221231_zarF75w7bzKk" title="Accumulated deficit"&gt;70,932,435&lt;/span&gt;, respectively, as of December 31, 2023 and 2022. We had negative cash flow from
operations of $&lt;span id="xdx_907_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iN_di_c20230101__20231231_zQWxJ9bOSo7" title="Cash flow from operations"&gt;1,807,987&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iN_di_c20220101__20221231_zhuYbUHOMUch" title="Cash flow from operations"&gt;1,099,461&lt;/span&gt; during the years ended December 31, 2023 and 2022. These factors raise a substantial doubt about
the Companys ability to continue as a going concern. The accompanying consolidated financial statements do not reflect any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might
result if the Company is unable to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The ability of the Company to continue as a going
concern and the appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusions. Management
has prospective investors and believes the raising of capital will allow the Company to fund its cash flow shortfalls and pursue new acquisitions.
There can be no assurance that the Company will be able to obtain sufficient capital from debt or equity transactions or from operations
in the necessary time frame or on terms acceptable to it. Should the Company be unable to raise sufficient funds, it may be required to
curtail its operating plans. In addition, increases in expenses may require cost reductions. No assurance can be given that the Company
will be able to operate profitably on a consistent basis, or at all, in the future. Should the Company not be able to raise sufficient
funds, it may cause cessation of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</cardifflexington.com:GoingConcernPolicyTextBlock>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="f236" decimals="0" contextRef="c44" unitRef="usd">-2178883.0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DividendsPreferredStock id="f237" decimals="0" contextRef="c101" unitRef="usd">76982.0</us-gaap:DividendsPreferredStock>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f238" decimals="0" contextRef="c31" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:StockRedeemedOrCalledDuringPeriodShares id="f239" decimals="INF" contextRef="c102" unitRef="shares">175045.0</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
  <cardifflexington.com:MezzanineEquity id="f240" decimals="0" contextRef="c7" unitRef="usd">3125004.0</cardifflexington.com:MezzanineEquity>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f241" decimals="0" contextRef="c44" unitRef="usd">150000.0</cardifflexington.com:CancellationOfSeriesDPreferredStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="f242" decimals="0" contextRef="c12" unitRef="usd">2369325.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:SharesOutstanding id="f243" decimals="INF" contextRef="c103" unitRef="shares">3595952.0</us-gaap:SharesOutstanding>
  <us-gaap:AccruedPayrollTaxesCurrent id="f244" decimals="0" contextRef="c8" unitRef="usd">17472.0</us-gaap:AccruedPayrollTaxesCurrent>
  <us-gaap:IncomeLossFromContinuingOperations id="f245" decimals="0" contextRef="c104" unitRef="usd">74880.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:ConvertibleDebt id="f246" decimals="0" contextRef="c105" unitRef="usd">113167.0</us-gaap:ConvertibleDebt>
  <us-gaap:DividendsPreferredStock id="f247" decimals="0" contextRef="c28" unitRef="usd">630065.0</us-gaap:DividendsPreferredStock>
  <us-gaap:OperatingExpenses id="f248" decimals="0" contextRef="c44" unitRef="usd">2726273.0</us-gaap:OperatingExpenses>
  <cardifflexington.com:GainOnReversalOfRrtLiability id="f249" decimals="0" contextRef="c33" unitRef="usd">510418.0</cardifflexington.com:GainOnReversalOfRrtLiability>
  <us-gaap:InventoryRealEstate id="f250" decimals="0" contextRef="c21" unitRef="usd">540000.0</us-gaap:InventoryRealEstate>
  <us-gaap:PreferredStockSharesIssued id="f251" decimals="INF" contextRef="c64" unitRef="shares">2139478.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockValue id="f252" decimals="0" contextRef="c88" unitRef="usd">488.0</us-gaap:PreferredStockValue>
  <us-gaap:ProceedsFromConvertibleDebt id="f253" decimals="0" contextRef="c65" unitRef="usd">14000.0</us-gaap:ProceedsFromConvertibleDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f254" decimals="0" contextRef="c44" unitRef="usd">25000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="f255" decimals="0" contextRef="c8" unitRef="usd">0.0</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:StockholdersEquity id="f256" decimals="0" contextRef="c51" unitRef="usd">-274982.0</us-gaap:StockholdersEquity>
  <us-gaap:OtherIncome id="f257" decimals="0" contextRef="c44" unitRef="usd">150250.0</us-gaap:OtherIncome>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f258" contextRef="c79">2023-01-24</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f259" decimals="INF" contextRef="c95" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:EarningsPerShareDiluted id="f260" decimals="INF" contextRef="c28" unitRef="usd1">3.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:UseOfEstimates id="f261" contextRef="c12">&lt;p id="xdx_843_eus-gaap--UseOfEstimates_zpwUMQuBCV5i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zeiiyZ3ltjWl"&gt;Use of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements in conformity
with United States generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions
that affect certain reported amounts and disclosures. Management uses its historical records and knowledge of its business in making estimates.
Accordingly, actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
  <cardifflexington.com:AccruedInterest id="f262" decimals="0" contextRef="c30" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:EarningsPerShareBasic id="f263" decimals="INF" contextRef="c52" unitRef="usd1">56.0</us-gaap:EarningsPerShareBasic>
  <cardifflexington.com:MezzanineEquity id="f264" decimals="0" contextRef="c29" unitRef="usd">245520.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="f265" decimals="0" contextRef="c44" unitRef="usd">788794.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:Goodwill id="f266" decimals="0" contextRef="c8" unitRef="usd">5666608.0</us-gaap:Goodwill>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f267" decimals="0" contextRef="c1" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:InterestIncomeExpenseNet id="f268" decimals="0" contextRef="c22" unitRef="usd">-2428.0</us-gaap:InterestIncomeExpenseNet>
  <cardifflexington.com:MezzanineEquity id="f269" decimals="0" contextRef="c57" unitRef="usd">5171861.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:StockholdersEquity id="f270" decimals="0" contextRef="c103" unitRef="usd">14383808.0</us-gaap:StockholdersEquity>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive id="f271" decimals="0" contextRef="c8" unitRef="usd">124710.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
  <cardifflexington.com:AccruedInterest id="f272" decimals="0" contextRef="c97" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockValue id="f273" decimals="0" contextRef="c89" unitRef="usd">488.0</us-gaap:PreferredStockValue>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="f274" decimals="0" contextRef="c21" unitRef="usd">363.0</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:StockholdersEquity id="f275" decimals="0" contextRef="c63" unitRef="usd">-1744791.0</us-gaap:StockholdersEquity>
  <us-gaap:IncomeLossFromContinuingOperations id="f276" decimals="0" contextRef="c106" unitRef="usd">-3716.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:ProceedsFromConvertibleDebt id="f277" decimals="0" contextRef="c91" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="f278" decimals="0" contextRef="c12" unitRef="usd">6701334.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f279" contextRef="c9">2023-03-30</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:DebtInstrumentMaturityDate id="f280" contextRef="c79">2024-03-21</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="f281" decimals="INF" contextRef="c107" unitRef="shares">5000.0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <cardifflexington.com:LossOnSettlement id="f282" decimals="0" contextRef="c22" unitRef="usd">0.0</cardifflexington.com:LossOnSettlement>
  <cardifflexington.com:MezzanineEquity id="f283" decimals="0" contextRef="c47" unitRef="usd">3370524.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:DebtCurrent id="f284" decimals="0" contextRef="c108" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:DebtCurrent id="f285" decimals="0" contextRef="c109" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet id="f286" decimals="0" contextRef="c8" unitRef="usd">34661.0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:InterestIncomeExpenseNet id="f287" decimals="0" contextRef="c33" unitRef="usd">-44027.0</us-gaap:InterestIncomeExpenseNet>
  <cardifflexington.com:AnnualCashBonus id="f288" decimals="0" contextRef="c24" unitRef="usd">300000.0</cardifflexington.com:AnnualCashBonus>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt id="f289" decimals="0" contextRef="c12" unitRef="usd">115448.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <cardifflexington.com:MezzanineEquity id="f290" decimals="0" contextRef="c69" unitRef="usd">283118.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:SharesOutstanding id="f291" decimals="INF" contextRef="c110" unitRef="shares">123.0</us-gaap:SharesOutstanding>
  <us-gaap:EarningsPerShareBasic id="f292" decimals="INF" contextRef="c34" unitRef="usd1">-1.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:ConvertibleDebt id="f293" decimals="0" contextRef="c95" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="f294" decimals="0" contextRef="c107" unitRef="usd">5000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:SharesOutstanding id="f295" decimals="INF" contextRef="c17" unitRef="shares">2215.0</us-gaap:SharesOutstanding>
  <cardifflexington.com:AccruedInterest id="f296" decimals="0" contextRef="c111" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:IncomeLossFromContinuingOperations id="f297" decimals="0" contextRef="c12" unitRef="usd">3028394.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:ReceivablesPolicyTextBlock id="f298" contextRef="c12">&lt;p id="xdx_846_eus-gaap--ReceivablesPolicyTextBlock_z7txKT5t0DYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zYOovuOrftxh"&gt;Accounts Receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company adopted ASU 2016-13, Financial
Instruments  Credit Losses. In accordance with this standard, the Company recognizes an allowance for credit losses for
its trade receivables to present the net amount expected to be collected as of the balance sheet date. This allowance is based on the
credit losses expected to arise over the life of the asset and are based on Current Expected Credit Losses. Accounts receivable is reported
on the balance sheet at the net amounts expected to be collected by the Company. Management closely monitors outstanding accounts receivable
and recognized an additional allowance for credit losses in the amount of $&lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zQLQdAyLxvxh" title="Allowance for credit losses"&gt;122,190&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20221231_zx8fOEs9Fs7c" title="Allowance for credit losses"&gt;0&lt;/span&gt; as of December 31, 2023 and 2022, respectively.
As of December 31, 2023 and 2022, the Company had net accounts receivable of $&lt;span id="xdx_909_eus-gaap--AccountsReceivableNetCurrent_pp0p0_c20231231_z9qQQvHNN9Bg" title="Accounts receivable"&gt;13,305,254&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_c20221231_zLvzC4d3Vlr9" title="Accounts receivable"&gt;6,603,920&lt;/span&gt; respectively. Accounts receivables
are primarily generated from subsidiaries in their normal course of business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
  <us-gaap:AccruedIncomeTaxes id="f299" decimals="0" contextRef="c8" unitRef="usd">5346.0</us-gaap:AccruedIncomeTaxes>
  <us-gaap:InterestExpenseDebt id="f300" decimals="0" contextRef="c9" unitRef="usd">2836.0</us-gaap:InterestExpenseDebt>
  <us-gaap:IncomeLossFromContinuingOperations id="f301" decimals="0" contextRef="c112" unitRef="usd">-19345.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:OtherLongTermNotesPayable id="f302" decimals="0" contextRef="c21" unitRef="usd">139789.0</us-gaap:OtherLongTermNotesPayable>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f303" decimals="INF" contextRef="c113" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ProceedsFromConvertibleDebt id="f304" decimals="0" contextRef="c114" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:OperatingLeaseRightOfUseAsset id="f305" decimals="0" contextRef="c21" unitRef="usd">218926.0</us-gaap:OperatingLeaseRightOfUseAsset>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="f306" decimals="0" contextRef="c44" unitRef="usd">597521.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:NetIncomeLoss id="f307" decimals="0" contextRef="c19" unitRef="usd">-15991.0</us-gaap:NetIncomeLoss>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f308" contextRef="c18">2023-07-19</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:OperatingLeaseLiabilityCurrent id="f309" decimals="0" contextRef="c8" unitRef="usd">157669.0</us-gaap:OperatingLeaseLiabilityCurrent>
  <us-gaap:ConvertibleDebt id="f310" decimals="0" contextRef="c115" unitRef="usd">55000.0</us-gaap:ConvertibleDebt>
  <us-gaap:ConvertibleDebt id="f311" decimals="0" contextRef="c108" unitRef="usd">113166.0</us-gaap:ConvertibleDebt>
  <us-gaap:OperatingLeaseRightOfUseAsset id="f312" decimals="0" contextRef="c8" unitRef="usd">289062.0</us-gaap:OperatingLeaseRightOfUseAsset>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f313" decimals="0" contextRef="c99" unitRef="usd">7300849.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f314" decimals="0" contextRef="c12" unitRef="usd">3114914.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt id="f315" decimals="0" contextRef="c44" unitRef="usd">1397271.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <cardifflexington.com:AccruedInterest id="f316" decimals="0" contextRef="c116" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths id="f317" decimals="0" contextRef="c8" unitRef="usd">2136077.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f318" decimals="0" contextRef="c68" unitRef="usd">-5813691.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasic id="f319" decimals="INF" contextRef="c117" unitRef="usd1">-994.0</us-gaap:EarningsPerShareBasic>
  <cardifflexington.com:BonusStockToBeIssuedShares id="f320" decimals="INF" contextRef="c118" unitRef="shares">120000.0</cardifflexington.com:BonusStockToBeIssuedShares>
  <us-gaap:LiabilitiesCurrent id="f321" decimals="0" contextRef="c8" unitRef="usd">13860567.0</us-gaap:LiabilitiesCurrent>
  <us-gaap:ProceedsFromConvertibleDebt id="f322" decimals="0" contextRef="c10" unitRef="usd">50000.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:OperatingLeaseExpense id="f323" decimals="0" contextRef="c12" unitRef="usd">291040.0</us-gaap:OperatingLeaseExpense>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f324" decimals="0" contextRef="c65" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:Revenues id="f325" decimals="0" contextRef="c106" unitRef="usd">0.0</us-gaap:Revenues>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f326" decimals="0" contextRef="c119" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:Revenues id="f327" decimals="0" contextRef="c120" unitRef="usd">11853266.0</us-gaap:Revenues>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="f328" contextRef="c12">&lt;p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZOWjFLNrDIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_820_zB4kVpahBaO1"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Leases &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 842, Leases, requires that a
lessee recognize the assets and liabilities that arise from operating leases, A lessee should recognize in the statement of financial
position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying
asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by
class of underlying asset not to recognize lease assets and lease liabilities. In transaction, lessees and lessors are required to recognize
and measure leases at either the effective date (the effective date method) or the beginning of the earliest period presented
(the comparative method) using a modified retrospective approach. Under the effective date method, the Companys comparative
period reporting is unchanged. In contrast, under the comparative method, the Companys date of initial application is the beginning
of the earliest comparative period presented, and the Topic 842 transition guidance is then applied to all comparative periods presented.
Further, under either transition method, the standard includes certain practical expedients intended to ease the burden of adoption. The
Company adopted ASC 842, January 1, 2020, using the effective date method and elected certain practical expedients allowing the Company
not to reassess:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;whether expired or existing contracts contain leases under the new definition of a lease;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;lease classification for expired or existing leases; and&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also made the accounting policy decision
not to recognize lease assets and liabilities for leases with a term of 12 months or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company leases ten medical facilities and
one vehicle as operating leases as of December 31, 2023. The Company recorded operating lease expenses of $&lt;span id="xdx_905_eus-gaap--OperatingLeaseExpense_pp0p0_c20230101__20231231_zCACtQmECaje" title="Operating Leases"&gt;291,040&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--OperatingLeaseExpense_pp0p0_c20220101__20221231_zuCBKuxmWhqg" title="Operating Leases"&gt;301,321&lt;/span&gt; for the
years ended December 31, 2023 and 2022, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has operating leases with future
commitments as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z5BSOHNbCYW4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details - Lease maturities)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B4_zW0i3t666zb5" style="display: none"&gt;Schedule of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_491_20231231_z6TIRWXZ8ld4" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzDYa_zlZ3KJFZ1oue" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: justify"&gt;2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;157,669&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzDYa_zEKBnyCVaR7b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2025&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzDYa_zcmfVZvb6We4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;23,282&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzDYa_zLofrcblxCab" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;276,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zANNqaaKshYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes supplemental information
about the Companys leases:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_esrt--ScheduleOfSupplementalInformationForPropertyCasualtyInsuranceUnderwritersTextBlock_zO1gIUPAamfl" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details - Supplemental information)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;span id="xdx_8B4_zjzPJskslsrh" style="display: none"&gt;Schedule of supplemental information
about leases&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="vertical-align: bottom; width: 87%; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_ztO3SKmpajTh" title="Weighted-average remaining lease term"&gt;1.9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20231231_zburSSXDhhzl" title="Weighted-average discount rate"&gt;4.73&lt;/span&gt; %&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_z5In6fdBRQki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Employees&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company agreed to pay $360,000 per year and
$200,000 of targeted annual incentives to the Chief Executive Officer based on his employment agreement since July 1, 2020, of which currently
50% is paid in cash and 50% is accrued. The total outstanding accrued compensation as of December 31, 2023 and 2022 were $&lt;span id="xdx_90F_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20231231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zcttDZeJWZYe" title="Accrued compensation"&gt;2,365,500&lt;/span&gt; and
$&lt;span id="xdx_90F_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zt7kNBuJ736" title="Accrued compensation"&gt;1,870,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company agreed to pay $360,000 per year and
$200,000 of targeted annual incentives to the Chairman of the Board based on his employment agreement since July 1, 2020, of which currently
50% is paid in cash and 50% is accrued. The total outstanding accrued compensation as of December 31, 2023 and December 31, 2022 were
$&lt;span id="xdx_907_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20231231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z3YNenYYnV41" title="Accrued compensation"&gt;2,350,500&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20221231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z4eyC5lmGTe7" title="Accrued compensation"&gt;1,863,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company agreed to pay $&lt;span id="xdx_907_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20210515_zCEiT8lNWv5" title="Accrued compensation"&gt;156,000&lt;/span&gt; per year to
the previous Chief Financial Officer based on his amended employment agreement executed on May 15, 2021. The total outstanding accrued
compensation as of December 31, 2023 and December 31, 2022 was $&lt;span id="xdx_905_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20231231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zhHJMDmoVw9f" title="Accrued compensation"&gt;17,057&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AccruedBonusesCurrent_iI_pp0p0_c20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_z6gRMco5WXhb" title="Accrued compensation"&gt;17,057&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company entered into a management agreement
effective May 31, 2021 for compensation to the principals of Nova in the form of an annual base salaries of $&lt;span id="xdx_904_eus-gaap--SalariesWagesAndOfficersCompensation_pp0p0_c20210502__20210531__us-gaap--RelatedPartyTransactionAxis__custom--FirstDoctorMember_zQTOkr6Bdrcb"&gt;372,000
&lt;/span&gt;to one of the three doctors, $&lt;span id="xdx_90F_eus-gaap--SalariesWagesAndOfficersCompensation_pp0p0_c20210502__20210531__us-gaap--RelatedPartyTransactionAxis__custom--SecondDoctorMember_zhGrblh1EcGj"&gt;450,000
&lt;/span&gt;to the second, and $&lt;span id="xdx_905_eus-gaap--SalariesWagesAndOfficersCompensation_pp0p0_c20210502__20210531__us-gaap--RelatedPartyTransactionAxis__custom--ThirdDoctorMember_zMVjSUCpZ4I2"&gt;372,000
&lt;/span&gt;to the third doctor. Collectively, as a group, such principals will receive an annual cash bonus and stock equity set forth below,
which will be conditioned upon the Company achieving 100% of the annual objectives of financial performance goals as set forth below.
&lt;span style="background-color: white"&gt;For the year ended December 31, 2023 the Company recorded $0 in annual cash bonus as financial
performance objectives were not achieved.&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfAnnualObjectiveOfFinancialPerformanceTableTextBlock_zd0QjV6s3Yik" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details - Financial performance goals)"&gt;
  &lt;tr&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B4_z66GagkW3ZZ" style="display: none"&gt;Schedule of annual objectives of financial performance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 35%"&gt;&lt;span style="font-size: 10pt"&gt;Minimum Annual Nova EBITDA&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 25%"&gt;&lt;span style="font-size: 10pt"&gt;Cash Annual Bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 25%; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series J Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_90A_ecustom--MinimumAnnualAmount_iI_pn6n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2021Member_z93cW7XP62Y2" title="Minimum Annual Nova EBITDA"&gt;2&lt;/span&gt;.0M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2021Member_zkxYrKWVejOf" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$120,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2021Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zk36Oh3kCBOf" title="Shares"&gt;120,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_901_ecustom--MinimumAnnualAmount_iI_pn5n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2022Member_zbPW2A56ilSi" title="Minimum Annual Nova EBITDA"&gt;2.4&lt;/span&gt;M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2022Member_zMmNxpCtlV68" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$150,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2022Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zLbD2ksxCoY" title="Shares"&gt;135,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--MinimumAnnualAmount_iI_pn5n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2023Member_zBmDLHtAgG44" title="Minimum Annual Nova EBITDA"&gt;3.7&lt;/span&gt;M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2023Member_zgJOx5ibjc87" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$210,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2023Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zwpavuyA5IAg" title="Shares"&gt;150,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--MinimumAnnualAmount_iI_pn5n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2024Member_zWSA0OHHBjJd" title="Minimum Annual Nova EBITDA"&gt;5.5&lt;/span&gt;M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2024Member_zULyBCDnr17h" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zPuRjBpK9Qud" title="Shares"&gt;180,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_906_ecustom--MinimumAnnualAmount_iI_pn6n6_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2025Member_zEqiOY2GguP3" title="Minimum Annual Nova EBITDA"&gt;8&lt;/span&gt;.0M&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AnnualCashBonus_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2025Member_zEkT3W3mqROc" style="text-align: justify" title="Cash Annual Bonus"&gt;&lt;span style="font-size: 10pt"&gt;$420,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--BonusStockToBeIssuedShares_iI_c20231231__us-gaap--EffectOfFourthQuarterEventsByTypeAxis__custom--YearEnd2025Member__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zDkugtaqgvye" title="Shares"&gt;210,000&lt;/span&gt; Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="f329" decimals="0" contextRef="c44" unitRef="usd">-2178883.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:PreferredStockSharesIssued id="f330" decimals="INF" contextRef="c121" unitRef="shares">868056.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:StockRedeemedOrCalledDuringPeriodShares id="f331" decimals="INF" contextRef="c122" unitRef="shares">175045.0</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
  <cardifflexington.com:AccruedInterest id="f332" decimals="0" contextRef="c123" unitRef="usd">7826.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockSharesOutstanding id="f333" decimals="INF" contextRef="c121" unitRef="shares">868056.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f334" decimals="0" contextRef="c12" unitRef="usd">-187406.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:OperatingLeaseLiabilityCurrent id="f335" decimals="0" contextRef="c21" unitRef="usd">142307.0</us-gaap:OperatingLeaseLiabilityCurrent>
  <us-gaap:PreferredStockSharesIssued id="f336" decimals="INF" contextRef="c113" unitRef="shares">868056.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f337" decimals="0" contextRef="c104" unitRef="usd">5845052.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="f338" decimals="-5" contextRef="c124" unitRef="usd">4500000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:GainLossOnSaleOfBusiness id="f339" decimals="0" contextRef="c125" unitRef="usd">217769.0</us-gaap:GainLossOnSaleOfBusiness>
  <us-gaap:OperatingLeaseExpense id="f340" decimals="0" contextRef="c44" unitRef="usd">301321.0</us-gaap:OperatingLeaseExpense>
  <us-gaap:PreferredStockSharesOutstanding id="f341" decimals="INF" contextRef="c113" unitRef="shares">868056.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:DebtInstrumentMaturityDate id="f342" contextRef="c18">2024-07-19</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:OperatingLeaseLiabilityNoncurrent id="f343" decimals="0" contextRef="c8" unitRef="usd">119056.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
  <us-gaap:Cash id="f344" decimals="0" contextRef="c8" unitRef="usd">866943.0</us-gaap:Cash>
  <cardifflexington.com:DiscontinuedOperationsTableTextBlock id="f345" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DiscontinuedOperationsTableTextBlock_zx98WFibSEse" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DISCONTINUED OPERATIONS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B8_zay5UQP2NKd9" style="display: none"&gt;Schedule of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49A_20231231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zF5wEx2RwR34" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_493_20221231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zrPjGshvttD2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"&gt;Net liabilities of discontinued operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_pp0p0_zQyy8HxNlRVh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;342&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;7,717&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_pp0p0_zUmms472Cqda" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;300&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;860&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_pp0p0_zrJEV9kDGTKk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;238,285&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;159,700&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NetLiabilitiesOfDiscontinuedOperations_iI_pp0p0_z69kN7QeJidj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net liabilities of discontinued operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(237,643&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(151,123&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49A_20230101__20231231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zBRdI3ONhBQj" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49A_20220101__20221231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zykDKtcID7Uc" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"&gt;Gain (Loss) from discontinued operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_i01_pp0p0_zhnzMl1UH9fj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;307,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;1,438,294&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CostOfRevenue_i01N_pp0p0_di_zWObYkVynoul" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Cost of sales&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(462,556&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--SellingGeneralAndAdministrativeExpense_i01N_pp0p0_di_zfZtWbffr361" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(332,005&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,094,121&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--InterestIncomeExpenseNet_i01_pp0p0_zMQo52h9ZPH8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,428&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44,027&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GoodwillImpairmentLossNetOfTax_i01N_di0_z1Euw7vAPDA5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Impairment of Goodwill&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,092,048&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--LossOnDivestitureOfSubsidiary_i01N_pp0p0_di0_zeEiingcAm5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Loss on divestiture of subsidiary&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(217,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--GainOnChangeOfEstimate_i01_pp0p0_d0_zoktm1JmZJL4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Gain no change in estimate&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,474&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--GainOnReversalOfRrtLiability_i01_pp0p0_d0_zezsRbePHTL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Gain on reversal of Red Rock liability&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;510,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LossOnSettlement_i01_pp0p0_d0_z9E74lcDI5g6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Loss on settlement&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(212,600&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Loss from discontinued operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(86,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,178,883&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</cardifflexington.com:DiscontinuedOperationsTableTextBlock>
  <cardifflexington.com:LiabilitiesCurrent1 id="f346" decimals="0" contextRef="c126" unitRef="usd">12102942.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:DebtCurrent id="f347" decimals="0" contextRef="c127" unitRef="usd">77460.0</us-gaap:DebtCurrent>
  <cardifflexington.com:DueFromRelatedPartyNoncurrent id="f348" decimals="0" contextRef="c8" unitRef="usd">4979.0</cardifflexington.com:DueFromRelatedPartyNoncurrent>
  <cardifflexington.com:IncreaseDecreaseRightOfUseAssets id="f349" decimals="0" contextRef="c12" unitRef="usd">70136.0</cardifflexington.com:IncreaseDecreaseRightOfUseAssets>
  <us-gaap:DividendsPreferredStock id="f350" decimals="0" contextRef="c128" unitRef="usd">336811.0</us-gaap:DividendsPreferredStock>
  <us-gaap:LineOfCredit id="f351" decimals="0" contextRef="c8" unitRef="usd">2120100.0</us-gaap:LineOfCredit>
  <us-gaap:ProceedsFromConvertibleDebt id="f352" decimals="0" contextRef="c129" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:StockholdersEquity id="f353" decimals="0" contextRef="c130" unitRef="usd">-917038.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f354" decimals="INF" contextRef="c109" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:Revenues id="f355" decimals="0" contextRef="c112" unitRef="usd">0.0</us-gaap:Revenues>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f356" decimals="INF" contextRef="c131" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:PenaltiesAndFees id="f357" decimals="0" contextRef="c12" unitRef="usd">53000.0</cardifflexington.com:PenaltiesAndFees>
  <us-gaap:InterestExpenseDebt id="f358" decimals="0" contextRef="c132" unitRef="usd">175.0</us-gaap:InterestExpenseDebt>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="f359" decimals="0" contextRef="c8" unitRef="usd">4989.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:Revenues id="f360" decimals="0" contextRef="c133" unitRef="usd">10693196.0</us-gaap:Revenues>
  <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock id="f361" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z5BSOHNbCYW4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details - Lease maturities)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B4_zW0i3t666zb5" style="display: none"&gt;Schedule of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_491_20231231_z6TIRWXZ8ld4" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzDYa_zlZ3KJFZ1oue" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: justify"&gt;2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;157,669&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzDYa_zEKBnyCVaR7b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2025&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzDYa_zcmfVZvb6We4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;23,282&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzDYa_zLofrcblxCab" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;276,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
  <us-gaap:LineOfCreditFacilityExpirationDate1 id="f362" contextRef="c134">2025-09-29</us-gaap:LineOfCreditFacilityExpirationDate1>
  <us-gaap:CostOfRevenue id="f363" decimals="0" contextRef="c106" unitRef="usd">0.0</us-gaap:CostOfRevenue>
  <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount id="f364" decimals="0" contextRef="c121" unitRef="usd">3891439.0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
  <us-gaap:ProceedsFromOtherDebt id="f365" decimals="0" contextRef="c12" unitRef="usd">421375.0</us-gaap:ProceedsFromOtherDebt>
  <us-gaap:LongTermDebtTextBlock id="f366" contextRef="c12">&lt;p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zCgPDckzIMC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_829_zI5OXCQQ4SRl"&gt;CONVERTIBLE NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2023 and 2022, the Company
had convertible debt outstanding net of amortized debt discount of $&lt;span id="xdx_906_eus-gaap--ConvertibleDebtCurrent_iI_pp0p0_c20231231_zDFEM7pG4pSe" title="Convertible debt outstanding"&gt;3,807,030&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--ConvertibleDebtCurrent_iI_pp0p0_c20221231_z6m2CZYilmfl" title="Convertible debt outstanding"&gt;3,515,752&lt;/span&gt;, respectively. During the year ending December
31, 2023, the Company received net proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zdMCQRprogGl" title="Proceeds from convertible debt"&gt;421,375&lt;/span&gt; from convertible notes, repaid $&lt;span id="xdx_902_eus-gaap--RepaymentsOfConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqLVjyHnWtkc" title="Repayments of convertible debt"&gt;175,000&lt;/span&gt; and wrote off $&lt;span id="xdx_904_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zqYeH8xvrB73" title="Convertible debt written off"&gt;12,406&lt;/span&gt; to convertible noteholders.
During the year ending December 31, 2022, the Company received proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20220101__20221231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zDyonlFmcNU7" title="Proceeds from convertible debt"&gt;1,490,706&lt;/span&gt; from convertible notes and repaid $&lt;span id="xdx_908_eus-gaap--RepaymentsOfConvertibleDebt_pp0p0_c20220101__20221231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zxNYeTB48xqg" title="Repayments of convertible debt"&gt;5,908&lt;/span&gt; to convertible
noteholders. There are debt discounts associated with the convertible debt of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_pp0p0_c20231231_zNyRpnYsKQ32" title="Debt discount"&gt;24,820&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_pp0p0_c20221231_zJL4Zw9PG9Ik" title="Debt discount"&gt;46,797&lt;/span&gt; at December 31, 2023 and 2022, respectively.
For the years ended December 31, 2023 and 2022, the Company recorded amortization of debt discounts of $&lt;span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20230101__20231231_z8BFtVCwHzz6" title="Amortization of debt discount"&gt;136,518&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20221231_zykeAdA9NDc7" title="Amortization of debt discount"&gt;253,823&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2023, the Company
converted $&lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztxWubKIs1Ck" title="Debt converted, amount converted"&gt;87,460&lt;/span&gt; of convertible debt, $&lt;span id="xdx_900_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zP771ERE1aBi" title="Debt converted, interest converted"&gt;112,429&lt;/span&gt; in accrued interest and $&lt;span id="xdx_906_ecustom--DebtConversionConvertedCostAmount1_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zknVB9hDY702" title="Debt converted, conversion cost converted"&gt;3,000&lt;/span&gt; in conversion cost into &lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ziqebSoH0EGl" title="Debt converted, shares issued"&gt;13,068&lt;/span&gt; shares of the Companys
common stock. The Company recognized $&lt;span id="xdx_90F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zYbGqYZkBKTb" title="Adjustment to Additional Paid In Capital"&gt;777,217&lt;/span&gt; of additional paid-in capital to adjust fair value for the debt settlement during the year
ended December 31, 2023. The Company had &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_do_c20220101__20221231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zpub6JouFQgb" title="Debt converted, amount converted"&gt;no&lt;/span&gt; convertible debt conversions during the year ended December 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 22, 2022, the Company entered into
a security exchange and purchase agreement with its largest lender to consolidate all promissory notes held by them and related accrued
interest in exchange for (1) one consolidated senior secured convertible promissory note (New Promissory Note) in the amount
of $&lt;span id="xdx_900_ecustom--DebtConversionConvertedInstrumentNewDebtIssued_iI_c20220922__us-gaap--LongtermDebtTypeAxis__custom--NewPromissoryNoteMember_zBAimbETfBe9" title="Debt converted, new debt issued"&gt;2,600,000&lt;/span&gt; and (2) &lt;span id="xdx_90A_ecustom--DebtConversionConvertedSharesIssued_iI_c20220922__us-gaap--LongtermDebtTypeAxis__custom--NewPromissoryNoteMember__us-gaap--StatementClassOfStockAxis__custom--SeriesXSeniorConvertiblePreferredStockMember_zgjp8dS1eLAg" title="Debt converted, shares issued"&gt;375,000&lt;/span&gt; shares of series X senior convertible preferred stock totaling $&lt;span id="xdx_900_eus-gaap--PreferredStockValue_iI_c20220922__us-gaap--LongtermDebtTypeAxis__custom--NewPromissoryNoteMember__us-gaap--StatementClassOfStockAxis__custom--SeriesXSeniorConvertiblePreferredStockMember_z8rkKhLMhxUf" title="Preferred stock value"&gt;1,500,000&lt;/span&gt; with a par value of $0.001, stated
value of $4.00, convertible into common shares at a 1:1 conversion rate, non-dilutive and non-voting shares. Prior to conversion, all
promissory notes with this lender totaled to $&lt;span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_c20220920__us-gaap--LongtermDebtTypeAxis__custom--AllPromissoryNotesMember_zTgNhJmQRDF8" title="Convertible notes payable"&gt;4,791,099&lt;/span&gt; consisting of principal of $&lt;span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20220920__us-gaap--LongtermDebtTypeAxis__custom--AllPromissoryNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--PrincipalAmountMember_zVGYJU2h0LY3" title="Convertible notes payable"&gt;3,840,448&lt;/span&gt; and accrued interest of $&lt;span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_c20220920__us-gaap--LongtermDebtTypeAxis__custom--AllPromissoryNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--AccruedInterestAmountMember_zm8E51tc2wLa" title="Convertible notes payable"&gt;950,651&lt;/span&gt; resulting
in a gain on debt consolidation of $&lt;span id="xdx_90F_ecustom--GainsLossesOnConsolidationOfDebt_c20220921__20220922__us-gaap--LongtermDebtTypeAxis__custom--AllPromissoryNotesMember_zuCpUbw6xAMe" title="Gain on debt consolidation"&gt;1,397,271&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Convertible notes as of December 31, 2023 and
2022 are summarized as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ConvertibleDebtTableTextBlock_zBoRQ91qs6kk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details - Convertible notes)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B5_zdeEaq14krfi" style="display: none"&gt;Schedule of convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;&lt;td id="xdx_49E_20231231_zwdufDlBFb7g" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_496_20221231_zYJWGmTepJVb" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Convertible notes payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ConvertibleNotesPayableGross_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayablesMember_zuwhVflcG4Di" style="width: 13%; text-align: right" title="Convertible notes payable"&gt;3,831,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ConvertibleNotesPayableGross_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayablesMember_zsrrw00cK3f2" style="width: 13%; text-align: right" title="Convertible notes payable"&gt;3,562,550&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountNoncurrent_iNI_pp0p0_di_zmK28Ob4SMs2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Discounts on convertible notes payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,820&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(46,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total convertible debt less debt discount&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,807,030&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,515,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ConvertibleDebtCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,807,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,515,752&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_zQjwcMnDyw61" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long-term portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a schedule of convertible notes
payable as of and for the year ended December 31, 2023.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ConvertibleDebtDetailsTableTextBlock_zbsrRtePPX23" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details- Convertible debt instruments)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_8B7_zmS6oOuJyaPg" style="display: none"&gt;Schedule of convertible notes
payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Note #&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Issuance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Principal
    Balance 12/31/22&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;New
    Loan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Principal
    Conversions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Cash Paydown&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Shares Issued
    Upon Conversion&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Principal
    Balance 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Accrued
    Interest on Convertible Debt at 12/31/22&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Interest
    Expense On Convertible Debt For the Period Ended 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Accrued
    Interest on Convertible Debt at 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Unamortized
    Debt Discount At 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; width: 5%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;7-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zfGBLlQ5E0J4" title="Debt issuance date"&gt;10/28/2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zIxSaxNgKkxa" title="Debt Maturity date"&gt;10/28/2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_z2icn681a4Ac" style="vertical-align: bottom; width: 7%; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zV8GrHpcNjZ7" style="vertical-align: bottom; width: 6%; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtCurrent_iNI_pp0p0_di_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zTObqWbCKfEf" style="vertical-align: bottom; width: 6%; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;(10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zCgCgygyELOa" style="vertical-align: bottom; width: 6%; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zXhLrEosZR14" style="vertical-align: bottom; width: 6%; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_z0C2yIFfB2df" style="vertical-align: bottom; width: 6%; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zQVYIDMkgMh1" style="vertical-align: bottom; width: 6%; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;2,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--InterestExpenseDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zlhx0xq0lsKb" style="vertical-align: bottom; width: 6%; text-align: right" title="Interest Expense On Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_z6UmzRAQg1B5" style="vertical-align: bottom; width: 6%; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zJiRRcYiBbjb" style="vertical-align: bottom; width: 6%; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zwqODA7Pgfcj" title="Debt issuance date"&gt;09/12/2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zfYGdviWOrB7" title="Debt Maturity date"&gt;09/12/2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zmk5ZidGqlVg" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;50,080&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zhjPzqcUNuv9" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zC91JNpwLlGa" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zgWVASgDuRB8" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zeHDfIrQkut4" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;1,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_z3wfjxX6S925" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;50,080&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zJzGbtdgvbS" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;14,157&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zxEWI97IOlYl" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;9,181&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zOJ9rsgvy9Qc" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;5,581&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zXx5gPB6KgGe" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zt69aXUaZTJk" title="Debt issuance date"&gt;01/24/2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zzzk8EQq7qYl" title="Debt Maturity date"&gt;01/24/2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ConvertibleDebt_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zdncKvJgy1E4" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;55,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zYemANmEuCof" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zWMccQbxcS22" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zldaLS57Impj" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zkKLSRii3ke1" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zcnWlh0mOq3j" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;55,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zgVddJTjKps2" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;69,876&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zrQ9dOPFm4Uc" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;11,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zzKMMhdz5qzd" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;80,875&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zLb31DRuK8Ve" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zrFqwvp7P0b9" title="Debt issuance date"&gt;02/10/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zc3fBknS9YO7" title="Debt Maturity date"&gt;02/10/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zOHyFsG5uLka" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_z6KbiD6LtSl8" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zf1yYl3TvFB9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_z4cS6RdfF3N2" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_znbg52bYCfNd" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zNpqNTzqhzDc" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zf8zWzz9Hnl7" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,658&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_z7KMPGqa9Sj9" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;6,658&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zztwM9hkI8T5" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zswSSTwyLgQ3" title="Debt issuance date"&gt;03/30/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_z9lmJKcxb414" title="Debt Maturity date"&gt;03/30/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zbkWhNZC4ei5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_z6Z991CK7aM1" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zsVX05afwdwi" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zFZYHiXIwKYj" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zDEDFTCXloNk" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zmudB8Z2h0b3" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_z1ogwUYXzY7" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zaIhDqKy1VVb" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;2,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zwPl3qJj3y9d" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;2,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zJv8Rso8Jqkf" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10-3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zBrS500Eg0Zj" title="Debt issuance date"&gt;08/11/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_znTm2wn2aSZe" title="Debt Maturity date"&gt;08/11/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zgELlLSh2Vi2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zRBQL9sozQr9" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zX7U4g4IVlh6" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zLo9wX4T8yY7" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zLYwC52vHxv9" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_znAeuy6uEOi6" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zMDKsB32HtL5" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zXgmRwlyMeli" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;1,469&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zyVQJqSb8Gdd" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,469&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zMmWhprufC71" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;29-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zlscNvjWysP3" title="Debt issuance date"&gt;11/08/2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zZ3bC0ePXZlg" title="Debt Maturity date"&gt;11/08/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zGeHNlb6Z9W5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;36,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zXZZHo7bD2I8" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zsOVepSdUfr3" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zOqFFGJwmaqa" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zNLoS2LrEkQh" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;2,867&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zn2KqInjj7Kg" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;36,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zhVbVvq85FRa" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;20,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zlkZWN6CSE1e" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;2,849&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zCfQpj1df795" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;10,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_z2uTL0JpZ2P9" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;31&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zwEJbeceuI2l" title="Debt issuance date"&gt;08/28/2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zhX94g8piVzl" title="Debt Maturity date"&gt;08/28/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zmDa6LkktPQ2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zMCWu41DgDGa" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zU2XsCd0ooOc" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zFp6wB9Tj5bf" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zglu6Lihz3r9" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zPmXAyoK5bgh" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zgvcJYG4iTg3" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;8,385&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--InterestExpenseDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zK4YtL3rdMgd" style="vertical-align: bottom; text-align: right" title="Interest Expense On Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_ziAGhSgjuekc" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;8,385&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zZELeXFYQ7ze" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;37-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zdGBsk42ryk" title="Debt issuance date"&gt;09/03/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zIoxodDS35R1" title="Debt Maturity date"&gt;06/30/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zk9JyGE0gek" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_z26LbXF01Pxh" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zV4fV89IfgM5" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_z0vi0XMVpu01" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zJRGySdw3ZW6" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zYPavVSrCfpi" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zwMmn64FfiLi" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;28,756&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zB7qtebzI5Wd" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;19,507&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zB7rE44FqBPj" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;64,929&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_z2CFFTRaUDl3" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;37-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zddvCtd1Irr3" title="Debt issuance date"&gt;11/02/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zzDgoyjsmYX6" title="Debt Maturity date"&gt;08/31/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zYvo31DCd7G5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zWCHi39bdG3a" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zHU6jU31h0q6" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zzvFJ6UbG9bd" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zMlA3hOfUlw8" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zX1QYXHswy2l" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zm3tymYMHM5i" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;27,510&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zu5P206dwdag" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;19,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zFVtCOFNp5il" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;63,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_z8TV33wyoyxi" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;37-3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_z54istFqzlok" title="Debt issuance date"&gt;12/29/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zTX6WMhfmpGh" title="Debt Maturity date"&gt;09/30/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_z37HAolvBFK5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zDPHlIOxNbXj" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_ztmEgdUrJtPj" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zfsp2shQtCef" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zYCsx4L9K4je" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zuJTwZ740vX4" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zRYVszopxMBh" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;26,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_z4oBAYxw1rXa" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;19,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zuUMW3u8bU1d" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;62,558&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zHoY17XeWfPe" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;38&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zFAZGa13eWE4" title="Debt issuance date"&gt;02/09/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_z5eqdCD4i7vg" title="Debt Maturity date"&gt;02/09/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zmuw78X65tkl" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;96,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_z6qMM7F6D5U7" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--DebtCurrent_iNI_pp0p0_di_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zQskxNx7fYm5" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;(77,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zIoT4RzJ9jT" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;(18,540&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zq5KuZ3ytbi2" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;2,950&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zUsuRLUvgsKk" style="vertical-align: top; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_z6s4sW5syQ9g" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;27,939&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zTP9WbNkIZEh" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;7,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccruedInterest_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zGa7TDA9sII3" style="vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zbkReAJUv8uj" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;39&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zgsmQYrMYcJj" title="Debt issuance date"&gt;04/26/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member" title="Debt Maturity date"&gt;04/26/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;168,866&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zaupmAJoatyf" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zMkFf3cndZmh" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zXhTgh786kRc" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;(168,866&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zcPMcURzBV8l" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zw47tnwMjcOg" style="vertical-align: top; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zxdFTBKYvu09" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;39,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zgIOovkr95C8" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;27,787&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zfaWpcpze9n9" style="vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zlxJS8K1gG51" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member" title="Debt issuance date"&gt;09/22/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;2,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zPLNpx8dGCyc" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zyoKigX4fhPb" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zwMi5mNNYnc5" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zAaY71OPlpFh" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;5,267&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zqNYs5fbZB86" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;2,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zMM0uvbHTu9h" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;71,233&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zejbO9yvnVJ5" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;261,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zWet3HivCWel" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;252,665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_z4SCCT6MgH38" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member" title="Debt issuance date"&gt;11/04/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,666&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zi516HVyKxmh" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zj7ku0gxYvIh" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zQruHypWtGz9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zoUf4zoPQFzl" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zPI80XxfCpX9" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zsnKaRMnk3Qe" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zfmgIMY0sfwi" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,867&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_z6w7KegLhq5a" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,939&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zhUbqxgXI0Uk" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member" title="Debt issuance date"&gt;11/28/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zg96km1B6CQl" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zlL1D2GFIzna" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zLpg6dKmeLfl" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zVrYje6zX5Uj" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_z1W0aisAUToj" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zkmbPTgtoGPh" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;620&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_z9S793yhRyq1" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,886&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_z3ooUcgb6Xfi" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,506&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zh2dSu37BRgc" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member" title="Debt issuance date"&gt;12/21/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zCNj2i0JkWM6" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zJSToFa24K16" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zTtQii0Agwf3" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_ziZ366Afjsmi" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zfkM70yskQQc" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zYLjB83y2OGa" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;187&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_z1yFryrVA8V5" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,867&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zRJEyyAb2ava" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,054&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zFiRKB1zX3vg" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member" title="Debt issuance date"&gt;01/24/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zOYZR6HBL689" title="Debt Maturity date"&gt;03/21/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zMbrOiqBc7o1" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;90,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zbYxN1SFn7H4" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zcs108HcNEx6" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zWu3LGoVcR5b" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zDGXbbTQeF2b" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;90,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zmVlXfldrO33" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zF0KgxXiT3vd" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;8,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_z42TvDavfyDb" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;8,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zFaHmEXpRfe9" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member" title="Debt issuance date"&gt;03/21/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zGocHgkdpJne" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zvR5icMrCvC2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zmovZmB5ZqA8" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_znnCVoN8Yhy9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_z52DI4qiaJ8b" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zpGVPB19qGzk" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zKNzfEu4vXQ" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zTpyHqkBJj32" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;10,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_z9kLB1XT9ES8" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;10,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zScX5pCDN7j8" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member" title="Debt issuance date"&gt;06/05/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member" title="Debt Maturity date"&gt;06/05/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zo0jbyFD8mw7" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zJeJYrbGL6ql" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zkLTbn419KZd" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zDJbx9g2Y6yb" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zSYJx6IMj8Hj" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zYGrLmpoef19" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_z39nNcuBLVva" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;7,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zFMtMiAIzi26" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zxjswrHexNJ7" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;15,671&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member" title="Debt issuance date"&gt;06/13/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member" title="Debt Maturity date"&gt;06/13/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zrvygG0PiTS2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;21,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zKrkcYahw757" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zran7h2TaQD5" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zhjAq4ounBua" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zHtCfR4iiU96" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;21,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_ztHwG6fG2Bw" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zaQJAaDOWS1c" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;1,127&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zbk7xtYzxCN" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,127&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zRzLrOVSJgF5" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;2,321&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member" title="Debt issuance date"&gt;07/19/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member" title="Debt Maturity date"&gt;07/19/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zRmvYVjangQd" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;35,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zK2mgrePPiCg" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zYoo4MyDFpv9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_z8Xhkm26PGnj" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zXHC0IgyfYl" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;35,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zdzZil8ZHNef" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zbhfo0gpEDhb" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;1,605&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_ztaN9NBfPtof" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,605&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zD55K3ggfSZd" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;4,863&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member" title="Debt issuance date"&gt;07/24/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member" title="Debt Maturity date"&gt;07/24/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_znXZd3jy1KC5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;14,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zjLuYJ4Ovg42" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_z7tgnth80aSf" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zmXQlNmvSqag" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zFTPWmfajfhf" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;14,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zacqn1NsIiV9" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_ziUaJ2TLoER5" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zG0GteWoVWEd" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zPJmdLcJZNq6" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;1,965&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member" title="Debt issuance date"&gt;08/25/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member" title="Debt Maturity date"&gt;08/25/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zF8gh6d9PAOh" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_pp0p0" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zkhxrCYiOSk2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zC21ck6IYTR" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zqUlnJaoj7Y4" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zYEXvDPlHsl9" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_z46syryLkdrk" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zRjFTb8dw9d1" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;175&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zcryNvl39uF5" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;175&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zI9r8bLBqwL7" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231_zraP1kcqUnC1" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;3,562,550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231_zkZ617Idtb7g" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;544,165&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231_ziiIBCOG2KQj" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;(87,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_c20230101__20231231_zj8IKfZKgQRb" style="border-bottom: Black 2.25pt double; vertical-align: top; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;(187,406&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231_z384QkhEOO49" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;13,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231_zrcN0HvIIRn6" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;3,831,850&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231_zmNbj401sm7j" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;338,316&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231_zOdDLyeWRAp4" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Interest Expense On Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;439,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccruedInterest_iI_pp0p0_c20231231_zqjkVPUqozc9" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;612,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231_zBLEfJ27sAy8" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;24,820&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 7-1&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On October 28, 2016, the Company issued a convertible
promissory note in the principal amount of $50,000, which matured on October 28, 2017. Note 7-1 was fully converted into common shares
and there was no outstanding balance as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 9&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 12, 2016, the Company issued a convertible
promissory note in the principal of $80,000 for services rendered, which matured on September 12, 2017. Note 9 is currently in default
and accrues at a default interest rate of 20% per annum.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 10, 10-1, 10-2 and 10-3&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 24, 2017, the Company issued a convertible
promissory note in the principal amount of $80,000 for services rendered, which matured on January 24, 2018. Note 10 is currently in default
and accrues interest at a default interest rate of 20% per annum. On February 10, 2023, the Company executed a second tranche under this
note in the principal amount of $50,000 (Note 10-1). On March 30, 2023, the Company executed a third tranche under this note in the principal
amount of $25,000 (Note 10-2). On August 11, 2023, the Company executed a fourth tranche under this note in the principal amount of $25,000
(Note 10-3). Notes 10-1, 10-2 and 10-3 accrue interest at a rate of 15% per annum.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 29-2&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 10, 2019, the Company issued a convertible
promissory note in the principal amount of $150,000. On November 8, 2019, this note (Note 29) was purchased by and assigned to an unrelated
party. The amount assigned was the existing principal amount of $150,000 and accrued interest of $5,918, which was issued as Note 29-1,
plus a new convertible promissory note in the principal amount of $62,367, which was issued as Note 29-2. Note 29-2 is currently in default
and accrues interest at a default interest rate of 24% per annum.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 31&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On August 28, 2019, the Company issued a convertible
promissory note in the principal amount of $120,000, which matured on August 28, 2020. Note 31 is currently in default and accrues interest
at a default interest rate of 24% per annum. There was no outstanding principal balance as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Notes 37-1, 37-2 and 37-3&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 3, 2020, the Company issued a convertible
promissory note in the principal amount of $200,000, with an original issue discount of $50,000, which could be drawn in several tranches.
On September 3, 2020, the Company executed the first tranche in the principal amount of $67,000, less an original issue discount of $17,000,
which matured on June 30, 2021 (Note 37-1). On November 2, 2020, the Company executed the second tranche in the principal amount of $66,500,
less an original issue discount of $16,500, which matured on August 31, 2021 (Note 37-2). On December 29, 2020, the Company executed the
third tranche in the principal amount of $66,500, less an original issue discount of $16,500, which matured on September 30, 2021 (Note
37-3). Notes 37-1, 37-2 and 27-3 are currently in default and accrue interest at a default interest rate of 18% per annum.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 38&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 9, 2021, the Company issued a convertible
promissory note in the principal amount $103,500, which matured on February 9, 2022. Note 38 was converted into common shares and the
remaining balance was paid in cash. There was no outstanding balance on Note 38 as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 39&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 26, 2021, the Company issued a convertible
promissory note in the principal amount $153,500, which matured on May 10, 2022. Note 39 was paid in cash and there was no outstanding
balance as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Notes 40-1, 40-2, 40-3, 40-4, 40-5, 40-6, 40-7, 40-8, 40-9 and 40-10&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 22, 2022, the Company issued a convertible
promissory note in the principal amount of $2,600,000 in exchange for total of $4,791,099 of defaulted promissory notes balances (Note
40-1). On November 4, 2022, the Company executed a second tranche under this note in the principal amount of $68,667, less an original
issue discount and fee of $18,667 (Note 40-2). On November 28, 2022, the Company executed the third tranche under this note in the principal
amount of $68,667, less an original issue discount and fee of $18,667 (Note 40-3). On December 21, 2022, the Company executed a fourth
tranche under this note in the principal amount of $68,667, less an original issue discount and fee of $18,667 (Note 40-4). On January
24, 2023, the Company executed a fifth tranche under this note in the principal amount of $90,166, less an original issue discount and
fee of $25,166 (Note 40-5). On March 21, 2023, the Company executed a sixth tranche under this note in the principal amount of $136,666,
less an original issue discount and fee of $39,166 (Note 40-6). On June 5, 2023, the Company executed a seventh tranche under this note
in the principal amount of $136,667, less original issue discount and fee of $39,167 (Note 40-7). On June 13, 2023, the Company executed
an eighth tranche under this note in the principal amount of $21,167, less original issue discount and fee of $5,167 (Note 40-8). On July
19, 2023, the Company executed a ninth tranche under this note in the principal amount of $35,500, less an original issue discount and
fee of $8,875 (Note 40-9). On July 24, 2023, the Company executed a tenth tranche under this note in the principal amount of $14,000,
less an original issue discount and fee of $3,500 (Note 40-10). On December 1, 2023, the Company executed amendment on Notes series 40
consolidated senior secured convertible promissory note to extend the expired tranche note 40-1 through 40-5 due date to September
20, 2024. All of the Note 40 tranches mature in one year from the note issuance date and accrue interest at a rate of 10% per annum.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Note 41&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On August 25, 2023, the Company issued a twelve-month
convertible promissory note in the principal amount of $5,000 to the Companys CEO for the Companys operating expenses. The
rate of interest is 10% per annum.&lt;/p&gt;


</us-gaap:LongTermDebtTextBlock>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f367" decimals="INF" contextRef="c8" unitRef="shares">13068.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:NetIncomeLoss id="f368" decimals="0" contextRef="c12" unitRef="usd">3028394.0</us-gaap:NetIncomeLoss>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f369" contextRef="c132">2023-08-25</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:ConvertibleDebt id="f370" decimals="0" contextRef="c135" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:SubsequentEventsTextBlock id="f371" contextRef="c12">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zhuGFrBAYWU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;17.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_829_z9Nvo9f4kref"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has evaluated its operations subsequent
to December 31, 2023 to the date these consolidated financial statements were available to be issued and determined the following subsequent
events and transactions required disclosure in these consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 11, 2024, the Company issued 1,222
shares of common stock upon the conversion of a convertible note in the amount of $1,680.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 31, 2024, the Company issued 7,500
shares of series I preferred stock to the Company executives.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 5, 2024, the Company issued 7,500 shares
of common stock to John Nesbett for professional services provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 13, 2024, the Company paid $50,000 to
the noteholder for the accrued interest on &lt;i&gt;Notes 40-1.&lt;/i&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:OperatingLeaseLiabilityNoncurrent id="f372" decimals="0" contextRef="c21" unitRef="usd">84871.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
  <us-gaap:Cash id="f373" decimals="0" contextRef="c21" unitRef="usd">219085.0</us-gaap:Cash>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f374" decimals="0" contextRef="c123" unitRef="usd">15671.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:Revenues id="f375" decimals="0" contextRef="c22" unitRef="usd">307366.0</us-gaap:Revenues>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f376" decimals="INF" contextRef="c25" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <cardifflexington.com:LiabilitiesCurrent1 id="f377" decimals="0" contextRef="c55" unitRef="usd">0.0</cardifflexington.com:LiabilitiesCurrent1>
  <cardifflexington.com:DueFromRelatedPartyNoncurrent id="f378" decimals="0" contextRef="c21" unitRef="usd">4979.0</cardifflexington.com:DueFromRelatedPartyNoncurrent>
  <cardifflexington.com:IncreaseDecreaseRightOfUseAssets id="f379" decimals="0" contextRef="c44" unitRef="usd">-64696.0</cardifflexington.com:IncreaseDecreaseRightOfUseAssets>
  <us-gaap:DividendsPreferredStock id="f380" decimals="0" contextRef="c136" unitRef="usd">8136.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="f381" decimals="INF" contextRef="c137" unitRef="shares">3141.0</us-gaap:ClassOfWarrantOrRightOutstanding>
  <cardifflexington.com:DueToDirectorAndOfficer id="f382" decimals="0" contextRef="c8" unitRef="usd">120997.0</cardifflexington.com:DueToDirectorAndOfficer>
  <us-gaap:StockholdersEquity id="f383" decimals="0" contextRef="c138" unitRef="usd">-291345.0</us-gaap:StockholdersEquity>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f384" decimals="0" contextRef="c109" unitRef="usd">1965.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f385" decimals="0" contextRef="c106" unitRef="usd">-3716.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <cardifflexington.com:ConvertibleNotesPayableGross id="f386" decimals="0" contextRef="c139" unitRef="usd">3562550.0</cardifflexington.com:ConvertibleNotesPayableGross>
  <cardifflexington.com:PenaltiesAndFees id="f387" decimals="0" contextRef="c44" unitRef="usd">2063916.0</cardifflexington.com:PenaltiesAndFees>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="f388" decimals="0" contextRef="c12" unitRef="usd">86520.0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f389" decimals="0" contextRef="c114" unitRef="usd">-18540.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f390" decimals="0" contextRef="c74" unitRef="usd">300000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock>
  <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount id="f391" decimals="0" contextRef="c113" unitRef="usd">3125002.0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
  <us-gaap:DebtCurrent id="f392" decimals="0" contextRef="c140" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:ConvertibleDebt id="f393" decimals="0" contextRef="c109" unitRef="usd">14000.0</us-gaap:ConvertibleDebt>
  <us-gaap:ConvertibleDebt id="f394" decimals="0" contextRef="c131" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:AccruedInterest id="f395" decimals="0" contextRef="c141" unitRef="usd">175.0</cardifflexington.com:AccruedInterest>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree id="f396" decimals="0" contextRef="c8" unitRef="usd">4989.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:Revenues id="f397" decimals="0" contextRef="c12" unitRef="usd">11853266.0</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss id="f398" decimals="0" contextRef="c142" unitRef="usd">3028394.0</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareDiluted id="f399" decimals="INF" contextRef="c117" unitRef="usd1">-994.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:NetIncomeLoss id="f400" decimals="0" contextRef="c44" unitRef="usd">-5429521.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:AnnualCashBonus id="f401" decimals="0" contextRef="c143" unitRef="usd">120000.0</cardifflexington.com:AnnualCashBonus>
  <us-gaap:NetIncomeLoss id="f402" decimals="0" contextRef="c54" unitRef="usd">666293.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:AnnualCashBonus id="f403" decimals="0" contextRef="c144" unitRef="usd">150000.0</cardifflexington.com:AnnualCashBonus>
  <us-gaap:Assets id="f404" decimals="0" contextRef="c130" unitRef="usd">16053519.0</us-gaap:Assets>
  <cardifflexington.com:LiabilitiesCurrent1 id="f405" decimals="0" contextRef="c145" unitRef="usd">12102942.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:DividendsPreferredStock id="f406" decimals="0" contextRef="c19" unitRef="usd">344947.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ConvertibleDebt id="f407" decimals="0" contextRef="c116" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:ConvertibleDebt id="f408" decimals="0" contextRef="c8" unitRef="usd">3831850.0</us-gaap:ConvertibleDebt>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="f409" decimals="INF" contextRef="c137" unitRef="usd1">0.015</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <cardifflexington.com:DueToDirectorAndOfficer id="f410" decimals="0" contextRef="c21" unitRef="usd">123192.0</cardifflexington.com:DueToDirectorAndOfficer>
  <us-gaap:StockholdersEquity id="f411" decimals="0" contextRef="c146" unitRef="usd">-1208383.0</us-gaap:StockholdersEquity>
  <us-gaap:AdvertisingCostsPolicyTextBlock id="f412" contextRef="c12">&lt;p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zJokVzJXDIMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zaZjHGsV1yXj"&gt;Advertising Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Advertising costs are expensed as incurred. Advertising
costs are included as a component of cost of sales in the consolidated statements of operations and changes in stockholders equity.
The Company recognized advertising and marketing expense of $&lt;span id="xdx_904_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20231231_zugWZ481d3ca" title="Advertising and marketing expense"&gt;126,670&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zUoRQyd6ZZxc" title="Advertising and marketing expense"&gt;233,798&lt;/span&gt; for the years ended December 31, 2023 and 2022, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f413" decimals="0" contextRef="c112" unitRef="usd">-19345.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:ProceedsFromOtherDebt id="f414" decimals="0" contextRef="c44" unitRef="usd">879083.0</us-gaap:ProceedsFromOtherDebt>
  <us-gaap:ProceedsFromConvertibleDebt id="f415" decimals="0" contextRef="c18" unitRef="usd">35500.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:Liabilities id="f416" decimals="0" contextRef="c8" unitRef="usd">14124289.0</us-gaap:Liabilities>
  <us-gaap:AccountsReceivableNetCurrent id="f417" decimals="0" contextRef="c8" unitRef="usd">13305254.0</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f418" decimals="INF" contextRef="c127" unitRef="shares">2950.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:OtherAssets id="f419" decimals="0" contextRef="c8" unitRef="usd">33304.0</us-gaap:OtherAssets>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f420" decimals="0" contextRef="c44" unitRef="usd">270000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="f421" decimals="0" contextRef="c12" unitRef="usd">2481.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <dei:EntitySmallBusiness id="f422" contextRef="c12">true</dei:EntitySmallBusiness>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f423" decimals="0" contextRef="c95" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:AccruedInterest id="f424" decimals="0" contextRef="c147" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:InterestExpenseOther id="f425" decimals="0" contextRef="c12" unitRef="usd">1956266.0</us-gaap:InterestExpenseOther>
  <us-gaap:PreferredStockSharesAuthorized id="f426" decimals="INF" contextRef="c148" unitRef="shares">5000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:Revenues id="f427" decimals="0" contextRef="c44" unitRef="usd">10693196.0</us-gaap:Revenues>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f428" contextRef="c149">2023-06-13</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:NetIncomeLoss id="f429" decimals="0" contextRef="c" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockSharesAuthorized id="f430" decimals="INF" contextRef="c150" unitRef="shares">5000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:Assets id="f431" decimals="0" contextRef="c138" unitRef="usd">0.0</us-gaap:Assets>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f432" decimals="0" contextRef="c129" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:DistinguishingLiabilitiesFromEquityPolicyTextBlock id="f433" contextRef="c12">&lt;p id="xdx_84A_ecustom--DistinguishingLiabilitiesFromEquityPolicyTextBlock_zw9Mqr1Iveh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zdg0w45Lnc8f"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its series N senior convertible
preferred stock, series R convertible preferred stock, and series X senior convertible preferred stock subject to possible redemption
in accordance with ASC 480, Distinguishing Liabilities from Equity. Conditionally redeemable preferred shares are classified
as temporary equity within the Companys consolidated balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</cardifflexington.com:DistinguishingLiabilitiesFromEquityPolicyTextBlock>
  <cardifflexington.com:AccruedInterest id="f434" decimals="0" contextRef="c151" unitRef="usd">8385.0</cardifflexington.com:AccruedInterest>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f435" decimals="0" contextRef="c101" unitRef="usd">-76982.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f436" decimals="0" contextRef="c141" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:NetLiabilitiesOfDiscontinuedOperations id="f437" decimals="0" contextRef="c11" unitRef="usd">-151123.0</cardifflexington.com:NetLiabilitiesOfDiscontinuedOperations>
  <us-gaap:AdditionalPaidInCapital id="f438" decimals="0" contextRef="c8" unitRef="usd">-9365982.0</us-gaap:AdditionalPaidInCapital>
  <us-gaap:Liabilities id="f439" decimals="0" contextRef="c21" unitRef="usd">10189587.0</us-gaap:Liabilities>
  <us-gaap:PreferredStockSharesIssued id="f440" decimals="INF" contextRef="c25" unitRef="shares">2131328.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:AccountsReceivableNetCurrent id="f441" decimals="0" contextRef="c21" unitRef="usd">6603920.0</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="f442" decimals="INF" contextRef="c44" unitRef="shares">5822.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:StockholdersEquity id="f443" decimals="0" contextRef="c126" unitRef="usd">975351.0</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromConvertibleDebt id="f444" decimals="0" contextRef="c132" unitRef="usd">5000.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f445" decimals="INF" contextRef="c148" unitRef="usd1">1200.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:OtherAssets id="f446" decimals="0" contextRef="c21" unitRef="usd">30823.0</us-gaap:OtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="f447" decimals="0" contextRef="c44" unitRef="usd">-8058.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ProceedsFromConvertibleDebt id="f448" decimals="0" contextRef="c43" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f449" decimals="0" contextRef="c128" unitRef="usd">-352802.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:AccruedInterest id="f450" decimals="0" contextRef="c21" unitRef="usd">338316.0</cardifflexington.com:AccruedInterest>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="f451" decimals="INF" contextRef="c152" unitRef="shares">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:NotesPayableCurrent id="f452" decimals="0" contextRef="c8" unitRef="usd">2136077.0</us-gaap:NotesPayableCurrent>
  <us-gaap:InterestExpenseDebt id="f453" decimals="0" contextRef="c153" unitRef="usd">0.0</us-gaap:InterestExpenseDebt>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f454" decimals="INF" contextRef="c150" unitRef="usd1">1200.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f455" decimals="0" contextRef="c154" unitRef="usd">7297133.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:RepaymentsOfDebt id="f456" decimals="0" contextRef="c12" unitRef="usd">-0.0</us-gaap:RepaymentsOfDebt>
  <us-gaap:InterestExpenseOther id="f457" decimals="0" contextRef="c44" unitRef="usd">6387309.0</us-gaap:InterestExpenseOther>
  <us-gaap:DebtCurrent id="f458" decimals="0" contextRef="c46" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:DeferredTaxAssetsNet id="f459" decimals="0" contextRef="c8" unitRef="usd">0.0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:ConvertibleDebt id="f460" decimals="0" contextRef="c127" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:MinimumAnnualAmount id="f461" decimals="-6" contextRef="c143" unitRef="usd">2000000.0</cardifflexington.com:MinimumAnnualAmount>
  <us-gaap:NetIncomeLoss id="f462" decimals="0" contextRef="c26" unitRef="usd">666293.0</us-gaap:NetIncomeLoss>
  <us-gaap:Assets id="f463" decimals="0" contextRef="c146" unitRef="usd">16053519.0</us-gaap:Assets>
  <us-gaap:ProceedsFromConvertibleDebt id="f464" decimals="0" contextRef="c155" unitRef="usd">421375.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f465" decimals="INF" contextRef="c140" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:DebtInstrumentMaturityDate id="f466" contextRef="c149">2024-06-13</us-gaap:DebtInstrumentMaturityDate>
  <cardifflexington.com:MinimumAnnualAmount id="f467" decimals="-5" contextRef="c144" unitRef="usd">2400000.0</cardifflexington.com:MinimumAnnualAmount>
  <dei:EntityEmergingGrowthCompany id="f468" contextRef="c12">false</dei:EntityEmergingGrowthCompany>
  <us-gaap:RepaymentsOfConvertibleDebt id="f469" decimals="0" contextRef="c155" unitRef="usd">175000.0</us-gaap:RepaymentsOfConvertibleDebt>
  <srt:ScheduleOfSupplementalInformationForPropertyCasualtyInsuranceUnderwritersTextBlock id="f470" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_esrt--ScheduleOfSupplementalInformationForPropertyCasualtyInsuranceUnderwritersTextBlock_zO1gIUPAamfl" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details - Supplemental information)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;span id="xdx_8B4_zjzPJskslsrh" style="display: none"&gt;Schedule of supplemental information
about leases&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #EEEEEE"&gt;
    &lt;td style="vertical-align: bottom; width: 87%; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_ztO3SKmpajTh" title="Weighted-average remaining lease term"&gt;1.9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20231231_zburSSXDhhzl" title="Weighted-average discount rate"&gt;4.73&lt;/span&gt; %&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</srt:ScheduleOfSupplementalInformationForPropertyCasualtyInsuranceUnderwritersTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="f471" contextRef="c12">&lt;p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zwNplXTidKMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zWctnmQKBbOl"&gt;Stock-Based Compensation&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its stock-based compensation
in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of
the fair value recognition provisions of section 718-10-30 of the FASB ASC. Pursuant to paragraph 718-10-30-6 of the FASB ASC, all transactions
in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value
of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The measurement date used to determine the fair
value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable
that performance will occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Generally, all forms of share-based payments,
including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on
the awards grant date, based on estimated number of awards that are ultimately expected to vest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The expense resulting from share-based payments
is recorded in general and administrative expense in the consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f472" decimals="0" contextRef="c136" unitRef="usd">-8136.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="f473" decimals="INF" contextRef="c152" unitRef="usd1">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths id="f474" decimals="0" contextRef="c8" unitRef="usd">157669.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
  <us-gaap:NotesPayableCurrent id="f475" decimals="0" contextRef="c21" unitRef="usd">15809.0</us-gaap:NotesPayableCurrent>
  <us-gaap:PreferredStockSharesIssued id="f476" decimals="INF" contextRef="c148" unitRef="shares">165.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:DividendsPreferredStock id="f477" decimals="0" contextRef="c156" unitRef="usd">766437.0</us-gaap:DividendsPreferredStock>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f478" decimals="0" contextRef="c157" unitRef="usd">5825707.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:DebtInstrumentDecreaseForgiveness id="f479" decimals="0" contextRef="c155" unitRef="usd">12406.0</us-gaap:DebtInstrumentDecreaseForgiveness>
  <us-gaap:PreferredStockSharesOutstanding id="f480" decimals="INF" contextRef="c148" unitRef="shares">165.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:RepaymentsOfDebt id="f481" decimals="0" contextRef="c44" unitRef="usd">3068.0</us-gaap:RepaymentsOfDebt>
  <us-gaap:DeferredTaxAssetsNet id="f482" decimals="0" contextRef="c21" unitRef="usd">0.0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="f483" decimals="0" contextRef="c8" unitRef="usd">5000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PreferredStockSharesIssued id="f484" decimals="INF" contextRef="c150" unitRef="shares">165.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:DebtCurrent id="f485" decimals="0" contextRef="c141" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:Assets id="f486" decimals="0" contextRef="c8" unitRef="usd">20745811.0</us-gaap:Assets>
  <us-gaap:DebtCurrent id="f487" decimals="0" contextRef="c59" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:PreferredStockSharesOutstanding id="f488" decimals="INF" contextRef="c150" unitRef="shares">165.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:InterestExpenseDebt id="f489" decimals="0" contextRef="c12" unitRef="usd">439618.0</us-gaap:InterestExpenseDebt>
  <us-gaap:ProceedsFromConvertibleDebt id="f490" decimals="0" contextRef="c158" unitRef="usd">1490706.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:SharesOutstanding id="f491" decimals="INF" contextRef="c159" unitRef="shares">14885001.0</us-gaap:SharesOutstanding>
  <us-gaap:SegmentReportingDisclosureTextBlock id="f492" contextRef="c12">&lt;p id="xdx_809_eus-gaap--SegmentReportingDisclosureTextBlock_zUXiV2jsbQLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;16.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_822_zr9wbRVn2BZe"&gt;SEGMENT REPORTING&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2023, the Company had two reportable
operating segments as determined by management using the management approach as defined by the authoritative guidance on
&lt;i&gt;Disclosures about Segments of an Enterprise and Related Information&lt;/i&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Healthcare (Nova)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Real Estate (Edge View)&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These segments are a result of differences in
the nature of the products and services sold. Corporate administration costs, which include, but are not limited to, general accounting,
human resources, legal and credit and collections, are partially allocated to the three operating segments. Other revenue consists of
nonrecurring items.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The healthcare segment provides a full range of
diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments,
and nerves.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The real estate segment consists of Edge View,
a real estate company that owns five (5) acres zoned medium density residential (MDR) with 12 lots already platted, six (6) acres zoned
high-density residential (HDR)that can be platted in various configurations to meet current housing needs, and twelve (12) acres
zoned in Lemhi County as Agriculture that is available for further annexation into the City of Salmon for development, as well as a common
area for landowners to view wildlife, provide access to the Salmon River and fishing in a two (2) acre pond.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management uses numerous tools and methods to
evaluate and measure of its subsidiaries success. To help succeed, management retains the prior owners of the subsidiaries and
allow them to do what they do best is run the business. Additionally, management monitors key metrics primarily revenues and net income
from operations.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlsH2wcPUldi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BF_zGmhqirIGRK" style="display: none"&gt;Schedule of segment reporting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Asset:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zkwTNaAFC59k" style="width: 13%; text-align: right" title="Net Assets"&gt;18,955,991&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_pp0p0" style="width: 13%; text-align: right" title="Net Assets"&gt;12,692,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Real Estate&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zM29rMkHYLA8" style="text-align: right" title="Net Assets"&gt;587,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_pp0p0" style="text-align: right" title="Net Assets"&gt;592,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--OthersMember_zL7CXKr2H0M3" style="border-bottom: Black 1pt solid; text-align: right" title="Net Assets"&gt;1,202,364&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--OthersMember_zqMoPFI8Wnpj" style="border-bottom: Black 1pt solid; text-align: right" title="Net Assets"&gt;59,691&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsNet_pp0p0_c20231231_ztySOt9xEDwg" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets"&gt;20,745,811&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsNet_iI_pp0p0_c20221231_z4O4e9zG0pJ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets"&gt;13,344,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Revenues:&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_z2EBXfVa8AP7" style="width: 13%; text-align: right" title="Revenues"&gt;11,853,266&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_ziKpXQM9XMyh" style="width: 13%; text-align: right" title="Revenues"&gt;10,693,196&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Real Estate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_d0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zKIDq3PHzHPg" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zwbyWvvsgc09" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated revenues&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20230101__20231231_zPZqwzy1gbw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;11,853,266&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220101__20221231_zmkKMw9iJHMc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;10,693,196&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cost of Sales:&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CostOfRevenue_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zOcGNcEgRqFd" style="text-align: right" title="Cost of Revenue"&gt;3,560,624&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zWpUNrvJOrqg" style="text-align: right" title="Cost of Revenue"&gt;4,060,034&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Real Estate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CostOfRevenue_pp0p0_d0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zmh8tFgK879h" style="border-bottom: Black 1pt solid; text-align: right" title="Cost of Revenue"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CostOfRevenue_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zwbHB248B9Ga" style="border-bottom: Black 1pt solid; text-align: right" title="Cost of Revenue"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CostOfRevenue_pp0p0_c20230101__20231231_zWcE8AmPXWI7" style="border-bottom: Black 2.5pt double; text-align: right" title="Cost of Revenue"&gt;3,560,624&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CostOfRevenue_pp0p0_c20220101__20221231_za8wehFlMLY7" style="border-bottom: Black 2.5pt double; text-align: right" title="Cost of Revenue"&gt;4,060,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income from operations from subsidiaries&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zo2HKL5pGNI7" style="text-align: right" title="Income from operations from subsidiaries"&gt;7,300,849&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zqkhR1XNT2Pg" style="text-align: right" title="Income from operations from subsidiaries"&gt;5,845,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Real Estate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zQ16PVr3uQ04" style="border-bottom: Black 1pt solid; text-align: right" title="Income from operations from subsidiaries"&gt;(3,716&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zOTDn7ABdGT6" style="border-bottom: Black 1pt solid; text-align: right" title="Income from operations from subsidiaries"&gt;(19,345&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Income from operations from subsidiaries&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--SubsidiaryMember_zj7VXg1urpw" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;7,297,133&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--SubsidiaryMember_zCqeGBJLHhBj" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;5,825,707&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Loss from operations from Cardiff Lexington&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--CardiffLexingtonMember_zb91JX4lRG65" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;(2,102,088&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--CardiffLexingtonMember_z7WTWU5YVmTe" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;(1,918,818&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total income (loss) from operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231_zqGlmKClrxr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;5,195,045&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231_ztnBRAVE3Fqj" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;3,906,889&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income (Loss) before taxes&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zafRCy4ZMXB8" style="text-align: right" title="Income (Loss) before taxes"&gt;5,973,233&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zh1wZvKJ3Tuc" style="text-align: right" title="Income (Loss) before taxes"&gt;74,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Real Estate&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zYeeuj5vvm1g" style="text-align: right" title="Income (Loss) before taxes"&gt;(3,716&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zozNql9LHuP6" style="text-align: right" title="Income (Loss) before taxes"&gt;(19,345&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Corporate, administration and other non-operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_znLUFARitv43" style="border-bottom: Black 1pt solid; text-align: right" title="Income (Loss) before taxes"&gt;(2,941,123&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_z7tkGR5qRzni" style="border-bottom: Black 1pt solid; text-align: right" title="Income (Loss) before taxes"&gt;(5,485,056&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated income (loss) before taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231_zJ7byRrNpMI1" style="border-bottom: Black 2.5pt double; text-align: right" title="Income (Loss) before taxes"&gt;3,028,394&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231_zqE4p1KqFtvi" style="border-bottom: Black 2.5pt double; text-align: right" title="Income (Loss) before taxes"&gt;(5,429,521&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AB_zmDIy4fsrwUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



















</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:Goodwill id="f493" decimals="0" contextRef="c21" unitRef="usd">5666608.0</us-gaap:Goodwill>
  <cardifflexington.com:ReclassificationForCancelledShare id="f494" decimals="INF" contextRef="c160" unitRef="shares">619345.0</cardifflexington.com:ReclassificationForCancelledShare>
  <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent id="f495" decimals="0" contextRef="c8" unitRef="usd">24820.0</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
  <us-gaap:InterestExpenseDebt id="f496" decimals="0" contextRef="c149" unitRef="usd">1127.0</us-gaap:InterestExpenseDebt>
  <us-gaap:AmortizationOfDebtDiscountPremium id="f497" decimals="0" contextRef="c12" unitRef="usd">136518.0</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f498" decimals="0" contextRef="c18" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:CancellationOfSeriesHPreferredStockShares id="f499" decimals="INF" contextRef="c74" unitRef="shares">-37500.0</cardifflexington.com:CancellationOfSeriesHPreferredStockShares>
  <us-gaap:RepaymentsOfConvertibleDebt id="f500" decimals="0" contextRef="c158" unitRef="usd">5908.0</us-gaap:RepaymentsOfConvertibleDebt>
  <us-gaap:ConvertibleDebt id="f501" decimals="0" contextRef="c71" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:AccruedInterest id="f502" decimals="0" contextRef="c161" unitRef="usd">27939.0</cardifflexington.com:AccruedInterest>
  <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent id="f503" decimals="0" contextRef="c21" unitRef="usd">151123.0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
  <us-gaap:DividendsPreferredStock id="f504" decimals="0" contextRef="c54" unitRef="usd">201782.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ConvertibleDebt id="f505" decimals="0" contextRef="c140" unitRef="usd">55000.0</us-gaap:ConvertibleDebt>
  <us-gaap:RedeemablePreferredStockDividends id="f506" decimals="0" contextRef="c12" unitRef="usd">780074.0</us-gaap:RedeemablePreferredStockDividends>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f507" decimals="0" contextRef="c19" unitRef="usd">-360938.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f508" decimals="0" contextRef="c8" unitRef="usd">24820.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:ContractFeesNonPIPPolicyTextBlock id="f509" contextRef="c12">&lt;p id="xdx_842_ecustom--ContractFeesNonPIPPolicyTextBlock_zRK2uOtXX4O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span id="xdx_86C_zYgdIeUfsg88"&gt;Contract Fees (Non-PIP)&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has contract fees for amounts earned
from its Non-Personal Injury Protection (PIP) related procedures, typically car accidents, and are collected on a contingency
basis. Historically, these cases were sold to a factor who bears the risk of economic benefit or loss. After selling patient cases to
the factor, any additional funds collected by the Company were remitted to the factor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</cardifflexington.com:ContractFeesNonPIPPolicyTextBlock>
  <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount id="f510" decimals="0" contextRef="c148" unitRef="usd">307980.0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
  <us-gaap:NotesPayable id="f511" decimals="0" contextRef="c162" unitRef="usd">10989.0</us-gaap:NotesPayable>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="f512" decimals="0" contextRef="c21" unitRef="usd">5000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f513" decimals="0" contextRef="c21" unitRef="usd">46797.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:NotesPayable id="f514" decimals="0" contextRef="c163" unitRef="usd">10989.0</us-gaap:NotesPayable>
  <us-gaap:Assets id="f515" decimals="0" contextRef="c21" unitRef="usd">13344780.0</us-gaap:Assets>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f516" decimals="0" contextRef="c94" unitRef="usd">430180.0</cardifflexington.com:CancellationOfSeriesFPreferredStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised id="f517" decimals="INF" contextRef="c152" unitRef="shares">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo id="f518" decimals="0" contextRef="c8" unitRef="usd">95774.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
  <us-gaap:StockholdersEquity id="f519" decimals="0" contextRef="c159" unitRef="usd">59540000.0</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromLinesOfCredit id="f520" decimals="0" contextRef="c12" unitRef="usd">2164438.0</us-gaap:ProceedsFromLinesOfCredit>
  <cardifflexington.com:AccruedInterests id="f521" decimals="0" contextRef="c162" unitRef="usd">7547.0</cardifflexington.com:AccruedInterests>
  <us-gaap:AmortizationOfDebtDiscountPremium id="f522" decimals="0" contextRef="c44" unitRef="usd">253823.0</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f523" decimals="INF" contextRef="c46" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f524" decimals="0" contextRef="c74" unitRef="usd">150000.0</cardifflexington.com:CancellationOfSeriesHPreferredStock>
  <cardifflexington.com:ConvertibleNotesPayableGross id="f525" decimals="0" contextRef="c164" unitRef="usd">3831850.0</cardifflexington.com:ConvertibleNotesPayableGross>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f526" decimals="0" contextRef="c132" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:DividendsPreferredStock id="f527" decimals="0" contextRef="c" unitRef="usd">47520.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f528" decimals="0" contextRef="c43" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:AccruedInterest id="f529" decimals="0" contextRef="c8" unitRef="usd">612460.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f530" decimals="INF" contextRef="c64" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock id="f531" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zCWHnW27IUu1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RESTATEMENT AND REVISION OF FINANCIAL STATEMENTS (Details - Financical Statements)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B7_zZI1E8cmkmtd" style="display: none"&gt;Schedule of restated financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 25%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsED3V0iKNZi" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;15,297,039&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_iI_pp0p0_d0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z8BKXFX7urMl" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_zLNcX2FgX0ec" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;15,297,039&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zge5aI3TCc4f" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,439,675&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zRrE0TWHEsP2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_z7pwrQF8fGgb" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,439,675&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--MezzanineEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxzcdROXdt6" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;3,125,004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--MezzanineEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvon5NUppmq1" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;245,520&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MezzanineEquity_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_zDod0Ocgy2i4" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;3,370,524&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVVngQI9dTi6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;732,360&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z3OQ2Af9VOpi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(245,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iI_pp0p0_c20211231__srt--RestatementAxis__custom--RestatedMember_zC7TSppfx6rh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;486,840&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf03b9XT2Ki8" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;13,344,780&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_pp0p0_d0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zh2a43imrHf7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Assets_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zjJOCwDlcZH1" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;13,344,780&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvQHLxq1hCm2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,189,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z5eS9CIezdQ7" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zhixvwxQl93d" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,189,585&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--MezzanineEquity_iI_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHhPdHGPO5I8" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;4,625,002&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--MezzanineEquity_pp0p0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIWF1blafnEf" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;274,982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--MezzanineEquity_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zfLZPCgmlHB4" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;4,899,984&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockholdersEquity_pp0p0_c20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbBgEVqgBSfg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,469,809&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquity_pp0p0_c20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIL8eTWcCtg2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(274,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iI_pp0p0_c20221231__srt--RestatementAxis__custom--RestatedMember_zyJnK8PNqhZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,744,791&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;March 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3Wa8D6CQSVe" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;14,284,585&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_pp0p0_d0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_znhdu0bo4Az8" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Assets_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_z4y9sl1iX4R6" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;14,284,585&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOhlpfaUKIx2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,745,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvUnEwOFV1m2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_zY9OCGUhdtA5" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;10,745,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--MezzanineEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaPZc01R0cNk" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,171,861&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--MezzanineEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9hJ3W6zm3nl" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;283,118&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--MezzanineEquity_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_zkF4aVQIfmm7" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,454,979&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYiVUgmuoup1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,632,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zoJ1p50GKJVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(283,118&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iI_pp0p0_c20230331__srt--RestatementAxis__custom--RestatedMember_zJKTk4ccvgc3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,915,491&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Assets_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDeZinqYNNk9" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;16,053,519&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_iI_pp0p0_d0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zU5vZpB6xtae" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_z1UfLJ6yMvq3" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;16,053,519&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9DpK4abK8V6" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,672,952&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zxu0kMaMaEPi" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_zxzsAe0BZNxk" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;11,672,952&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--MezzanineEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z2xutyBA7dpc" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,297,605&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MezzanineEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zsZ5QRJtAsU3" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;291,345&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--MezzanineEquity_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_zLYSUHdjpqm" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,588,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zQuTh8n5vUY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(917,038&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iI_pp0p0_c20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zuXrGawJdUKl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(291,345&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquity_iI_pp0p0_c20230630__srt--RestatementAxis__custom--RestatedMember_zpAtMxIH9a56" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(1,208,383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 1pt"&gt;Total assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjpoDR2Y6aId" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;18,518,727&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_pp0p0_d0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zNAxJOMv2sY9" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_z2F9F5lEAzh8" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Total assets"&gt;18,518,727&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcjYqeJRtf52" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;12,102,942&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--LiabilitiesCurrent1_iI_pp0p0_d0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zBnnJbepuCQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--LiabilitiesCurrent1_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_zO2d7INlqLi9" style="border-bottom: Black 1pt solid; text-align: right" title="Current liabilities"&gt;12,102,942&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Mezzanine equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MezzanineEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjlvsUKVnp8" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,440,434&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--MezzanineEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvM43uQhh6al" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;299,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--MezzanineEquity_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_zUi5FklEn0o5" style="border-bottom: Black 1pt solid; text-align: right" title="Mezzanine equity"&gt;5,740,096&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stockholders' equity&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zA5rWcEVEwl4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;975,351&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iI_pp0p0_c20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2rAUNM6C9Wh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;(299,662&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iI_pp0p0_c20230930__srt--RestatementAxis__custom--RestatedMember_zZxyePGVY5ae" style="border-bottom: Black 2.5pt double; text-align: right" title="Total stockholders' equity"&gt;675,689&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ii. Consolidated statement of operations&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the year&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXm4akmYFl9b" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;666,293&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_d0_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zSXNY8tXN3il" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zDxIGxZ9O9se" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;666,293&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSXDaN8sNqdc" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(201,782&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z07Fi355OfU9" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(47,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zsc5CL1Y7cq1" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(249,302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0Om7dx994a7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;464,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_za4k3uG57vYb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(47,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zORbGaFuEc5j" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;416,991&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zV1J4N8usyz1" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5WIOThzCngb" title="Diluted earnings per share, continued operations"&gt;272&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zTS3V5R4Eiae" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zPaIEW9L4F0b" title="Diluted earnings per share, continued operations"&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_z59CxL5NsfFb" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20210101__20211231__srt--RestatementAxis__custom--RestatedMember_zTipFdqCElpf" title="Diluted earnings per share, continued operations"&gt;244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss for the year&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVGnbe57PYo4" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(5,429,521&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pp0p0_d0_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zcek9uzZB2Z9" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zgtfMEGEYbP3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(5,429,521&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4m2DGIl7Ec8" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(307,188&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zLZE8aE4OKHl" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(76,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zQuHeu2BDR2b" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(384,170&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYnEtxFBtFY1" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(5,736,709&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZGEsxoikSSl" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(76,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zTVCYoQ44E0f" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(5,813,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pdd" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsyLcE2osET1" title="Diluted earnings per share, continued operations"&gt;(994&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_pdd" title="Diluted earnings per share, continued operations"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_z7RcX91K8Tni" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20220101__20221231__srt--RestatementAxis__custom--RestatedMember_zmTClOpQ54t4" title="Diluted earnings per share, continued operations"&gt;(999&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Three months ended March 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net loss for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8ZZ4jSHQFJ3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(15,991&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9k7pyT9fyw2" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zRVkUtV5zbNh" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;(15,991&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6xATN3s7S51" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(336,811&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zi1U1wEwHqB1" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(8,136&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zB2p7rCH1Sl5" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(344,947&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zD4NSrbmuOmk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(352,802&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z3nt3j93UgE3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(8,136&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_z7EkZ1jZlAi" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(360,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zY6OeQVcPhp5" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230101__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyepbM3zKoP2" title="Diluted earnings per share, continued operations"&gt;(30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zVy5nYHQSgdj" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20230101__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zxrClIL2iYb7" title="Diluted earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zbq2YAsnxjXl" title="Basic earnings per share, continued operations"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20230101__20230331__srt--RestatementAxis__custom--RestatedMember_zP7Xsw87Q28d" title="Diluted earnings per share, continued operations"&gt;(31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Three months ended June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_pp0p0_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zhZNlMsCHish" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;816,078&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGUoYkuyqBW7" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLoss_pp0p0_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zR5OUnBcGcZj" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;816,078&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zal4pFqADfGf" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(125,744&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_znk6gZVM3E9c" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(8,227&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zI2BXYX1osg6" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(133,971&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsqzb7SiGF0d" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;690,334&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zVhY7Vt8APxj" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(8,227&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zFbbEgqJoxgf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;682,107&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zO0DZY6DJ8y5" title="Basic earnings per share, continued operations"&gt;56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQAstmoLSR33" title="Basic earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_zQKLiEWaQ6Ph" title="Basic earnings per share, continued operations"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230401__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM0aDP2Kpe1a" title="Diluted earnings per share, continued operations"&gt;(21&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_c20230401__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zAZrxaLQY0we" title="Diluted earnings per share, continued operations"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230401__20230630__srt--RestatementAxis__custom--RestatedMember_z0dN77DcY1ef" title="Diluted earnings per share, continued operations"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Six months ended June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zclEgbf6jOgl" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;800,087&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMQXP8JQJTc9" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zqNUwtRxculc" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;800,087&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zClAQqQ4J0s2" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(462,555&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zynEqd8Z8Fm5" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(16,363&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zVPmo2SKVF2k" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(478,918&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqUgd4CcY167" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;337,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zZpOj9lUgUO6" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(16,363&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zixyHC3M2fE7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;321,169&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHhDg4HMfPpd" title="Basic earnings per share, continued operations"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zDbEgXiLTrGi" title="Basic earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_z8d5niw8Uk19" title="Basic earnings per share, continued operations"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20230101__20230630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z14Z2Akq7n7d" title="Diluted earnings per share, continued operations"&gt;(16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20230101__20230630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCyk0gyhYf3c" title="Diluted earnings per share, continued operations"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20230101__20230630__srt--RestatementAxis__custom--RestatedMember_zWPbwthPgV9g" title="Diluted earnings per share, continued operations"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Three months ended September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the period&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ziLlobifr5C3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;1,981,520&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zDDyyVl1dTH" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_zDYIX5Etq9Wl" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;1,981,520&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcH43c2KTkcl" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(142,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zMZAOY2lSdTf" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(8,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_zhaMYZ0sNGIl" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(151,146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM8VGcLKgkwa" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;1,838,691&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zp3HrFYXVgOg" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(8,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_z8UIX6ov9NK2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;1,830,374&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcgqJPLLMNOj" title="Basic earnings per share, continued operations"&gt;137&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zb9fDu07cJoa" title="Basic earnings per share, continued operations"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_z8Pt0SvcNJMh" title="Basic earnings per share, continued operations"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ztVTJLRUyppf" title="Diluted earnings per share, continued operations"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zOWUpTfDMhnf" title="Diluted earnings per share, continued operations"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230701__20230930__srt--RestatementAxis__custom--RestatedMember_zBx5MQ8jRDr4" title="Diluted earnings per share, continued operations"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;Impact of correction of error&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Nine months ended September 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As previously reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;As restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: left; padding-bottom: 2.5pt"&gt;Net income for the year&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwVSiHOxca2g" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;2,781,608&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_pp0p0_d0_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zA7NnoAXOafc" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pp0p0_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_zACpT12tNVO3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Net income (loss)"&gt;2,781,608&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred stock dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqNwTQmSYNMd" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(605,384&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_z9pAvw1GTldk" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(24,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DividendsPreferredStock_iN_pp0p0_di_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_z9FFKGf8B0el" style="border-bottom: Black 2.5pt double; text-align: right" title="Preferred stock dividends"&gt;(630,065&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrF0xlnWAc41" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;2,176,224&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwFTReh9Z7vi" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;(24,681&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_z6deMxdJldMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss attributable to common shareholders"&gt;2,151,543&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZeZn88CUpnc" title="Basic earnings per share, continued operations"&gt;167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zfBoNQWRMfC6" title="Basic earnings per share, continued operations"&gt;(2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_zFSc1yT1KFXd" title="Basic earnings per share, continued operations"&gt;165&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted earnings per share for continuing operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zU6tlKYUvWn" title="Diluted earnings per share, continued operations"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgNG5hYmJXae" title="Diluted earnings per share, continued operations"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_c20230101__20230930__srt--RestatementAxis__custom--RestatedMember_zPFbTZJFPAy1" title="Diluted earnings per share, continued operations"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
  <us-gaap:StockholdersEquity id="f532" decimals="0" contextRef="c165" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:RedeemablePreferredStockDividends id="f533" decimals="0" contextRef="c44" unitRef="usd">384170.0</us-gaap:RedeemablePreferredStockDividends>
  <cardifflexington.com:AccruedInterests id="f534" decimals="0" contextRef="c163" unitRef="usd">6229.0</cardifflexington.com:AccruedInterests>
  <cardifflexington.com:MezzanineEquity id="f535" decimals="0" contextRef="c126" unitRef="usd">5440434.0</cardifflexington.com:MezzanineEquity>
  <cardifflexington.com:AccruedInterest id="f536" decimals="0" contextRef="c166" unitRef="usd">1127.0</cardifflexington.com:AccruedInterest>
  <us-gaap:ConvertibleDebt id="f537" decimals="0" contextRef="c21" unitRef="usd">3562550.0</us-gaap:ConvertibleDebt>
  <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount id="f538" decimals="0" contextRef="c150" unitRef="usd">274982.0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents id="f539" decimals="0" contextRef="c42" unitRef="usd">342.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f540" decimals="0" contextRef="c74" unitRef="usd">270000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF>
  <us-gaap:InterestExpenseDebt id="f541" decimals="0" contextRef="c114" unitRef="usd">7242.0</us-gaap:InterestExpenseDebt>
  <us-gaap:PreferredStockSharesOutstanding id="f542" decimals="INF" contextRef="c25" unitRef="shares">2131328.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CostOfRevenue id="f543" decimals="0" contextRef="c44" unitRef="usd">4060034.0</us-gaap:CostOfRevenue>
  <cardifflexington.com:AccruedInterest id="f544" decimals="0" contextRef="c115" unitRef="usd">69876.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue id="f545" decimals="INF" contextRef="c152" unitRef="usd1">0.0</cardifflexington.com:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue>
  <us-gaap:SharesOutstanding id="f546" decimals="INF" contextRef="c167" unitRef="shares">4364057.0</us-gaap:SharesOutstanding>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="f547" decimals="0" contextRef="c12" unitRef="usd">341261.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:ProceedsFromLinesOfCredit id="f548" decimals="0" contextRef="c44" unitRef="usd">0.0</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:AssetsCurrent id="f549" decimals="0" contextRef="c8" unitRef="usd">14177197.0</us-gaap:AssetsCurrent>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f550" decimals="INF" contextRef="c141" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:AccruedInterest id="f551" decimals="0" contextRef="c109" unitRef="usd">614.0</cardifflexington.com:AccruedInterest>
  <us-gaap:MarketingAndAdvertisingExpense id="f552" decimals="0" contextRef="c12" unitRef="usd">126670.0</us-gaap:MarketingAndAdvertisingExpense>
  <cardifflexington.com:NetLiabilitiesOfDiscontinuedOperations id="f553" decimals="0" contextRef="c42" unitRef="usd">-237643.0</cardifflexington.com:NetLiabilitiesOfDiscontinuedOperations>
  <us-gaap:DividendsPreferredStock id="f554" decimals="0" contextRef="c26" unitRef="usd">249302.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f555" decimals="INF" contextRef="c59" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:EarningsPerShareBasic id="f556" decimals="INF" contextRef="c128" unitRef="usd1">-30.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="f557" decimals="INF" contextRef="c38" unitRef="usd1">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 id="f558" decimals="0" contextRef="c155" unitRef="usd">87460.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree id="f559" decimals="0" contextRef="c8" unitRef="usd">23282.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
  <us-gaap:EarningsPerShareDiluted id="f560" decimals="INF" contextRef="c128" unitRef="usd1">-30.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="f561" decimals="INF" contextRef="c12" unitRef="shares">15001.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:NonoperatingIncomeExpense id="f562" decimals="0" contextRef="c12" unitRef="usd">-2080131.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f563" decimals="0" contextRef="c117" unitRef="usd">-5736709.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ConvertibleDebt id="f564" decimals="0" contextRef="c46" unitRef="usd">35500.0</us-gaap:ConvertibleDebt>
  <us-gaap:MarketingAndAdvertisingExpense id="f565" decimals="0" contextRef="c44" unitRef="usd">233798.0</us-gaap:MarketingAndAdvertisingExpense>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents id="f566" decimals="0" contextRef="c11" unitRef="usd">7717.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
  <cardifflexington.com:DebtConversionConvertedInterestAmount1 id="f567" decimals="0" contextRef="c155" unitRef="usd">112429.0</cardifflexington.com:DebtConversionConvertedInterestAmount1>
  <us-gaap:PreferredStockSharesAuthorized id="f568" decimals="INF" contextRef="c2" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f569" decimals="0" contextRef="c12" unitRef="usd">2248320.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:MezzanineEquity id="f570" decimals="0" contextRef="c146" unitRef="usd">5588950.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:ProceedsFromLoans id="f571" decimals="0" contextRef="c168" unitRef="usd">150000.0</us-gaap:ProceedsFromLoans>
  <us-gaap:DividendsPreferredStock id="f572" decimals="0" contextRef="c169" unitRef="usd">109980.0</us-gaap:DividendsPreferredStock>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock id="f573" contextRef="c12">&lt;p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zRvia7QiEcQk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zsX095o5zvfi"&gt;Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment
associated with the inputs used to measure their fair value. The fair value hierarchy distinguishes between (1) market participant assumptions
developed based on market data obtained from independent sources (observable inputs), and (2) an entitys own assumptions about
market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair
value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical
assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy
are described below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 5%"&gt;&lt;/td&gt;
  &lt;td style="text-align: left; width: 10%"&gt;Level 1&lt;/td&gt;
  &lt;td style="text-align: justify; width: 85%"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;Level 2&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;Inputs,
other than quoted prices included in Level 1, which are observable for the asset or liability through corroboration with market data at
the measurement date.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;Level 3&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;Unobservable
inputs that reflect managements best estimate of what market participants would use in pricing the asset or liability at the measurement
date.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -81pt"&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:StockholdersEquity id="f574" decimals="0" contextRef="c167" unitRef="usd">17436228.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f575" decimals="0" contextRef="c44" unitRef="usd">-270000.0</cardifflexington.com:CancellationOfSeriesFPreferredStock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="f576" decimals="0" contextRef="c44" unitRef="usd">-1150677.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PreferredStockSharesAuthorized id="f577" decimals="INF" contextRef="c3" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f578" decimals="0" contextRef="c166" unitRef="usd">2321.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:DebtConversionConvertedCostAmount1 id="f579" decimals="0" contextRef="c155" unitRef="usd">3000.0</cardifflexington.com:DebtConversionConvertedCostAmount1>
  <us-gaap:ProceedsFromConvertibleDebt id="f580" decimals="0" contextRef="c12" unitRef="usd">544165.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="f581" decimals="0" contextRef="c44" unitRef="usd">750878.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <cardifflexington.com:AccruedInterest id="f582" decimals="0" contextRef="c127" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:AssetsCurrent id="f583" decimals="0" contextRef="c21" unitRef="usd">6828005.0</us-gaap:AssetsCurrent>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="f584" decimals="INF" contextRef="c168" unitRef="pure">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f585" decimals="0" contextRef="c170" unitRef="usd">-2102088.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations id="f586" decimals="INF" contextRef="c152" unitRef="shares">1.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 id="f587" decimals="0" contextRef="c155" unitRef="shares">13068.0</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock id="f588" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zlsH2wcPUldi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BF_zGmhqirIGRK" style="display: none"&gt;Schedule of segment reporting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;Asset:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zkwTNaAFC59k" style="width: 13%; text-align: right" title="Net Assets"&gt;18,955,991&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_pp0p0" style="width: 13%; text-align: right" title="Net Assets"&gt;12,692,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Real Estate&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsNet_iI_pp0p0_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zM29rMkHYLA8" style="text-align: right" title="Net Assets"&gt;587,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_pp0p0" style="text-align: right" title="Net Assets"&gt;592,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--OthersMember_zL7CXKr2H0M3" style="border-bottom: Black 1pt solid; text-align: right" title="Net Assets"&gt;1,202,364&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--OthersMember_zqMoPFI8Wnpj" style="border-bottom: Black 1pt solid; text-align: right" title="Net Assets"&gt;59,691&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsNet_pp0p0_c20231231_ztySOt9xEDwg" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets"&gt;20,745,811&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsNet_iI_pp0p0_c20221231_z4O4e9zG0pJ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets"&gt;13,344,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Revenues:&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_z2EBXfVa8AP7" style="width: 13%; text-align: right" title="Revenues"&gt;11,853,266&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_ziKpXQM9XMyh" style="width: 13%; text-align: right" title="Revenues"&gt;10,693,196&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Real Estate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_d0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zKIDq3PHzHPg" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zwbyWvvsgc09" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated revenues&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pp0p0_c20230101__20231231_zPZqwzy1gbw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;11,853,266&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220101__20221231_zmkKMw9iJHMc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;10,693,196&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cost of Sales:&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CostOfRevenue_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zOcGNcEgRqFd" style="text-align: right" title="Cost of Revenue"&gt;3,560,624&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CostOfRevenue_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zWpUNrvJOrqg" style="text-align: right" title="Cost of Revenue"&gt;4,060,034&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Real Estate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CostOfRevenue_pp0p0_d0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zmh8tFgK879h" style="border-bottom: Black 1pt solid; text-align: right" title="Cost of Revenue"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CostOfRevenue_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zwbHB248B9Ga" style="border-bottom: Black 1pt solid; text-align: right" title="Cost of Revenue"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CostOfRevenue_pp0p0_c20230101__20231231_zWcE8AmPXWI7" style="border-bottom: Black 2.5pt double; text-align: right" title="Cost of Revenue"&gt;3,560,624&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CostOfRevenue_pp0p0_c20220101__20221231_za8wehFlMLY7" style="border-bottom: Black 2.5pt double; text-align: right" title="Cost of Revenue"&gt;4,060,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income from operations from subsidiaries&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zo2HKL5pGNI7" style="text-align: right" title="Income from operations from subsidiaries"&gt;7,300,849&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zqkhR1XNT2Pg" style="text-align: right" title="Income from operations from subsidiaries"&gt;5,845,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Real Estate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zQ16PVr3uQ04" style="border-bottom: Black 1pt solid; text-align: right" title="Income from operations from subsidiaries"&gt;(3,716&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zOTDn7ABdGT6" style="border-bottom: Black 1pt solid; text-align: right" title="Income from operations from subsidiaries"&gt;(19,345&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Income from operations from subsidiaries&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--SubsidiaryMember_zj7VXg1urpw" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;7,297,133&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--SubsidiaryMember_zCqeGBJLHhBj" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;5,825,707&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Loss from operations from Cardiff Lexington&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--CardiffLexingtonMember_zb91JX4lRG65" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;(2,102,088&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--CardiffLexingtonMember_z7WTWU5YVmTe" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;(1,918,818&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total income (loss) from operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20230101__20231231_zqGlmKClrxr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;5,195,045&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20220101__20221231_ztnBRAVE3Fqj" style="border-bottom: Black 2.5pt double; text-align: right" title="Income from operations from subsidiaries"&gt;3,906,889&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income (Loss) before taxes&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Healthcare&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zafRCy4ZMXB8" style="text-align: right" title="Income (Loss) before taxes"&gt;5,973,233&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zh1wZvKJ3Tuc" style="text-align: right" title="Income (Loss) before taxes"&gt;74,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Real Estate&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zYeeuj5vvm1g" style="text-align: right" title="Income (Loss) before taxes"&gt;(3,716&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstatesMember_zozNql9LHuP6" style="text-align: right" title="Income (Loss) before taxes"&gt;(19,345&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Corporate, administration and other non-operating expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_znLUFARitv43" style="border-bottom: Black 1pt solid; text-align: right" title="Income (Loss) before taxes"&gt;(2,941,123&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_z7tkGR5qRzni" style="border-bottom: Black 1pt solid; text-align: right" title="Income (Loss) before taxes"&gt;(5,485,056&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Consolidated income (loss) before taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20230101__20231231_zJ7byRrNpMI1" style="border-bottom: Black 2.5pt double; text-align: right" title="Income (Loss) before taxes"&gt;3,028,394&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220101__20221231_zqE4p1KqFtvi" style="border-bottom: Black 2.5pt double; text-align: right" title="Income (Loss) before taxes"&gt;(5,429,521&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:PreferredStockSharesAuthorized id="f589" decimals="INF" contextRef="c25" unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
  <cardifflexington.com:LiabilitiesCurrent1 id="f590" decimals="0" contextRef="c130" unitRef="usd">11672952.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f591" decimals="INF" contextRef="c2" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:DebtInstrumentMaturityDate id="f592" contextRef="c43">2021-06-30</us-gaap:DebtInstrumentMaturityDate>
  <cardifflexington.com:CommonStockIssuedUponConversionOfNotesPayable id="f593" decimals="0" contextRef="c44" unitRef="usd">0.0</cardifflexington.com:CommonStockIssuedUponConversionOfNotesPayable>
  <us-gaap:RepaymentsOfLinesOfCredit id="f594" decimals="0" contextRef="c12" unitRef="usd">39293.0</us-gaap:RepaymentsOfLinesOfCredit>
  <us-gaap:LoansPayable id="f595" decimals="0" contextRef="c171" unitRef="usd">149655.0</us-gaap:LoansPayable>
  <us-gaap:NonoperatingIncomeExpense id="f596" decimals="0" contextRef="c44" unitRef="usd">-7157527.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:DebtCurrent id="f597" decimals="0" contextRef="c31" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:CostOfRevenue id="f598" decimals="0" contextRef="c120" unitRef="usd">3560624.0</us-gaap:CostOfRevenue>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f599" decimals="INF" contextRef="c3" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ConvertibleDebt id="f600" decimals="0" contextRef="c141" unitRef="usd">5000.0</us-gaap:ConvertibleDebt>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt id="f601" decimals="0" contextRef="c155" unitRef="usd">777217.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:OtherLongTermNotesPayable id="f602" decimals="0" contextRef="c8" unitRef="usd">144666.0</us-gaap:OtherLongTermNotesPayable>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f603" decimals="0" contextRef="c54" unitRef="usd">464511.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ConvertibleDebt id="f604" decimals="0" contextRef="c59" unitRef="usd">113667.0</us-gaap:ConvertibleDebt>
  <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue id="f605" decimals="0" contextRef="c8" unitRef="usd">276725.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
  <cardifflexington.com:AccruedInterest id="f606" decimals="0" contextRef="c95" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f607" decimals="0" contextRef="c44" unitRef="usd">-5813691.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasic id="f608" decimals="INF" contextRef="c136" unitRef="usd1">-1.0</us-gaap:EarningsPerShareBasic>
  <cardifflexington.com:AccruedInterests id="f609" decimals="0" contextRef="c171" unitRef="usd">956.0</cardifflexington.com:AccruedInterests>
  <us-gaap:PreferredStockSharesAuthorized id="f610" decimals="INF" contextRef="c121" unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:SharesOutstanding id="f611" decimals="INF" contextRef="c5" unitRef="shares">123.0</us-gaap:SharesOutstanding>
  <cardifflexington.com:AccruedInterest id="f612" decimals="0" contextRef="c135" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:EarningsPerShareDiluted id="f613" decimals="INF" contextRef="c136" unitRef="usd1">-1.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet id="f614" decimals="0" contextRef="c42" unitRef="usd">300.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="f615" decimals="0" contextRef="c12" unitRef="usd">-86520.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:PreferredStockSharesAuthorized id="f616" decimals="INF" contextRef="c113" unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="f617" decimals="INF" contextRef="c64" unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:LoansPayable id="f618" decimals="0" contextRef="c172" unitRef="usd">144609.0</us-gaap:LoansPayable>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="f619" decimals="0" contextRef="c173" unitRef="usd">-1918818.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="f620" decimals="INF" contextRef="c152" unitRef="usd1">0.0146</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent id="f621" decimals="0" contextRef="c8" unitRef="usd">237643.0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
  <us-gaap:DebtCurrent id="f622" decimals="0" contextRef="c8" unitRef="usd">87460.0</us-gaap:DebtCurrent>
  <us-gaap:IncreaseDecreaseInDueFromRelatedParties id="f623" decimals="0" contextRef="c12" unitRef="usd">-0.0</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
  <us-gaap:RepaymentsOfLinesOfCredit id="f624" decimals="0" contextRef="c44" unitRef="usd">-0.0</us-gaap:RepaymentsOfLinesOfCredit>
  <cardifflexington.com:AccruedInterests id="f625" decimals="0" contextRef="c172" unitRef="usd">5723.0</cardifflexington.com:AccruedInterests>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f626" decimals="0" contextRef="c127" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:PreferredStockSharesIssued id="f627" decimals="INF" contextRef="c2" unitRef="shares">375000.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:CostOfRevenue id="f628" decimals="0" contextRef="c133" unitRef="usd">4060034.0</us-gaap:CostOfRevenue>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f629" decimals="INF" contextRef="c108" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f630" decimals="INF" contextRef="c121" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <cardifflexington.com:AccruedInterest id="f631" decimals="0" contextRef="c131" unitRef="usd">8385.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:CancellationOfCommonStock id="f632" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:NetIncomeLoss id="f633" decimals="0" contextRef="c60" unitRef="usd">1981520.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:MinimumAnnualAmount id="f634" decimals="-5" contextRef="c174" unitRef="usd">3700000.0</cardifflexington.com:MinimumAnnualAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="f635" decimals="INF" contextRef="c137" unitRef="shares">3141.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f636" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <cardifflexington.com:ConversionOfConvertibleNotesPayableShares id="f637" decimals="INF" contextRef="c176" unitRef="shares">13068.0</cardifflexington.com:ConversionOfConvertibleNotesPayableShares>
  <cardifflexington.com:LossOnSettlement id="f638" decimals="0" contextRef="c33" unitRef="usd">-212600.0</cardifflexington.com:LossOnSettlement>
  <us-gaap:SharesOutstanding id="f639" decimals="INF" contextRef="c177" unitRef="shares">14885001.0</us-gaap:SharesOutstanding>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f640" decimals="INF" contextRef="c178" unitRef="shares">1672.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f641" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:DebtInstrumentMaturityDate id="f642" contextRef="c180">2024-06-05</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:NetIncomeLoss id="f643" decimals="0" contextRef="c53" unitRef="usd">2781608.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f644" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:GrossProfit id="f645" decimals="0" contextRef="c44" unitRef="usd">6633162.0</us-gaap:GrossProfit>
  <us-gaap:StockholdersEquity id="f646" decimals="0" contextRef="c110" unitRef="usd">488.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f647" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:LeaseholdImprovementsGross id="f648" decimals="0" contextRef="c21" unitRef="usd">15950.0</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:ConvertibleDebt id="f649" decimals="0" contextRef="c181" unitRef="usd">68667.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f650" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <dei:EntityAddressPostalZipCode id="f651" contextRef="c12">89169</dei:EntityAddressPostalZipCode>
  <us-gaap:PreferredStockValue id="f652" decimals="0" contextRef="c182" unitRef="usd">1277972.0</us-gaap:PreferredStockValue>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f653" contextRef="c70">2020-12-29</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f654" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:InterestExpenseDebt id="f655" decimals="0" contextRef="c183" unitRef="usd">2849.0</us-gaap:InterestExpenseDebt>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f656" xsi:nil="true" contextRef="c74" unitRef="usd"/>
  <cardifflexington.com:AccruedInterest id="f657" decimals="0" contextRef="c140" unitRef="usd">80875.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:AccruedInterest id="f658" decimals="0" contextRef="c66" unitRef="usd">39684.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f659" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:Assets id="f660" decimals="0" contextRef="c51" unitRef="usd">0.0</us-gaap:Assets>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f661" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:NetIncomeLoss id="f662" decimals="0" contextRef="c14" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="f663" decimals="INF" contextRef="c184" unitRef="shares">3140.0</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ConvertibleNotesPayable id="f664" decimals="0" contextRef="c21" unitRef="usd">3515752.0</us-gaap:ConvertibleNotesPayable>
  <cardifflexington.com:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable id="f665" decimals="INF" contextRef="c137" unitRef="usd1">0.015</cardifflexington.com:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f666" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f667" decimals="0" contextRef="c176" unitRef="usd">980006.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:DebtCurrent id="f668" decimals="0" contextRef="c185" unitRef="usd">10000.0</us-gaap:DebtCurrent>
  <us-gaap:StockholdersEquity id="f669" decimals="0" contextRef="c177" unitRef="usd">59540000.0</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromConvertibleDebt id="f670" decimals="0" contextRef="c186" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f671" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:ConvertibleDebt id="f672" decimals="0" contextRef="c187" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:NetIncomeLoss id="f673" decimals="0" contextRef="c15" unitRef="usd">800087.0</us-gaap:NetIncomeLoss>
  <us-gaap:AdditionalPaidInCapital id="f674" decimals="0" contextRef="c21" unitRef="usd">-8581265.0</us-gaap:AdditionalPaidInCapital>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f675" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:AssetsNet id="f676" decimals="0" contextRef="c8" unitRef="usd">20745811.0</us-gaap:AssetsNet>
  <us-gaap:SharesOutstanding id="f677" decimals="INF" contextRef="c188" unitRef="shares">-619345.0</us-gaap:SharesOutstanding>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f678" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f679" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:DebtInstrumentMaturityDate id="f680" contextRef="c10">2024-02-10</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="f681" decimals="0" contextRef="c22" unitRef="usd">-86520.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:NatureOfOperations id="f682" contextRef="c12">&lt;p id="xdx_842_eus-gaap--NatureOfOperations_z6CG88wIodMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zqBM2VhAuvyj"&gt;Organization and Nature of Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cardiff Lexington Corporation (Cardiff)
was originally incorporated on September 3, 1986 in Colorado as Cardiff International Inc. On November 10, 2005, Cardiff merged with Legacy
Card Company, LLC and changed its name to Cardiff Lexington Corporation. On August 27, 2014, Cardiff redomiciled and became a corporation
under the laws of Florida. On April 13, 2021, Cardiff redomiciled and became a corporation under the laws of Nevada.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cardiff is an acquisition holding company focused
on locating undervalued and undercapitalized companies, primarily in the healthcare industry, and providing them capitalization and leadership
to maximize the value and potential of their private enterprises while also providing diversification and risk mitigation for stockholders.
All of Cardiffs operations are conducted through, and its income derived from, its various subsidiaries, which includes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;We Three, LLC dba Affordable Housing Initiative (AHI), which was acquired on May 15, 2014
and sold on October 31, 2022;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Edge View Properties, Inc. (Edge View), which was acquired on July 16, 2014;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Platinum Tax Defenders (Platinum Tax), which was acquired on July 31, 2018 and sold on November
10, 2023; and&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Nova Ortho and Spine, LLC (Nova), which was acquired on May 31, 2021.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
  <us-gaap:ConvertibleDebt id="f683" decimals="0" contextRef="c178" unitRef="usd">50080.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f684" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f685" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:DebtInstrumentMaturityDate id="f686" contextRef="c70">2021-09-30</us-gaap:DebtInstrumentMaturityDate>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f687" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="f688" decimals="0" contextRef="c12" unitRef="usd">647858.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <us-gaap:Assets id="f689" decimals="0" contextRef="c63" unitRef="usd">13344780.0</us-gaap:Assets>
  <us-gaap:PropertyPlantAndEquipmentGross id="f690" decimals="0" contextRef="c8" unitRef="usd">136750.0</us-gaap:PropertyPlantAndEquipmentGross>
  <cardifflexington.com:PreferredStockIssuedForBusinessAcquisition id="f691" decimals="0" contextRef="c12" unitRef="usd">0.0</cardifflexington.com:PreferredStockIssuedForBusinessAcquisition>
  <cardifflexington.com:AccruedInterest id="f692" decimals="0" contextRef="c189" unitRef="usd">2263.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:AccruedInterest id="f693" decimals="0" contextRef="c190" unitRef="usd">1072.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f694" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:NetIncomeLoss id="f695" decimals="0" contextRef="c37" unitRef="usd">1981520.0</us-gaap:NetIncomeLoss>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="f696" decimals="INF" contextRef="c184" unitRef="usd1">0.015</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f697" decimals="0" contextRef="c94" unitRef="usd">-8201.0</cardifflexington.com:CancellationOfSeriesKPreferredStock>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f698" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <cardifflexington.com:ReclassificationForCancelledShares id="f699" decimals="0" contextRef="c160" unitRef="usd">4967686.0</cardifflexington.com:ReclassificationForCancelledShares>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f700" decimals="0" contextRef="c191" unitRef="usd">-777117.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f701" decimals="INF" contextRef="c192" unitRef="shares">10000.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <cardifflexington.com:AccruedInterest id="f702" decimals="0" contextRef="c193" unitRef="usd">10109.0</cardifflexington.com:AccruedInterest>
  <us-gaap:SharesOutstanding id="f703" decimals="INF" contextRef="c194" unitRef="shares">4350907.0</us-gaap:SharesOutstanding>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f704" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <cardifflexington.com:PropertyPlantAndEquipmentEstimatedUsefulLives1 id="f705" contextRef="c195">5 - 7 years</cardifflexington.com:PropertyPlantAndEquipmentEstimatedUsefulLives1>
  <us-gaap:NetIncomeLoss id="f706" decimals="0" contextRef="c39" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f707" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:AssetsNet id="f708" decimals="0" contextRef="c21" unitRef="usd">13344780.0</us-gaap:AssetsNet>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f709" contextRef="c10">2023-02-10</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:StockholdersEquity id="f710" decimals="0" contextRef="c188" unitRef="usd">-4967686.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f711" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="f712" decimals="0" contextRef="c192" unitRef="usd">10000.0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f713" xsi:nil="true" contextRef="c74" unitRef="usd"/>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="f714" decimals="0" contextRef="c33" unitRef="usd">-2178883.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:DebtCurrent id="f715" decimals="0" contextRef="c196" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f716" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="f717" decimals="0" contextRef="c8" unitRef="usd">-68684115.0</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:ProceedsFromConvertibleDebt id="f718" decimals="0" contextRef="c180" unitRef="usd">139166.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f719" decimals="INF" contextRef="c185" unitRef="shares">312.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f720" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:ConvertibleDebt id="f721" decimals="0" contextRef="c197" unitRef="usd">113166.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:ReclassificationForCancelledShares id="f722" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:DividendsPreferredStock id="f723" decimals="0" contextRef="c198" unitRef="usd">190685.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ProfitLoss id="f724" decimals="0" contextRef="c12" unitRef="usd">3028394.0</us-gaap:ProfitLoss>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="f725" decimals="0" contextRef="c44" unitRef="usd">-361883.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <us-gaap:PropertyPlantAndEquipmentGross id="f726" decimals="0" contextRef="c21" unitRef="usd">141883.0</us-gaap:PropertyPlantAndEquipmentGross>
  <cardifflexington.com:PreferredStockIssuedForBusinessAcquisition id="f727" decimals="0" contextRef="c44" unitRef="usd">3275000.0</cardifflexington.com:PreferredStockIssuedForBusinessAcquisition>
  <us-gaap:InterestExpenseDebt id="f728" decimals="0" contextRef="c70" unitRef="usd">19417.0</us-gaap:InterestExpenseDebt>
  <cardifflexington.com:ReclassificationForCancelledShares id="f729" xsi:nil="true" contextRef="c74" unitRef="usd"/>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare id="f730" decimals="INF" contextRef="c12" unitRef="usd1">232.0</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <cardifflexington.com:AccruedInterest id="f731" decimals="0" contextRef="c199" unitRef="usd">14157.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:ReclassificationForCancelledShares id="f732" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:DividendsPreferredStock id="f733" decimals="0" contextRef="c6" unitRef="usd">24681.0</us-gaap:DividendsPreferredStock>
  <us-gaap:StockholdersEquity id="f734" decimals="0" contextRef="c194" unitRef="usd">17403628.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertibleDebt id="f735" decimals="0" contextRef="c1" unitRef="usd">25000.0</us-gaap:ConvertibleDebt>
  <us-gaap:Dividends id="f736" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:Assets id="f737" decimals="0" contextRef="c7" unitRef="usd">15297039.0</us-gaap:Assets>
  <us-gaap:NetIncomeLoss id="f738" decimals="0" contextRef="c200" unitRef="usd">800087.0</us-gaap:NetIncomeLoss>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f739" decimals="0" contextRef="c201" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:Dividends id="f740" xsi:nil="true" contextRef="c74" unitRef="usd"/>
  <us-gaap:InterestExpenseDebt id="f741" decimals="0" contextRef="c202" unitRef="usd">6867.0</us-gaap:InterestExpenseDebt>
  <us-gaap:Dividends id="f742" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:DividendsPreferredStock id="f743" decimals="0" contextRef="c60" unitRef="usd">142829.0</us-gaap:DividendsPreferredStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="f744" decimals="INF" contextRef="c184" unitRef="shares">3140.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:Dividends id="f745" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <dei:CityAreaCode id="f746" contextRef="c12">844</dei:CityAreaCode>
  <us-gaap:ProceedsFromConvertibleDebt id="f747" decimals="0" contextRef="c149" unitRef="usd">21167.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f748" decimals="0" contextRef="c193" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:NetIncomeLoss id="f749" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="f750" decimals="0" contextRef="c21" unitRef="usd">-70932435.0</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:NetIncomeLoss id="f751" xsi:nil="true" contextRef="c74" unitRef="usd"/>
  <us-gaap:InterestPaidNet id="f752" decimals="0" contextRef="c44" unitRef="usd">0.0</us-gaap:InterestPaidNet>
  <us-gaap:RealEstateDisclosureTextBlock id="f753" contextRef="c12">&lt;p id="xdx_802_eus-gaap--RealEstateDisclosureTextBlock_z4Qb7is75pC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;5.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_821_zpQuLhmfNWog"&gt;LAND&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2023 and 2022, the Company
had 27 acres of land of approximately $&lt;span id="xdx_90E_eus-gaap--Land_iI_c20231231_zQr73FOn1Que" title="Land value"&gt;&lt;span id="xdx_905_eus-gaap--Land_iI_c20221231_zVbIJ8P1VdS4" title="Land value"&gt;540,000&lt;/span&gt;&lt;/span&gt;. The land is currently vacant and is expected to be developed into a residential community.&lt;/p&gt;

</us-gaap:RealEstateDisclosureTextBlock>
  <dei:DocumentFinStmtErrorCorrectionFlag id="f754" contextRef="c12">false</dei:DocumentFinStmtErrorCorrectionFlag>
  <us-gaap:NetIncomeLoss id="f755" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <dei:LocalPhoneNumber id="f756" contextRef="c12">628-2100</dei:LocalPhoneNumber>
  <us-gaap:ProfitLoss id="f757" decimals="0" contextRef="c44" unitRef="usd">-5429521.0</us-gaap:ProfitLoss>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 id="f758" decimals="INF" contextRef="c203" unitRef="shares">13068.0</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:NetIncomeLoss id="f759" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare id="f760" decimals="INF" contextRef="c44" unitRef="usd1">-999.0</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f761" decimals="0" contextRef="c186" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:SharesOutstanding id="f762" xsi:nil="true" contextRef="c204" unitRef="shares"/>
  <cardifflexington.com:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue id="f763" decimals="INF" contextRef="c38" unitRef="usd1">0.0</cardifflexington.com:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue>
  <us-gaap:DebtCurrent id="f764" decimals="0" contextRef="c123" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:SharesOutstanding id="f765" decimals="INF" contextRef="c205" unitRef="shares">123.0</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f766" xsi:nil="true" contextRef="c206" unitRef="usd"/>
  <cardifflexington.com:MezzanineEquity id="f767" decimals="0" contextRef="c130" unitRef="usd">5297605.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f768" decimals="0" contextRef="c12" unitRef="usd">202889.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:Assets id="f769" decimals="0" contextRef="c29" unitRef="usd">0.0</us-gaap:Assets>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f770" xsi:nil="true" contextRef="c83" unitRef="usd"/>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f771" decimals="0" contextRef="c21" unitRef="usd">219085.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="f772" decimals="0" contextRef="c8" unitRef="usd">102089.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <cardifflexington.com:PreferredStockIssuedUponExchangeOfDefaultedConvertibleNotesPayable id="f773" decimals="0" contextRef="c12" unitRef="usd">0.0</cardifflexington.com:PreferredStockIssuedUponExchangeOfDefaultedConvertibleNotesPayable>
  <cardifflexington.com:AccruedInterest id="f774" decimals="0" contextRef="c108" unitRef="usd">62558.0</cardifflexington.com:AccruedInterest>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f775" xsi:nil="true" contextRef="c207" unitRef="usd"/>
  <us-gaap:GrossProfit id="f776" decimals="0" contextRef="c12" unitRef="usd">8292642.0</us-gaap:GrossProfit>
  <us-gaap:DividendsPreferredStock id="f777" decimals="0" contextRef="c14" unitRef="usd">8317.0</us-gaap:DividendsPreferredStock>
  <cardifflexington.com:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable id="f778" decimals="INF" contextRef="c184" unitRef="usd1">0.015</cardifflexington.com:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable>
  <us-gaap:InterestExpenseDebt id="f779" decimals="0" contextRef="c208" unitRef="usd">9181.0</us-gaap:InterestExpenseDebt>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f780" xsi:nil="true" contextRef="c209" unitRef="usd"/>
  <us-gaap:Dividends id="f781" xsi:nil="true" contextRef="c206" unitRef="usd"/>
  <cardifflexington.com:StockIssuedForSettlement id="f782" decimals="INF" contextRef="c210" unitRef="shares">8782.0</cardifflexington.com:StockIssuedForSettlement>
  <us-gaap:DividendsPreferredStock id="f783" decimals="0" contextRef="c15" unitRef="usd">462555.0</us-gaap:DividendsPreferredStock>
  <us-gaap:Dividends id="f784" xsi:nil="true" contextRef="c83" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f785" decimals="0" contextRef="c74" unitRef="usd">75000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment>
  <cardifflexington.com:AccruedInterest id="f786" decimals="0" contextRef="c181" unitRef="usd">7939.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:WarrantsDisclosureTextBlock id="f787" contextRef="c12">&lt;p id="xdx_80A_ecustom--WarrantsDisclosureTextBlock_zcheSzPY7v03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;10.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_822_zx9GVklynvCc"&gt;WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The table below sets forth warrant activity during
the years ended December 31, 2023 and 2022:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXR0xcpGxoz" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Warrant outstanding)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zfIoGh2y2zs7" style="display: none"&gt;Schedule of warrant activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average &lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Balance at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQrmRSiyxE2j" style="width: 13%; text-align: right" title="Number of warrants, Beginning balance"&gt;3,141&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pip0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3UKohsJp2Z8" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance"&gt;0.015&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Granted&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPD1qWkhGzLj" style="text-align: right" title="Number of warrants, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pip0_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzTP2OCnBqP6" style="text-align: right" title="Weighted average exercise price, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Exercised&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpx0nVqNPRkh" style="text-align: right" title="Number of warrants, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_pip0_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z4ncKU9n7A24" style="text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zyiJitJjzbC5" style="text-align: right" title="Number of warrants, Expired"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pip0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z2yG8eReqbY5" style="text-align: right" title="Weighted average exercise price, Expired"&gt;0.0146&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zh7ePKXbZGz4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ending balance"&gt;3,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pip0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zx4gHJWGDDx6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Ending balance"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Warrants Exercisable at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5Eyqptwfgt7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable"&gt;3,140&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_pip0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zt3LzByx0Def" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average &lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Balance at January 1, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQeGgsRJyTKk" style="width: 13%; text-align: right" title="Number of warrants, Beginning balance"&gt;3,259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pip0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zxUF3yUSSL7h" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance"&gt;0.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Granted&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z9YyMDgmWngj" style="text-align: right" title="Number of warrants, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pip0_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjiSmD0az6Tb" style="text-align: right" title="Weighted average exercise price, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Exercised&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_za9YR7AnXvH8" style="text-align: right" title="Number of warrants, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_pip0_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3pJm5fgzox7" style="text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5pneNR4rwqe" style="text-align: right" title="Number of warrants, Expired"&gt;(118&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pip0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNAcHLB049xd" style="text-align: right" title="Weighted average exercise price, Expired"&gt;0.146&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzGrh3N5Dn9k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ending balance"&gt;3,141&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pip0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zo3NnRQbq8t6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Ending balance"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Warrants Exercisable at December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTu7qJCpMit5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable"&gt;3,141&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_pip0_c20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjvkcukIYc3i" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zIcOXpSQWX7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of the settlement agreement with
Red Rock on July 29, 2022, the Company required the previous owners to relinquish warrants for 25,000 shares of common stock. The warrants
were returned and cancelled during the second quarter of 2023. There was no impact on the consolidated financial statements as of December
31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</cardifflexington.com:WarrantsDisclosureTextBlock>
  <us-gaap:Dividends id="f788" xsi:nil="true" contextRef="c207" unitRef="usd"/>
  <us-gaap:ConvertibleLongTermNotesPayable id="f789" decimals="0" contextRef="c8" unitRef="usd">0.0</us-gaap:ConvertibleLongTermNotesPayable>
  <us-gaap:DebtInstrumentMaturityDate id="f790" contextRef="c186">2024-09-22</us-gaap:DebtInstrumentMaturityDate>
  <dei:AuditorFirmId id="f791" contextRef="c12">606</dei:AuditorFirmId>
  <us-gaap:Dividends id="f792" xsi:nil="true" contextRef="c209" unitRef="usd"/>
  <cardifflexington.com:AccruedLiabilityForCollectionsOfPreviouslyFactoredReceivables id="f793" decimals="0" contextRef="c21" unitRef="usd">776414.0</cardifflexington.com:AccruedLiabilityForCollectionsOfPreviouslyFactoredReceivables>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f794" decimals="INF" contextRef="c196" unitRef="shares">5267.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f795" xsi:nil="true" contextRef="c206" unitRef="usd"/>
  <us-gaap:StockholdersEquity id="f796" decimals="0" contextRef="c8" unitRef="usd">731418.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStockShares id="f797" decimals="INF" contextRef="c74" unitRef="shares">75000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStockShares>
  <us-gaap:StockholdersEquity id="f798" decimals="0" contextRef="c205" unitRef="usd">488.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f799" xsi:nil="true" contextRef="c207" unitRef="usd"/>
  <us-gaap:Assets id="f800" decimals="0" contextRef="c47" unitRef="usd">15297039.0</us-gaap:Assets>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f801" xsi:nil="true" contextRef="c209" unitRef="usd"/>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f802" decimals="0" contextRef="c62" unitRef="usd">580968.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="f803" decimals="0" contextRef="c21" unitRef="usd">86444.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <cardifflexington.com:PreferredStockIssuedUponExchangeOfDefaultedConvertibleNotesPayable id="f804" decimals="0" contextRef="c44" unitRef="usd">1500000.0</cardifflexington.com:PreferredStockIssuedUponExchangeOfDefaultedConvertibleNotesPayable>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f805" xsi:nil="true" contextRef="c206" unitRef="usd"/>
  <us-gaap:DividendsPreferredStock id="f806" decimals="0" contextRef="c37" unitRef="usd">151146.0</us-gaap:DividendsPreferredStock>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare id="f807" decimals="INF" contextRef="c12" unitRef="usd1">-6.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:OtherOperatingIncome id="f808" decimals="0" contextRef="c44" unitRef="usd">150250.0</us-gaap:OtherOperatingIncome>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f809" contextRef="c119">2019-08-28</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:AccruedInterest id="f810" decimals="0" contextRef="c211" unitRef="usd">620.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f811" xsi:nil="true" contextRef="c207" unitRef="usd"/>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f812" decimals="0" contextRef="c180" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f813" xsi:nil="true" contextRef="c209" unitRef="usd"/>
  <us-gaap:StockholdersEquity id="f814" decimals="0" contextRef="c47" unitRef="usd">486840.0</us-gaap:StockholdersEquity>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="f815" decimals="INF" contextRef="c212" unitRef="usd1">0.02</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:DividendsPreferredStock id="f816" decimals="0" contextRef="c39" unitRef="usd">16363.0</us-gaap:DividendsPreferredStock>
  <us-gaap:NetIncomeLoss id="f817" xsi:nil="true" contextRef="c206" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContributionShares id="f818" decimals="INF" contextRef="c74" unitRef="shares">25000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForContributionShares>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f819" decimals="0" contextRef="c108" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:NetIncomeLoss id="f820" xsi:nil="true" contextRef="c83" unitRef="usd"/>
  <us-gaap:ConvertibleLongTermNotesPayable id="f821" decimals="0" contextRef="c21" unitRef="usd">0.0</us-gaap:ConvertibleLongTermNotesPayable>
  <cardifflexington.com:AccruedInterest id="f822" decimals="0" contextRef="c178" unitRef="usd">5581.0</cardifflexington.com:AccruedInterest>
  <us-gaap:NetIncomeLoss id="f823" xsi:nil="true" contextRef="c207" unitRef="usd"/>
  <us-gaap:Assets id="f824" decimals="0" contextRef="c69" unitRef="usd">0.0</us-gaap:Assets>
  <cardifflexington.com:BonusStockToBeIssuedShares id="f825" decimals="INF" contextRef="c213" unitRef="shares">135000.0</cardifflexington.com:BonusStockToBeIssuedShares>
  <us-gaap:NetIncomeLoss id="f826" xsi:nil="true" contextRef="c209" unitRef="usd"/>
  <us-gaap:StockholdersEquity id="f827" decimals="0" contextRef="c21" unitRef="usd">-1744791.0</us-gaap:StockholdersEquity>
  <us-gaap:EarningsPerShareBasic id="f828" decimals="INF" contextRef="c200" unitRef="usd1">27.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:InterestExpenseDebt id="f829" decimals="0" contextRef="c119" unitRef="usd">0.0</us-gaap:InterestExpenseDebt>
  <us-gaap:SharesOutstanding id="f830" xsi:nil="true" contextRef="c165" unitRef="shares"/>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f831" decimals="0" contextRef="c181" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f832" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f833" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <dei:EntityWellKnownSeasonedIssuer id="f834" contextRef="c12">No</dei:EntityWellKnownSeasonedIssuer>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare id="f835" decimals="INF" contextRef="c44" unitRef="usd1">-374.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <cardifflexington.com:LiabilitiesCurrent1 id="f836" decimals="0" contextRef="c36" unitRef="usd">10189585.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock id="f837" contextRef="c12">&lt;p id="xdx_80B_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zm7MqunmuQ79" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_829_zXGm26SApAK"&gt;ACCOUNTS PAYABLE AND ACCRUED EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_ztnfGL6iXwu6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B6_zlueNDa8Ykgi" style="display: none"&gt;Schedule of accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_493_20231231_zoUbhoaEaR3" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49D_20221231_zLOxRA3niEL3" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_maCzSBC_z8gw74UImHr1" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;720,774&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;342,331&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AccruedCreditCards_iI_d0_maCzSBC_zatM7ulfD5Ri" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued credit cards&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,994&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccruedLiabilityForCollectionsOfPreviouslyFactoredReceivables_iI_pp0p0_maCzSBC_zGGGBA7ZIMEg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Accrued liability for collections of previously factored receivables&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;776,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedIncomeTaxes_iI_pp0p0_maCzSBC_zC9PIfeyzNUg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued property taxes&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,346&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,732&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedProfessionalFees_iI_maCzSBC_ziQkTYT1AOkd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,122&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;573,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedPayrollTaxesCurrent_iI_d0_maCzSBC_zZUDVR42s2Ra" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_d0_maCzSBC_zwdgXG12jbU9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Accrue expense - other&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;363&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedExpenseDividendPayable_iI_d0_maCzSBC_zjr7jjyd2A9b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued expense - dividend payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;210,046&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtCzSBC_znAKxRDiOxi8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,047,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,915,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is delinquent paying certain property
taxes. As of December 31, 2023 and 2022, the balance for these property taxes, was $&lt;span id="xdx_908_ecustom--AccruedTaxesPenaltiesAndInterest_iI_pp0p0_c20231231_zXCMzyQtzIf4" title="Accrued taxes, penalties and interest"&gt;5,346&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--AccruedTaxesPenaltiesAndInterest_c20221231_pp0p0" title="Accrued taxes, penalties and interest"&gt;6,732&lt;/span&gt;, respectively.&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations id="f838" decimals="INF" contextRef="c38" unitRef="shares">118.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
  <us-gaap:ConvertibleDebt id="f839" decimals="0" contextRef="c196" unitRef="usd">2600000.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f840" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f841" decimals="INF" contextRef="c123" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f842" xsi:nil="true" contextRef="c94" unitRef="usd"/>
  <us-gaap:DividendsPreferredStock id="f843" decimals="0" contextRef="c200" unitRef="usd">478918.0</us-gaap:DividendsPreferredStock>
  <cardifflexington.com:ConvertibleDebtDetailsTableTextBlock id="f844" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ConvertibleDebtDetailsTableTextBlock_zbsrRtePPX23" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details- Convertible debt instruments)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_8B7_zmS6oOuJyaPg" style="display: none"&gt;Schedule of convertible notes
payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Note #&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Issuance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Principal
    Balance 12/31/22&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;New
    Loan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Principal
    Conversions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Cash Paydown&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Shares Issued
    Upon Conversion&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Principal
    Balance 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Accrued
    Interest on Convertible Debt at 12/31/22&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Interest
    Expense On Convertible Debt For the Period Ended 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Accrued
    Interest on Convertible Debt at 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Unamortized
    Debt Discount At 12/31/23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; width: 5%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;7-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zfGBLlQ5E0J4" title="Debt issuance date"&gt;10/28/2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zIxSaxNgKkxa" title="Debt Maturity date"&gt;10/28/2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_z2icn681a4Ac" style="vertical-align: bottom; width: 7%; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zV8GrHpcNjZ7" style="vertical-align: bottom; width: 6%; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtCurrent_iNI_pp0p0_di_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zTObqWbCKfEf" style="vertical-align: bottom; width: 6%; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;(10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zCgCgygyELOa" style="vertical-align: bottom; width: 6%; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zXhLrEosZR14" style="vertical-align: bottom; width: 6%; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;312&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_z0C2yIFfB2df" style="vertical-align: bottom; width: 6%; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zQVYIDMkgMh1" style="vertical-align: bottom; width: 6%; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;2,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--InterestExpenseDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zlhx0xq0lsKb" style="vertical-align: bottom; width: 6%; text-align: right" title="Interest Expense On Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_z6UmzRAQg1B5" style="vertical-align: bottom; width: 6%; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote71Member_zJiRRcYiBbjb" style="vertical-align: bottom; width: 6%; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zwqODA7Pgfcj" title="Debt issuance date"&gt;09/12/2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zfYGdviWOrB7" title="Debt Maturity date"&gt;09/12/2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zmk5ZidGqlVg" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;50,080&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zhjPzqcUNuv9" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zC91JNpwLlGa" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zgWVASgDuRB8" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zeHDfIrQkut4" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;1,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_z3wfjxX6S925" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;50,080&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zJzGbtdgvbS" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;14,157&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zxEWI97IOlYl" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;9,181&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zOJ9rsgvy9Qc" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;5,581&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote9Member_zXx5gPB6KgGe" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zt69aXUaZTJk" title="Debt issuance date"&gt;01/24/2017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zzzk8EQq7qYl" title="Debt Maturity date"&gt;01/24/2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ConvertibleDebt_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zdncKvJgy1E4" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;55,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zYemANmEuCof" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zWMccQbxcS22" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zldaLS57Impj" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zkKLSRii3ke1" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zcnWlh0mOq3j" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;55,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zgVddJTjKps2" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;69,876&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zrQ9dOPFm4Uc" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;11,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zzKMMhdz5qzd" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;80,875&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote10Member_zLb31DRuK8Ve" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zrFqwvp7P0b9" title="Debt issuance date"&gt;02/10/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zc3fBknS9YO7" title="Debt Maturity date"&gt;02/10/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zOHyFsG5uLka" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_z6KbiD6LtSl8" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zf1yYl3TvFB9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_z4cS6RdfF3N2" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_znbg52bYCfNd" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zNpqNTzqhzDc" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zf8zWzz9Hnl7" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,658&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_z7KMPGqa9Sj9" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;6,658&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote101Member_zztwM9hkI8T5" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_906_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zswSSTwyLgQ3" title="Debt issuance date"&gt;03/30/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_z9lmJKcxb414" title="Debt Maturity date"&gt;03/30/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zbkWhNZC4ei5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_z6Z991CK7aM1" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zsVX05afwdwi" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zFZYHiXIwKYj" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zDEDFTCXloNk" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zmudB8Z2h0b3" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_z1ogwUYXzY7" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zaIhDqKy1VVb" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;2,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zwPl3qJj3y9d" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;2,836&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote102Member_zJv8Rso8Jqkf" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;10-3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zBrS500Eg0Zj" title="Debt issuance date"&gt;08/11/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_znTm2wn2aSZe" title="Debt Maturity date"&gt;08/11/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zgELlLSh2Vi2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zRBQL9sozQr9" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zX7U4g4IVlh6" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zLo9wX4T8yY7" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zLYwC52vHxv9" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_znAeuy6uEOi6" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zMDKsB32HtL5" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zXgmRwlyMeli" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;1,469&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zyVQJqSb8Gdd" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,469&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote103Member_zMmWhprufC71" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;29-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zlscNvjWysP3" title="Debt issuance date"&gt;11/08/2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zZ3bC0ePXZlg" title="Debt Maturity date"&gt;11/08/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zGeHNlb6Z9W5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;36,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zXZZHo7bD2I8" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zsOVepSdUfr3" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zOqFFGJwmaqa" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zNLoS2LrEkQh" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;2,867&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zn2KqInjj7Kg" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;36,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zhVbVvq85FRa" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;20,160&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zlkZWN6CSE1e" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;2,849&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_zCfQpj1df795" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;10,109&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote292Member_z2uTL0JpZ2P9" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;31&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zwEJbeceuI2l" title="Debt issuance date"&gt;08/28/2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zhX94g8piVzl" title="Debt Maturity date"&gt;08/28/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zmDa6LkktPQ2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zMCWu41DgDGa" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zU2XsCd0ooOc" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zFp6wB9Tj5bf" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zglu6Lihz3r9" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zPmXAyoK5bgh" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zgvcJYG4iTg3" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;8,385&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--InterestExpenseDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zK4YtL3rdMgd" style="vertical-align: bottom; text-align: right" title="Interest Expense On Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_ziAGhSgjuekc" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;8,385&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote31Member_zZELeXFYQ7ze" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;37-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zdGBsk42ryk" title="Debt issuance date"&gt;09/03/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zIoxodDS35R1" title="Debt Maturity date"&gt;06/30/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zk9JyGE0gek" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_z26LbXF01Pxh" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zV4fV89IfgM5" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_z0vi0XMVpu01" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zJRGySdw3ZW6" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zYPavVSrCfpi" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zwMmn64FfiLi" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;28,756&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zB7qtebzI5Wd" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;19,507&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_zB7rE44FqBPj" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;64,929&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote371Member_z2CFFTRaUDl3" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;37-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zddvCtd1Irr3" title="Debt issuance date"&gt;11/02/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zzDgoyjsmYX6" title="Debt Maturity date"&gt;08/31/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zYvo31DCd7G5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zWCHi39bdG3a" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zHU6jU31h0q6" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zzvFJ6UbG9bd" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zMlA3hOfUlw8" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zX1QYXHswy2l" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zm3tymYMHM5i" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;27,510&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zu5P206dwdag" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;19,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_zFVtCOFNp5il" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;63,594&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote372Member_z8TV33wyoyxi" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;37-3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_z54istFqzlok" title="Debt issuance date"&gt;12/29/2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zTX6WMhfmpGh" title="Debt Maturity date"&gt;09/30/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_z37HAolvBFK5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zDPHlIOxNbXj" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_ztmEgdUrJtPj" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zfsp2shQtCef" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zYCsx4L9K4je" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zuJTwZ740vX4" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;113,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zRYVszopxMBh" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;26,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_z4oBAYxw1rXa" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;19,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zuUMW3u8bU1d" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;62,558&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote373Member_zHoY17XeWfPe" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;38&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zFAZGa13eWE4" title="Debt issuance date"&gt;02/09/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_z5eqdCD4i7vg" title="Debt Maturity date"&gt;02/09/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zmuw78X65tkl" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;96,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_z6qMM7F6D5U7" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--DebtCurrent_iNI_pp0p0_di_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zQskxNx7fYm5" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;(77,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zIoT4RzJ9jT" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;(18,540&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zq5KuZ3ytbi2" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;2,950&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zUsuRLUvgsKk" style="vertical-align: top; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_z6s4sW5syQ9g" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;27,939&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zTP9WbNkIZEh" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;7,242&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccruedInterest_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zGa7TDA9sII3" style="vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote38Member_zbkReAJUv8uj" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;39&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zgsmQYrMYcJj" title="Debt issuance date"&gt;04/26/2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member" title="Debt Maturity date"&gt;04/26/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;168,866&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zaupmAJoatyf" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zMkFf3cndZmh" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zXhTgh786kRc" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;(168,866&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zcPMcURzBV8l" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zw47tnwMjcOg" style="vertical-align: top; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zxdFTBKYvu09" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;39,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zgIOovkr95C8" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;27,787&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccruedInterest_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zfaWpcpze9n9" style="vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote39Member_zlxJS8K1gG51" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member" title="Debt issuance date"&gt;09/22/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;2,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zPLNpx8dGCyc" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zyoKigX4fhPb" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zwMi5mNNYnc5" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zAaY71OPlpFh" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;5,267&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zqNYs5fbZB86" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;2,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zMM0uvbHTu9h" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;71,233&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zejbO9yvnVJ5" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;261,333&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_zWet3HivCWel" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;252,665&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote401Member_z4SCCT6MgH38" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member" title="Debt issuance date"&gt;11/04/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,666&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zi516HVyKxmh" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zj7ku0gxYvIh" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zQruHypWtGz9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zoUf4zoPQFzl" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zPI80XxfCpX9" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zsnKaRMnk3Qe" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zfmgIMY0sfwi" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,867&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_z6w7KegLhq5a" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,939&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote402Member_zhUbqxgXI0Uk" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member" title="Debt issuance date"&gt;11/28/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zg96km1B6CQl" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zlL1D2GFIzna" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zLpg6dKmeLfl" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zVrYje6zX5Uj" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_z1W0aisAUToj" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zkmbPTgtoGPh" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;620&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_z9S793yhRyq1" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,886&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_z3ooUcgb6Xfi" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,506&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote403Member_zh2dSu37BRgc" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member" title="Debt issuance date"&gt;12/21/2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_pp0p0" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zCNj2i0JkWM6" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zJSToFa24K16" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zTtQii0Agwf3" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_ziZ366Afjsmi" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zfkM70yskQQc" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;68,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zYLjB83y2OGa" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;187&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_z1yFryrVA8V5" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;6,867&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zRJEyyAb2ava" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,054&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote404Member_zFiRKB1zX3vg" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member" title="Debt issuance date"&gt;01/24/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zOYZR6HBL689" title="Debt Maturity date"&gt;03/21/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zMbrOiqBc7o1" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;90,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zbYxN1SFn7H4" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zcs108HcNEx6" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zWu3LGoVcR5b" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zDGXbbTQeF2b" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;90,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zmVlXfldrO33" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zF0KgxXiT3vd" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;8,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_z42TvDavfyDb" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;8,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote405Member_zFaHmEXpRfe9" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member" title="Debt issuance date"&gt;03/21/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zGocHgkdpJne" title="Debt Maturity date"&gt;09/22/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zvR5icMrCvC2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zmovZmB5ZqA8" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_znnCVoN8Yhy9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_z52DI4qiaJ8b" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zpGVPB19qGzk" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zKNzfEu4vXQ" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zTpyHqkBJj32" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;10,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_z9kLB1XT9ES8" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;10,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote406Member_zScX5pCDN7j8" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member" title="Debt issuance date"&gt;06/05/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member" title="Debt Maturity date"&gt;06/05/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zo0jbyFD8mw7" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zJeJYrbGL6ql" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zkLTbn419KZd" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zDJbx9g2Y6yb" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zSYJx6IMj8Hj" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;139,166&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zYGrLmpoef19" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_z39nNcuBLVva" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;7,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zFMtMiAIzi26" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;7,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote407Member_zxjswrHexNJ7" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;15,671&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member" title="Debt issuance date"&gt;06/13/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member" title="Debt Maturity date"&gt;06/13/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zrvygG0PiTS2" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;21,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zKrkcYahw757" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zran7h2TaQD5" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zhjAq4ounBua" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zHtCfR4iiU96" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;21,167&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_ztHwG6fG2Bw" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zaQJAaDOWS1c" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;1,127&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zbk7xtYzxCN" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,127&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote408Member_zRzLrOVSJgF5" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;2,321&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member" title="Debt issuance date"&gt;07/19/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member" title="Debt Maturity date"&gt;07/19/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zRmvYVjangQd" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;35,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zK2mgrePPiCg" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zYoo4MyDFpv9" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_z8Xhkm26PGnj" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zXHC0IgyfYl" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;35,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zdzZil8ZHNef" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zbhfo0gpEDhb" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;1,605&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_ztaN9NBfPtof" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;1,605&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote409Member_zD55K3ggfSZd" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;4,863&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;40-10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member" title="Debt issuance date"&gt;07/24/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member" title="Debt Maturity date"&gt;07/24/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_znXZd3jy1KC5" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_pp0p0" style="vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;14,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zjLuYJ4Ovg42" style="vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_z7tgnth80aSf" style="vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zmXQlNmvSqag" style="vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zFTPWmfajfhf" style="vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;14,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zacqn1NsIiV9" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_ziUaJ2TLoER5" style="vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zG0GteWoVWEd" style="vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote4010Member_zPJmdLcJZNq6" style="vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;1,965&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIssuanceDate1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member" title="Debt issuance date"&gt;08/25/2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member" title="Debt Maturity date"&gt;08/25/2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zF8gh6d9PAOh" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_pp0p0" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zkhxrCYiOSk2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_d0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zC21ck6IYTR" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zqUlnJaoj7Y4" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zYEXvDPlHsl9" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccruedInterest_iI_pp0p0_d0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_z46syryLkdrk" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zRjFTb8dw9d1" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Interest expense"&gt;&lt;span style="font-size: 8pt"&gt;175&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccruedInterest_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zcryNvl39uF5" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-size: 8pt"&gt;175&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_d0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNote41Member_zI9r8bLBqwL7" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(238,238,238)"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pp0p0_d0_c20221231_zraP1kcqUnC1" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;3,562,550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231_zkZ617Idtb7g" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="New Loans"&gt;&lt;span style="font-size: 8pt"&gt;544,165&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DebtCurrent_iNI_pp0p0_di0_c20231231_ziiIBCOG2KQj" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Principal Conversions"&gt;&lt;span style="font-size: 8pt"&gt;(87,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ProceedsFromRepaymentsOfDebt_pp0p0_c20230101__20231231_zj8IKfZKgQRb" style="border-bottom: Black 2.25pt double; vertical-align: top; text-align: right" title="Cash Paydown"&gt;&lt;span style="font-size: 8pt"&gt;(187,406&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_d0_c20231231_z384QkhEOO49" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Shares Issued Upon Conversion"&gt;&lt;span style="font-size: 8pt"&gt;13,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pp0p0_c20231231_zrcN0HvIIRn6" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Principal Balance"&gt;&lt;span style="font-size: 8pt"&gt;3,831,850&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccruedInterest_iI_pp0p0_c20221231_zmNbj401sm7j" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;338,316&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231_zOdDLyeWRAp4" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Interest Expense On Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;439,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccruedInterest_iI_pp0p0_c20231231_zqjkVPUqozc9" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Accrued Interest on Convertible Debt"&gt;&lt;span style="font-size: 8pt"&gt;612,460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231_zBLEfJ27sAy8" style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: right" title="Unamortized Debt Discount"&gt;&lt;span style="font-size: 8pt"&gt;24,820&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cardifflexington.com:ConvertibleDebtDetailsTableTextBlock>
  <us-gaap:DebtInstrumentMaturityDate id="f845" contextRef="c119">2020-08-28</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f846" decimals="0" contextRef="c208" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f847" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f848" decimals="0" contextRef="c8" unitRef="usd">866943.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:InventoryRealEstate id="f849" decimals="0" contextRef="c8" unitRef="usd">540000.0</us-gaap:InventoryRealEstate>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f850" decimals="0" contextRef="c74" unitRef="usd">100000.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution>
  <cardifflexington.com:CancellationOfCommonStock id="f851" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f852" decimals="0" contextRef="c60" unitRef="usd">1838691.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ProceedsFromConvertibleDebt id="f853" decimals="0" contextRef="c153" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <cardifflexington.com:CancellationOfCommonStock id="f854" xsi:nil="true" contextRef="c44" unitRef="usd"/>
  <us-gaap:InterestExpenseDebt id="f855" decimals="0" contextRef="c129" unitRef="usd">11000.0</us-gaap:InterestExpenseDebt>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f856" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f857" contextRef="c186">2022-09-22</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f858" xsi:nil="true" contextRef="c94" unitRef="usd"/>
  <us-gaap:StockholdersEquity id="f859" decimals="0" contextRef="c204" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f860" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <cardifflexington.com:CancellationOfSeriesFPreferredStockShares id="f861" decimals="INF" contextRef="c74" unitRef="shares">-175045.0</cardifflexington.com:CancellationOfSeriesFPreferredStockShares>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock id="f862" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXR0xcpGxoz" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Warrant outstanding)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zfIoGh2y2zs7" style="display: none"&gt;Schedule of warrant activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average &lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Balance at January 1, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQrmRSiyxE2j" style="width: 13%; text-align: right" title="Number of warrants, Beginning balance"&gt;3,141&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pip0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3UKohsJp2Z8" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance"&gt;0.015&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Granted&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPD1qWkhGzLj" style="text-align: right" title="Number of warrants, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pip0_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzTP2OCnBqP6" style="text-align: right" title="Weighted average exercise price, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Exercised&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpx0nVqNPRkh" style="text-align: right" title="Number of warrants, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_pip0_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z4ncKU9n7A24" style="text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zyiJitJjzbC5" style="text-align: right" title="Number of warrants, Expired"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pip0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z2yG8eReqbY5" style="text-align: right" title="Weighted average exercise price, Expired"&gt;0.0146&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zh7ePKXbZGz4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ending balance"&gt;3,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pip0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zx4gHJWGDDx6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Ending balance"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Warrants Exercisable at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5Eyqptwfgt7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable"&gt;3,140&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_pip0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zt3LzByx0Def" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of &lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average &lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Balance at January 1, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQeGgsRJyTKk" style="width: 13%; text-align: right" title="Number of warrants, Beginning balance"&gt;3,259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pip0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zxUF3yUSSL7h" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance"&gt;0.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Granted&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z9YyMDgmWngj" style="text-align: right" title="Number of warrants, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pip0_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjiSmD0az6Tb" style="text-align: right" title="Weighted average exercise price, Granted"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Exercised&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_za9YR7AnXvH8" style="text-align: right" title="Number of warrants, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_pip0_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3pJm5fgzox7" style="text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expired&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5pneNR4rwqe" style="text-align: right" title="Number of warrants, Expired"&gt;(118&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pip0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNAcHLB049xd" style="text-align: right" title="Weighted average exercise price, Expired"&gt;0.146&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzGrh3N5Dn9k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ending balance"&gt;3,141&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pip0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zo3NnRQbq8t6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Ending balance"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Warrants Exercisable at December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTu7qJCpMit5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable"&gt;3,141&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Exercisable_iI_pip0_c20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjvkcukIYc3i" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"&gt;0.015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f863" decimals="0" contextRef="c178" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f864" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <cardifflexington.com:LiabilitiesCurrent1 id="f865" decimals="0" contextRef="c51" unitRef="usd">0.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="f866" decimals="INF" contextRef="c38" unitRef="usd1">0.146</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f867" xsi:nil="true" contextRef="c94" unitRef="usd"/>
  <dei:DocumentType id="f868" contextRef="c12">10-K</dei:DocumentType>
  <us-gaap:LiabilitiesAndStockholdersEquity id="f869" decimals="0" contextRef="c8" unitRef="usd">20745811.0</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DepreciationDepletionAndAmortization id="f870" decimals="0" contextRef="c12" unitRef="usd">20777.0</us-gaap:DepreciationDepletionAndAmortization>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f871" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <dei:EntityVoluntaryFilers id="f872" contextRef="c12">No</dei:EntityVoluntaryFilers>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f873" decimals="0" contextRef="c94" unitRef="usd">-56250.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment>
  <us-gaap:ConvertibleDebt id="f874" decimals="0" contextRef="c151" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f875" contextRef="c114">2021-02-09</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f876" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <cardifflexington.com:PropertyPlantAndEquipmentUsefulLifeTextBlock id="f877" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--PropertyPlantAndEquipmentUsefulLifeTextBlock_zmNeau8MZivk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zOA5hmjon6t9" style="display: none"&gt;Schedule of estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 35%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Classification&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 65%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #EEEEEE"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z8elNfWLgwZe" title="Property and equipment, useful live"&gt;5 - 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MedicalEquipmentMember_zNVhPkdecQtb" title="Property and equipment, useful live"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #EEEEEE"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z6OXlvIpluw7" title="Property and equipment, useful live"&gt;10 years or lease term, if shorter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cardifflexington.com:PropertyPlantAndEquipmentUsefulLifeTextBlock>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f878" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f879" decimals="0" contextRef="c14" unitRef="usd">-8317.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:AccruedInterest id="f880" decimals="0" contextRef="c78" unitRef="usd">71233.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f881" xsi:nil="true" contextRef="c44" unitRef="usd"/>
  <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax id="f882" decimals="0" contextRef="c44" unitRef="usd">0.0</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
  <us-gaap:ConvertibleDebt id="f883" decimals="0" contextRef="c123" unitRef="usd">139166.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f884" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <dei:IcfrAuditorAttestationFlag id="f885" contextRef="c12">false</dei:IcfrAuditorAttestationFlag>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f886" decimals="0" contextRef="c15" unitRef="usd">337532.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <ecd:Rule10b51ArrAdoptedFlag id="f887" contextRef="c215">false</ecd:Rule10b51ArrAdoptedFlag>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f888" contextRef="c201">2022-11-28</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f889" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <us-gaap:InterestPaidNet id="f890" decimals="0" contextRef="c12" unitRef="usd">239296.0</us-gaap:InterestPaidNet>
  <us-gaap:ConvertibleDebt id="f891" decimals="0" contextRef="c185" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f892" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f893" decimals="0" contextRef="c74" unitRef="usd">-700180.0</cardifflexington.com:CancellationOfSeriesFPreferredStock>
  <ecd:NonRule10b51ArrAdoptedFlag id="f894" contextRef="c215">false</ecd:NonRule10b51ArrAdoptedFlag>
  <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock id="f895" contextRef="c12">&lt;p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_z6mIMw0c4g12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82F_znWve4SKCzRh"&gt;DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Platinum Tax&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 10, 2023, the Company sold Platinum
Tax, which was a full-service tax resolution firm located in Los Angeles, California. Through this subsidiary the Company provided fee-based
tax resolution services to individuals and companies that have federal and state tax liabilities by assisting clients to settle outstanding
tax debts. As part of the Asset Purchase Agreement between us and the purchaser, the assets that were purchased included substantially
all assets, rights, interests, and licenses except for banks accounts in place prior to the sale for the purchase consideration of 15%
of cash collected by the purchaser within one year following the sale date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company and the managers of AHI entered into
a resignation, release and buyback agreement and addendum, effective October 31, 2022, pursuant to which the managers purchased AHI in
exchange for returning &lt;span id="xdx_90D_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20221001__20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--BuyBackAgreementMember__srt--CounterpartyNameAxis__custom--AHIMember_z6YXXj5fph22"&gt;175,045
&lt;/span&gt;shares of series F preferred stock. There was a loss on disposal in the amount of $&lt;span id="xdx_90D_eus-gaap--GainLossOnSaleOfBusiness_c20221001__20221031__srt--CounterpartyNameAxis__custom--AHIMember_zYuFOgpXcez"&gt;217,769
&lt;/span&gt;on October 31, 2022, which represented net assets and liabilities at the time of sale back.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DiscontinuedOperationsTableTextBlock_zx98WFibSEse" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DISCONTINUED OPERATIONS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B8_zay5UQP2NKd9" style="display: none"&gt;Schedule of discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49A_20231231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zF5wEx2RwR34" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_493_20221231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zrPjGshvttD2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"&gt;Net liabilities of discontinued operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_pp0p0_zQyy8HxNlRVh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;342&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;7,717&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_pp0p0_zUmms472Cqda" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;300&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;860&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_pp0p0_zrJEV9kDGTKk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;238,285&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;159,700&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NetLiabilitiesOfDiscontinuedOperations_iI_pp0p0_z69kN7QeJidj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net liabilities of discontinued operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(237,643&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(151,123&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49A_20230101__20231231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zBRdI3ONhBQj" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49A_20220101__20221231__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--RedRockMember_zykDKtcID7Uc" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: justify"&gt;Gain (Loss) from discontinued operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_i01_pp0p0_zhnzMl1UH9fj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: justify"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;307,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;1,438,294&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CostOfRevenue_i01N_pp0p0_di_zWObYkVynoul" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Cost of sales&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(462,556&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--SellingGeneralAndAdministrativeExpense_i01N_pp0p0_di_zfZtWbffr361" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(332,005&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,094,121&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--InterestIncomeExpenseNet_i01_pp0p0_zMQo52h9ZPH8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,428&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44,027&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GoodwillImpairmentLossNetOfTax_i01N_di0_z1Euw7vAPDA5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Impairment of Goodwill&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,092,048&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--LossOnDivestitureOfSubsidiary_i01N_pp0p0_di0_zeEiingcAm5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Loss on divestiture of subsidiary&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(217,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--GainOnChangeOfEstimate_i01_pp0p0_d0_zoktm1JmZJL4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Gain no change in estimate&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,474&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--GainOnReversalOfRrtLiability_i01_pp0p0_d0_zezsRbePHTL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Gain on reversal of Red Rock liability&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;510,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--LossOnSettlement_i01_pp0p0_d0_z9E74lcDI5g6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Loss on settlement&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(212,600&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Loss from discontinued operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(86,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,178,883&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zGK1MBE7aVk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesF id="f896" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <cardifflexington.com:LiabilitiesCurrent1 id="f897" decimals="0" contextRef="c63" unitRef="usd">10189585.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f898" decimals="INF" contextRef="c84" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f899" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <us-gaap:LiabilitiesAndStockholdersEquity id="f900" decimals="0" contextRef="c21" unitRef="usd">13344780.0</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DepreciationDepletionAndAmortization id="f901" decimals="0" contextRef="c44" unitRef="usd">23132.0</us-gaap:DepreciationDepletionAndAmortization>
  <cardifflexington.com:ReclassificationForCancelledShares id="f902" decimals="0" contextRef="c94" unitRef="usd">-4967686.0</cardifflexington.com:ReclassificationForCancelledShares>
  <us-gaap:Land id="f903" decimals="0" contextRef="c8" unitRef="usd">540000.0</us-gaap:Land>
  <cardifflexington.com:CancellationOfSeriesFPreferredStock id="f904" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <dei:EntityCurrentReportingStatus id="f905" contextRef="c12">Yes</dei:EntityCurrentReportingStatus>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f906" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <us-gaap:Dividends id="f907" decimals="0" contextRef="c142" unitRef="usd">780074.0</us-gaap:Dividends>
  <us-gaap:Land id="f908" decimals="0" contextRef="c21" unitRef="usd">540000.0</us-gaap:Land>
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock id="f909" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_ztnfGL6iXwu6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B6_zlueNDa8Ykgi" style="display: none"&gt;Schedule of accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_493_20231231_zoUbhoaEaR3" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49D_20221231_zLOxRA3niEL3" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_maCzSBC_z8gw74UImHr1" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;720,774&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;342,331&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AccruedCreditCards_iI_d0_maCzSBC_zatM7ulfD5Ri" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued credit cards&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,994&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccruedLiabilityForCollectionsOfPreviouslyFactoredReceivables_iI_pp0p0_maCzSBC_zGGGBA7ZIMEg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Accrued liability for collections of previously factored receivables&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;776,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedIncomeTaxes_iI_pp0p0_maCzSBC_zC9PIfeyzNUg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued property taxes&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,346&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,732&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedProfessionalFees_iI_maCzSBC_ziQkTYT1AOkd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,122&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;573,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedPayrollTaxesCurrent_iI_d0_maCzSBC_zZUDVR42s2Ra" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_d0_maCzSBC_zwdgXG12jbU9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Accrue expense - other&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;363&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedExpenseDividendPayable_iI_d0_maCzSBC_zjr7jjyd2A9b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued expense - dividend payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;210,046&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtCzSBC_znAKxRDiOxi8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,047,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,915,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f910" contextRef="c153">2016-10-28</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:AnnualCashBonus id="f911" decimals="0" contextRef="c174" unitRef="usd">210000.0</cardifflexington.com:AnnualCashBonus>
  <ecd:Rule10b51ArrTrmntdFlag id="f912" contextRef="c215">false</ecd:Rule10b51ArrTrmntdFlag>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f913" xsi:nil="true" contextRef="c94" unitRef="usd"/>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f914" decimals="0" contextRef="c37" unitRef="usd">1830374.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <cardifflexington.com:GoodwillidentifiableintangibleassetsnetTextBlock id="f915" contextRef="c12">&lt;p id="xdx_803_ecustom--GoodwillidentifiableintangibleassetsnetTextBlock_zFo3evaqHGS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_823_zpY89rwQlEfc"&gt;GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reviews goodwill for impairment on
a reporting unit basis annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable.
During the year ended December 31, 2023, the Company determined there to be &lt;span id="xdx_903_eus-gaap--GoodwillImpairmentLossNetOfTax_do_c20230101__20231231_za5YceBMSAZg" title="Goodwill impairment"&gt;no&lt;/span&gt; impairment, and during the year ended December 31, 2022,
the Company recognized goodwill impairment in the amount of $&lt;span id="xdx_90E_eus-gaap--GoodwillImpairmentLossNetOfTax_c20220101__20221231_zwVUB2BwXlOf" title="Goodwill impairment"&gt;2,092,048&lt;/span&gt;, which was recorded to its former financial services segment now
reflected in discontinued operations. The Company based this decision on impairment testing of the underlying assets, expected cash flows,
decreased asset value and other factors.&lt;/p&gt;

</cardifflexington.com:GoodwillidentifiableintangibleassetsnetTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="f916" contextRef="c12">&lt;p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zgfxFZQecC46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_820_zdCy47uSPejl"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the acquisition of Edge View
on July 16, 2014, the Company assumed amounts due to previous owners who are current managers of Edge View. These amounts are due on demand
and do not bear interest. The balance of these amounts are $&lt;span id="xdx_90B_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PreviousOwnersOfEdgeViewMember_zMyA6S2T99Dg" title="Due from related party"&gt;&lt;span id="xdx_90D_eus-gaap--NotesAndLoansPayable_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PreviousOwnersOfEdgeViewMember_pp0p0" title="Due from related party"&gt;4,979&lt;/span&gt;&lt;/span&gt; due from the previous owners as of December 31, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company obtained short-term advances from
the Chairman of the Board that are non-interest bearing and due on demand. As of December 31, 2023 and 2022, the Company owed the Chairman
$&lt;span id="xdx_903_eus-gaap--ShortTermBorrowings_iI_pp0p0_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChairmanMember_zKcSxzGeOeeg" title="Short-Term Debt"&gt;120,997&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--ShortTermBorrowings_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChairmanMember_pp0p0" title="Short-Term Debt"&gt;123,192&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;See also Note 8 and the disclosure regarding Note
41.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;See also Note 13 for compensation paid to employees
of the Company.&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:DebtInstrumentMaturityDate id="f917" contextRef="c114">2022-02-09</us-gaap:DebtInstrumentMaturityDate>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f918" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <dei:DocumentAnnualReport id="f919" contextRef="c12">true</dei:DocumentAnnualReport>
  <ecd:NonRule10b51ArrTrmntdFlag id="f920" contextRef="c215">false</ecd:NonRule10b51ArrTrmntdFlag>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f921" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <cardifflexington.com:AccruedLiabilityForCollectionsOfPreviouslyFactoredReceivables id="f922" decimals="0" contextRef="c8" unitRef="usd">1247772.0</cardifflexington.com:AccruedLiabilityForCollectionsOfPreviouslyFactoredReceivables>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f923" decimals="0" contextRef="c39" unitRef="usd">-16363.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ProceedsFromConvertibleDebt id="f924" decimals="0" contextRef="c119" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <cardifflexington.com:ReclassificationForCancelledShares id="f925" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f926" contextRef="c129">2017-01-24</us-gaap:DebtInstrumentIssuanceDate1>
  <cardifflexington.com:ReclassificationForCancelledShares id="f927" xsi:nil="true" contextRef="c214" unitRef="usd"/>
  <us-gaap:InterestExpenseDebt id="f928" decimals="0" contextRef="c186" unitRef="usd">261333.0</us-gaap:InterestExpenseDebt>
  <us-gaap:DebtInstrumentMaturityDate id="f929" contextRef="c201">2024-09-22</us-gaap:DebtInstrumentMaturityDate>
  <cardifflexington.com:ReclassificationForCancelledShares id="f930" xsi:nil="true" contextRef="c44" unitRef="usd"/>
  <cardifflexington.com:AccruedInterest id="f931" decimals="0" contextRef="c187" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:Dividends id="f932" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <us-gaap:Revenues id="f933" decimals="0" contextRef="c99" unitRef="usd">11853266.0</us-gaap:Revenues>
  <cardifflexington.com:CancellationOfSeriesDPreferredStockShares id="f934" decimals="INF" contextRef="c74" unitRef="shares">-37500.0</cardifflexington.com:CancellationOfSeriesDPreferredStockShares>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f935" contextRef="c216">2023-03-21</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:Dividends id="f936" xsi:nil="true" contextRef="c94" unitRef="usd"/>
  <us-gaap:OtherOperatingIncome id="f937" decimals="0" contextRef="c12" unitRef="usd">-0.0</us-gaap:OtherOperatingIncome>
  <us-gaap:GainsLossesOnRestructuringOfDebt id="f938" decimals="0" contextRef="c44" unitRef="usd">1397271.0</us-gaap:GainsLossesOnRestructuringOfDebt>
  <us-gaap:StockholdersEquity id="f939" decimals="0" contextRef="c29" unitRef="usd">-245520.0</us-gaap:StockholdersEquity>
  <us-gaap:DebtCurrent id="f940" decimals="0" contextRef="c84" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:NetIncomeLoss id="f941" xsi:nil="true" contextRef="c82" unitRef="usd"/>
  <dei:DocumentPeriodEndDate id="f942" contextRef="c12">2023-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:Dividends id="f943" decimals="0" contextRef="c12" unitRef="usd">780074.0</us-gaap:Dividends>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="f944" decimals="INF" contextRef="c212" unitRef="shares">3259.0</us-gaap:ClassOfWarrantOrRightOutstanding>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment id="f945" decimals="0" contextRef="c44" unitRef="usd">18750.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmployment>
  <us-gaap:NetIncomeLoss id="f946" xsi:nil="true" contextRef="c94" unitRef="usd"/>
  <dei:EntityInteractiveDataCurrent id="f947" contextRef="c12">Yes</dei:EntityInteractiveDataCurrent>
  <us-gaap:ConvertibleDebt id="f948" decimals="0" contextRef="c147" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <dei:AmendmentFlag id="f949" contextRef="c12">false</dei:AmendmentFlag>
  <us-gaap:ConvertibleDebt id="f950" decimals="0" contextRef="c161" unitRef="usd">96000.0</us-gaap:ConvertibleDebt>
  <dei:DocumentFiscalYearFocus id="f951" contextRef="c12">2023</dei:DocumentFiscalYearFocus>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f952" xsi:nil="true" contextRef="c142" unitRef="usd"/>
  <us-gaap:Assets id="f953" decimals="0" contextRef="c57" unitRef="usd">14284585.0</us-gaap:Assets>
  <cardifflexington.com:IncreaseDecreaseAmortizationOfDebtDiscount id="f954" decimals="0" contextRef="c12" unitRef="usd">-136518.0</cardifflexington.com:IncreaseDecreaseAmortizationOfDebtDiscount>
  <us-gaap:DebtInstrumentMaturityDate id="f955" contextRef="c153">2017-10-28</us-gaap:DebtInstrumentMaturityDate>
  <dei:DocumentFiscalPeriodFocus id="f956" contextRef="c12">FY</dei:DocumentFiscalPeriodFocus>
  <us-gaap:Dividends id="f957" xsi:nil="true" contextRef="c176" unitRef="usd"/>
  <dei:CurrentFiscalYearEndDate id="f958" contextRef="c12">--12-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="f959" decimals="0" contextRef="c200" unitRef="usd">321169.0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <dei:EntityCentralIndexKey id="f960" contextRef="c12">0000811222</dei:EntityCentralIndexKey>
  <us-gaap:Dividends id="f961" xsi:nil="true" contextRef="c191" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f962" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f963" xsi:nil="true" contextRef="c176" unitRef="usd"/>
  <cardifflexington.com:AccruedInterest id="f964" decimals="0" contextRef="c92" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f965" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f966" xsi:nil="true" contextRef="c142" unitRef="usd"/>
  <cardifflexington.com:MezzanineEquity id="f967" decimals="0" contextRef="c138" unitRef="usd">291345.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:InterestExpenseDebt id="f968" decimals="0" contextRef="c201" unitRef="usd">6886.0</us-gaap:InterestExpenseDebt>
  <us-gaap:DebtInstrumentMaturityDate id="f969" contextRef="c129">2018-01-24</us-gaap:DebtInstrumentMaturityDate>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForContribution id="f970" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f971" xsi:nil="true" contextRef="c176" unitRef="usd"/>
  <us-gaap:EarningsPerShareBasic id="f972" decimals="INF" contextRef="c60" unitRef="usd1">137.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:Revenues id="f973" decimals="0" contextRef="c104" unitRef="usd">10693196.0</us-gaap:Revenues>
  <cardifflexington.com:CancellationOfSeriesDPreferredStock id="f974" decimals="0" contextRef="c74" unitRef="usd">150000.0</cardifflexington.com:CancellationOfSeriesDPreferredStock>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="f975" contextRef="c12">&lt;p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zBRTE3s3uO48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_825_zdqQArTRa2Fe"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NatureOfOperations_z6CG88wIodMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zqBM2VhAuvyj"&gt;Organization and Nature of Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cardiff Lexington Corporation (Cardiff)
was originally incorporated on September 3, 1986 in Colorado as Cardiff International Inc. On November 10, 2005, Cardiff merged with Legacy
Card Company, LLC and changed its name to Cardiff Lexington Corporation. On August 27, 2014, Cardiff redomiciled and became a corporation
under the laws of Florida. On April 13, 2021, Cardiff redomiciled and became a corporation under the laws of Nevada.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cardiff is an acquisition holding company focused
on locating undervalued and undercapitalized companies, primarily in the healthcare industry, and providing them capitalization and leadership
to maximize the value and potential of their private enterprises while also providing diversification and risk mitigation for stockholders.
All of Cardiffs operations are conducted through, and its income derived from, its various subsidiaries, which includes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;We Three, LLC dba Affordable Housing Initiative (AHI), which was acquired on May 15, 2014
and sold on October 31, 2022;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Edge View Properties, Inc. (Edge View), which was acquired on July 16, 2014;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Platinum Tax Defenders (Platinum Tax), which was acquired on July 31, 2018 and sold on November
10, 2023; and&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Nova Ortho and Spine, LLC (Nova), which was acquired on May 31, 2021.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zNDlfC5iduj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zS3aqjFUe9ii"&gt;Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of Cardiff and its wholly owned subsidiaries, AHI, Edge View, Platinum Tax and Nova (collectively, the Company).
Subsidiaries shown as discontinued operations include AHI and Platinum Tax. All significant intercompany accounts and transactions are
eliminated in consolidation. Subsidiaries discontinued are shown as discontinued operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--ReverseStockSplitPolicyTextBlock_zbXKqSZAHDbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zwsZ02TZenr"&gt;Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 9, 2024, the Company effected a &lt;span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20240108__20240109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkTJpYVjVRib" title="Reverse stock split"&gt;1-for-75,000
reverse split&lt;/span&gt; of its outstanding common stock. All outstanding shares of common stock and warrant to purchase common stock were adjusted
to reflect the 1-for-75,000 reverse split, with respective exercise prices of the warrants proportionately increased. The conversion prices
of the outstanding convertible notes and certain series of preferred stock were adjusted to reflect a proportional decrease in the number
of shares of common stock to be issued upon conversion.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All share and per share data throughout these
consolidated financial statements have been retroactively adjusted to reflect the reverse stock split. The total number of authorized
shares of common stock did not change. As a result of the reverse stock split, an amount equal to the decreased value of the common stock
was reclassified from common stock to additional paid-in capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p id="xdx_843_eus-gaap--UseOfEstimates_zpwUMQuBCV5i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zeiiyZ3ltjWl"&gt;Use of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements in conformity
with United States generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions
that affect certain reported amounts and disclosures. Management uses its historical records and knowledge of its business in making estimates.
Accordingly, actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ReceivablesPolicyTextBlock_z7txKT5t0DYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zYOovuOrftxh"&gt;Accounts Receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company adopted ASU 2016-13, Financial
Instruments  Credit Losses. In accordance with this standard, the Company recognizes an allowance for credit losses for
its trade receivables to present the net amount expected to be collected as of the balance sheet date. This allowance is based on the
credit losses expected to arise over the life of the asset and are based on Current Expected Credit Losses. Accounts receivable is reported
on the balance sheet at the net amounts expected to be collected by the Company. Management closely monitors outstanding accounts receivable
and recognized an additional allowance for credit losses in the amount of $&lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zQLQdAyLxvxh" title="Allowance for credit losses"&gt;122,190&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20221231_zx8fOEs9Fs7c" title="Allowance for credit losses"&gt;0&lt;/span&gt; as of December 31, 2023 and 2022, respectively.
As of December 31, 2023 and 2022, the Company had net accounts receivable of $&lt;span id="xdx_909_eus-gaap--AccountsReceivableNetCurrent_pp0p0_c20231231_z9qQQvHNN9Bg" title="Accounts receivable"&gt;13,305,254&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_c20221231_zLvzC4d3Vlr9" title="Accounts receivable"&gt;6,603,920&lt;/span&gt; respectively. Accounts receivables
are primarily generated from subsidiaries in their normal course of business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z69rx47LiPt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zkqlXPIzHFN4"&gt;Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment are carried at cost. Expenditures
for renewals and betterments that extend the useful lives of property, equipment or leasehold improvements are capitalized. Expenditures
for maintenance and repairs are charged to expense as incurred. Depreciation is calculated using the straight-line method for financial
reporting purposes based on the following estimated useful lives:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--PropertyPlantAndEquipmentUsefulLifeTextBlock_zmNeau8MZivk" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zOA5hmjon6t9" style="display: none"&gt;Schedule of estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 35%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Classification&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 65%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #EEEEEE"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z8elNfWLgwZe" title="Property and equipment, useful live"&gt;5 - 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MedicalEquipmentMember_zNVhPkdecQtb" title="Property and equipment, useful live"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #EEEEEE"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLives1_c20230101__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z6OXlvIpluw7" title="Property and equipment, useful live"&gt;10 years or lease term, if shorter&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zhnQFPExdSlj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zciSHIJA7fW2"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill and indefinite-lived assets are not amortized
but are evaluated for impairment annually or when indicators of a potential impairment are present. The Companys impairment testing
of goodwill is performed separately from its impairment testing of indefinite-lived intangibles. The Company reviews goodwill for impairment
on a reporting unit basis annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be
recoverable. Goodwill is tested first for impairment based on qualitative factors on an annual basis or in between if an event occurs
or circumstances change that indicate the fair value may be below its carrying amount, otherwise known as a triggering event.
An assessment is made of these qualitative factors as such to determine whether it is more likely than not the fair value is less than
the carry amount, including goodwill. The annual evaluation for impairment of indefinite-lived intangibles and, if then needed after the
first step, Goodwill, is based on valuation models that incorporate assumptions and internal projections of expected future cash flows
and operating plans. The Company believes such assumptions are also comparable to those that would be used by other marketplace participants.
For the year ended December 31, 2023, the Company determined there to be &lt;span id="xdx_909_eus-gaap--GoodwillImpairmentLossNetOfTax_do_c20230101__20231231_zwahgm8qvjAi" title="Goodwill impairment amount"&gt;no&lt;/span&gt; impairment. For the year ended December 31, 2022, the Company
recognized goodwill impairment in the amount of $&lt;span id="xdx_904_eus-gaap--GoodwillImpairmentLossNetOfTax_do_c20220101__20221231_ztK44OXP6Ttd" title="Goodwill impairment amount"&gt;2,092,048&lt;/span&gt; in its former financial services segment, which is now reflected in discontinued
operations. The Company based this decision on impairment testing of the underlying assets, expected cash flows, decreased asset value
and other factors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zm4v7KxK1oy5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z75Aq0Qks1ze"&gt;Valuation of Long-lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with the provisions of Accounting
Standards Codification (ASC) Topic 360-10-5, Impairment or Disposal of Long-Lived Assets, all long-lived assets
such as plant and equipment and construction in progress held and used by the Company are reviewed for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
evaluated by a comparison of the carrying amount of assets to estimated cash flows expected to be generated by the assets. If such assets
are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed
the fair value of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zKyyZknwr8Tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zGUnkCSJsP0k"&gt;Revenue Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys primary source of revenue
is its healthcare subsidiary, which records revenues from providing licensed and/or certified orthopedic procedures. Revenue is recognized
at a point in time in accordance with ASC 606. The Companys healthcare subsidiary does not have contract liabilities or deferred
revenue as there are no amounts prepaid for services. The Company applies the following five-step ASC 606 model to determine revenue recognition:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of a contract with a customer&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of the performance obligations in the contact&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Determination of the transaction price&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Allocation of the transaction price to the separate performance obligations&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognition of revenue when performance obligations are satisfied.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company applies the five-step model when it
is probable that the Company will collect the consideration it is entitled to in exchange for thegoodsor services it transfers
to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses services
promised within each contract and determines those that are a performance obligation and assesses whether each promised service is distinct.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys contracts for both its contract
and service fees each contain a single performance obligation (providing orthopedic services), as the promise to transfer the individual
services is not separately identifiable from other promises in the contracts and, therefore, not distinct, as a result, the entire transaction
price is allocated to this single performance obligation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, the Company recognizes revenues (net)
when the patient receives orthopedic care services. The Companys patient service contracts generally have performance obligations
which are satisfied at a point in time. The performance obligation is for onsite or off-site care provided. Patient service contracts
are generally fixed-price, and the transaction price is in the contract. Revenue is recognized when obligations under the terms of the
contract with our patients are satisfied; generally, at the time of patient care.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Established billing rates are not the same as
actual amounts recovered for the Companys healthcare subsidiary.They generally do not reflect what the Company is ultimately
paid by the customer, insurance carriers and other payors, and therefore are not reported in the consolidated financial statements at
that rate. The Company is typically paid amounts based on established charges per procedure with guidance from the annually
updated Current Procedural Terminology (CPT) guidelines (a code set maintained by the American Medical Association through
the CPT Editorial Panel), that designates relative value units and a suggested range of charges for each procedure which is then assigned
a CPT code.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This fee is discounted to reflect the percentage
paid to the Company using a modifier recognized by each insurance carrier for services, less deductible, co-pay, and contractual
adjustments which are deducted from the calculated fee. The net revenue is recorded at the time the services are rendered.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--ContractFeesNonPIPPolicyTextBlock_zRK2uOtXX4O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span id="xdx_86C_zYgdIeUfsg88"&gt;Contract Fees (Non-PIP)&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has contract fees for amounts earned
from its Non-Personal Injury Protection (PIP) related procedures, typically car accidents, and are collected on a contingency
basis. Historically, these cases were sold to a factor who bears the risk of economic benefit or loss. After selling patient cases to
the factor, any additional funds collected by the Company were remitted to the factor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--ServiceFeesNetPIPPolicyTextBlock_zLkfShGdonuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span id="xdx_860_zCTCOMk8xHc4"&gt;Service Fees  Net (PIP)&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company generates services fees from performing
various procedures on the date the services are performed. These services primarily include slip and falls as well as smaller nominal
Non-PIP services. Fees are collected primarily from third party insurance providers. These revenues are based on established insurance
billing rates, less allowances for contractual adjustments and uncollectible amounts. These contractual adjustments vary by insurance
company and self-pay patients. The Company computes these contractual adjustments and collection allowances based on its historical collection
experience.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Completing the paperwork for each case and preparing
it for billing takes approximately ten business days after a procedure is performed. The majority of claims are then filed electronically
except for those remaining insurance carriers requiring paper filing. An initial response is usually received within four weeks from electronic
filing and up to six weeks from paper filing. Responses may be a payment, a denial, or a request for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys healthcare revenues are generated
from professional medical billings including facility and anesthesia services. With respect to facility and anesthesia services, the Company
is the primary obligor as the facility and anesthesia services are considered part of one integrated performance obligation. Historically
the Company receives 49% of collections from total gross billed. Accordingly, the Company recognized net healthcare service revenue as
49% of gross billed amounts. Historical collection rates are estimated using the most current prior 12-month historical payment and collection
percentages.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Historically through April 2023, the Companys
healthcare subsidiary has had contractual medical receivable sales and purchase agreements with third party factors which result in approximately
54% reduction from the accounts receivables amounts when a receivable is sold to the factors. The Company evaluated the factored adjustments
considering the actual factored amounts per patient on a quarterly interval, and the reductions from accounts receivable that were factored
were recorded in finance charges as other expenses on the consolidated statement of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zJokVzJXDIMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zaZjHGsV1yXj"&gt;Advertising Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Advertising costs are expensed as incurred. Advertising
costs are included as a component of cost of sales in the consolidated statements of operations and changes in stockholders equity.
The Company recognized advertising and marketing expense of $&lt;span id="xdx_904_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20231231_zugWZ481d3ca" title="Advertising and marketing expense"&gt;126,670&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zUoRQyd6ZZxc" title="Advertising and marketing expense"&gt;233,798&lt;/span&gt; for the years ended December 31, 2023 and 2022, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zRvia7QiEcQk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zsX095o5zvfi"&gt;Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment
associated with the inputs used to measure their fair value. The fair value hierarchy distinguishes between (1) market participant assumptions
developed based on market data obtained from independent sources (observable inputs), and (2) an entitys own assumptions about
market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair
value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical
assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy
are described below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 5%"&gt;&lt;/td&gt;
  &lt;td style="text-align: left; width: 10%"&gt;Level 1&lt;/td&gt;
  &lt;td style="text-align: justify; width: 85%"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;Level 2&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;Inputs,
other than quoted prices included in Level 1, which are observable for the asset or liability through corroboration with market data at
the measurement date.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;/td&gt;
  &lt;td style="text-align: left"&gt;Level 3&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;Unobservable
inputs that reflect managements best estimate of what market participants would use in pricing the asset or liability at the measurement
date.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -81pt"&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--DistinguishingLiabilitiesFromEquityPolicyTextBlock_zw9Mqr1Iveh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zdg0w45Lnc8f"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its series N senior convertible
preferred stock, series R convertible preferred stock, and series X senior convertible preferred stock subject to possible redemption
in accordance with ASC 480, Distinguishing Liabilities from Equity. Conditionally redeemable preferred shares are classified
as temporary equity within the Companys consolidated balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zwNplXTidKMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zWctnmQKBbOl"&gt;Stock-Based Compensation&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its stock-based compensation
in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of
the fair value recognition provisions of section 718-10-30 of the FASB ASC. Pursuant to paragraph 718-10-30-6 of the FASB ASC, all transactions
in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value
of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The measurement date used to determine the fair
value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable
that performance will occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Generally, all forms of share-based payments,
including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on
the awards grant date, based on estimated number of awards that are ultimately expected to vest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The expense resulting from share-based payments
is recorded in general and administrative expense in the consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zSBknmBorPi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zDu2EIpL31D9"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income taxes are determined in accordance with
ASC Topic 740, Income Taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax
basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years
in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 740 prescribes a comprehensive model for how
companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to
be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely
than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be
measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the
tax authority assuming full knowledge of the position and relevant facts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended December 31, 2023 and 2022,
the Company did not have any interest and penalties associated with tax positions and did &lt;span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zp7DrnNjADzd" title="Uncertain tax positions"&gt;&lt;span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zXewDvvHcI5f" title="Uncertain tax positions"&gt;no&lt;/span&gt;&lt;/span&gt;t have any significant unrecognized uncertain
tax positions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zCZWYPQPJYzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zyIaYTsDZib7"&gt;Income (Loss) per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;FASB ASC Subtopic 260, &lt;i&gt;Earnings Per Share&lt;/i&gt;,
provides for the calculation of Basic and Diluted earnings per share. Basic earnings per common share is computed
by dividing income available to common stockholders by the weighted-average number of shares of common stock outstanding during the period.
Diluted earnings per common share is computed by dividing income available to common stockholders by the weighted-average number of shares
of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been
outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options,
warrants, and debts convertible into common stock. The dilutive effect of stock options and warrants are reflected in diluted earnings
per common share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of
the Companys common stock can result in a greater dilutive effect from potentially dilutive securities. The diluted effect of debt
convertibles is reflected utilizing the if converted method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--GoingConcernPolicyTextBlock_zLvenyvwvAeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zEUKaBIiLKH1"&gt;Going Concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial statements
have been prepared using the going concern basis of accounting, which contemplates continuity of operations, realization of assets and
liabilities and commitments in the normal course of business. The Company had previously sustained operating losses since its inception,
has an accumulated deficit of $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20231231_zlX72OBegjPf" title="Accumulated deficit"&gt;68,684,115&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20221231_zarF75w7bzKk" title="Accumulated deficit"&gt;70,932,435&lt;/span&gt;, respectively, as of December 31, 2023 and 2022. We had negative cash flow from
operations of $&lt;span id="xdx_907_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iN_di_c20230101__20231231_zQWxJ9bOSo7" title="Cash flow from operations"&gt;1,807,987&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iN_di_c20220101__20221231_zhuYbUHOMUch" title="Cash flow from operations"&gt;1,099,461&lt;/span&gt; during the years ended December 31, 2023 and 2022. These factors raise a substantial doubt about
the Companys ability to continue as a going concern. The accompanying consolidated financial statements do not reflect any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might
result if the Company is unable to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The ability of the Company to continue as a going
concern and the appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusions. Management
has prospective investors and believes the raising of capital will allow the Company to fund its cash flow shortfalls and pursue new acquisitions.
There can be no assurance that the Company will be able to obtain sufficient capital from debt or equity transactions or from operations
in the necessary time frame or on terms acceptable to it. Should the Company be unable to raise sufficient funds, it may be required to
curtail its operating plans. In addition, increases in expenses may require cost reductions. No assurance can be given that the Company
will be able to operate profitably on a consistent basis, or at all, in the future. Should the Company not be able to raise sufficient
funds, it may cause cessation of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zgfiXiwtk898" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zNh80TzMl9A6"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The FASB issuedASU 2023-07 on November
27, 2023. The amendments improve reportable segment disclosure requirements, primarily through enhanced disclosures about
significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in
which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities
with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable
investors to better understand an entitys overall performance and assess potential future cash
flows. The Management is evaluating the impact of ASU 2023-07 on the consolidated financial statements and does not expect
there to be any changes or impact to the financial statements.&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:DebtCurrent id="f976" decimals="0" contextRef="c131" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f977" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f978" xsi:nil="true" contextRef="c142" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f979" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f980" xsi:nil="true" contextRef="c12" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmploymentShares id="f981" decimals="INF" contextRef="c74" unitRef="shares">18750.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockForSettlementOfEmploymentShares>
  <cardifflexington.com:ServiceFeesNetPIPPolicyTextBlock id="f982" contextRef="c12">&lt;p id="xdx_841_ecustom--ServiceFeesNetPIPPolicyTextBlock_zLkfShGdonuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span id="xdx_860_zCTCOMk8xHc4"&gt;Service Fees  Net (PIP)&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company generates services fees from performing
various procedures on the date the services are performed. These services primarily include slip and falls as well as smaller nominal
Non-PIP services. Fees are collected primarily from third party insurance providers. These revenues are based on established insurance
billing rates, less allowances for contractual adjustments and uncollectible amounts. These contractual adjustments vary by insurance
company and self-pay patients. The Company computes these contractual adjustments and collection allowances based on its historical collection
experience.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Completing the paperwork for each case and preparing
it for billing takes approximately ten business days after a procedure is performed. The majority of claims are then filed electronically
except for those remaining insurance carriers requiring paper filing. An initial response is usually received within four weeks from electronic
filing and up to six weeks from paper filing. Responses may be a payment, a denial, or a request for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys healthcare revenues are generated
from professional medical billings including facility and anesthesia services. With respect to facility and anesthesia services, the Company
is the primary obligor as the facility and anesthesia services are considered part of one integrated performance obligation. Historically
the Company receives 49% of collections from total gross billed. Accordingly, the Company recognized net healthcare service revenue as
49% of gross billed amounts. Historical collection rates are estimated using the most current prior 12-month historical payment and collection
percentages.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Historically through April 2023, the Companys
healthcare subsidiary has had contractual medical receivable sales and purchase agreements with third party factors which result in approximately
54% reduction from the accounts receivables amounts when a receivable is sold to the factors. The Company evaluated the factored adjustments
considering the actual factored amounts per patient on a quarterly interval, and the reductions from accounts receivable that were factored
were recorded in finance charges as other expenses on the consolidated statement of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</cardifflexington.com:ServiceFeesNetPIPPolicyTextBlock>
  <cardifflexington.com:AccruedInterest id="f983" decimals="0" contextRef="c196" unitRef="usd">252665.0</cardifflexington.com:AccruedInterest>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeOfSeriesDPreferredStockAndSeriesHPreferredStock id="f984" xsi:nil="true" contextRef="c160" unitRef="usd"/>
  <us-gaap:NetIncomeLoss id="f985" xsi:nil="true" contextRef="c176" unitRef="usd"/>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f986" decimals="0" contextRef="c191" unitRef="usd">-20000.0</cardifflexington.com:IssuanceOfSeriesEPreferredStock>
  <us-gaap:InterestExpenseDebt id="f987" decimals="0" contextRef="c180" unitRef="usd">7826.0</us-gaap:InterestExpenseDebt>
  <cardifflexington.com:CancellationOfCommonStock id="f988" xsi:nil="true" contextRef="c175" unitRef="usd"/>
  <us-gaap:NetIncomeLoss id="f989" xsi:nil="true" contextRef="c191" unitRef="usd"/>
  <cardifflexington.com:IncreaseDecreaseAmortizationOfDebtDiscount id="f990" decimals="0" contextRef="c44" unitRef="usd">-253823.0</cardifflexington.com:IncreaseDecreaseAmortizationOfDebtDiscount>
  <us-gaap:ConvertibleDebt id="f991" decimals="0" contextRef="c189" unitRef="usd">10000.0</us-gaap:ConvertibleDebt>
  <us-gaap:ConsolidationPolicyTextBlock id="f992" contextRef="c12">&lt;p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zNDlfC5iduj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zS3aqjFUe9ii"&gt;Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of Cardiff and its wholly owned subsidiaries, AHI, Edge View, Platinum Tax and Nova (collectively, the Company).
Subsidiaries shown as discontinued operations include AHI and Platinum Tax. All significant intercompany accounts and transactions are
eliminated in consolidation. Subsidiaries discontinued are shown as discontinued operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
  <cardifflexington.com:CancellationOfCommonStock id="f993" xsi:nil="true" contextRef="c74" unitRef="usd"/>
  <dei:DocumentTransitionReport id="f994" contextRef="c12">false</dei:DocumentTransitionReport>
  <cardifflexington.com:CancellationOfCommonStock id="f995" xsi:nil="true" contextRef="c179" unitRef="usd"/>
  <us-gaap:Assets id="f996" decimals="0" contextRef="c36" unitRef="usd">13344780.0</us-gaap:Assets>
  <us-gaap:PreferredStockSharesAuthorized id="f997" decimals="INF" contextRef="c217" unitRef="shares">1000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:Depreciation id="f998" decimals="0" contextRef="c44" unitRef="usd">23132.0</us-gaap:Depreciation>
  <cardifflexington.com:DebtConversionConvertedInstrumentNewDebtIssued id="f999" decimals="0" contextRef="c218" unitRef="usd">2600000.0</cardifflexington.com:DebtConversionConvertedInstrumentNewDebtIssued>
  <us-gaap:CommonStockParOrStatedValuePerShare id="f1000" decimals="INF" contextRef="c21" unitRef="usd1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:EarningsPerShareDiluted id="f1001" decimals="INF" contextRef="c200" unitRef="usd1">4.0</us-gaap:EarningsPerShareDiluted>
  <cardifflexington.com:BonusStockToBeIssuedShares id="f1002" decimals="INF" contextRef="c219" unitRef="shares">180000.0</cardifflexington.com:BonusStockToBeIssuedShares>
  <us-gaap:PreferredStockSharesAuthorized id="f1003" decimals="INF" contextRef="c220" unitRef="shares">1000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ConvertibleDebt id="f1004" decimals="0" contextRef="c111" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:CancellationOfSeriesHPreferredStock id="f1005" decimals="0" contextRef="c44" unitRef="usd">150000.0</cardifflexington.com:CancellationOfSeriesHPreferredStock>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f1006" contextRef="c183">2019-11-08</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1007" decimals="0" contextRef="c216" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <dei:EntityCommonStockSharesOutstanding id="f1008" decimals="INF" contextRef="c221" unitRef="shares">8664495.0</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:IncomeTaxDisclosureTextBlock id="f1009" contextRef="c12">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_z6abDivAy26c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;15.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_824_zeNVxQNMpSMe"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At December 31, 2023, the Company had federal
and state net operating loss carry forwards of approximately $24 million that expire in various years through the year 2039. Due to carryforwards
of past net operating losses, there is no provision for current federal or state income taxes for the years ended December 31, 2023 and
2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred income taxes reflect the net tax effects
of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for
federal and state income tax purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys deferred tax asset at December
31, 2023 and 2022 consists of net operating loss carry forwards calculated using federal and state effective tax rates equating to approximately
$&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsGross_pp0p0_c20231231_zZhzvYDNEqGi" title="Deferred tax assets"&gt;5,291,000&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsGross_pp0p0_c20221231_zdbr4wbTChWi" title="Deferred tax assets"&gt;5,991,000&lt;/span&gt;, respectively, less a valuation allowance in the amount of approximately $&lt;span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_pp0p0_c20231231_z96pMjrDErFc" title="Valuation allowance"&gt;5,291,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--DeferredTaxAssetsValuationAllowance_pp0p0_c20221231_zKji0GJFTyNg" title="Valuation allowance"&gt;5,991,000&lt;/span&gt;, respectively.
Because of the Companys lack of earnings history, the deferred tax asset has been fully offset by a valuation allowance in both
2023 and 2022. The valuation allowance decreased by approximately $&lt;span id="xdx_908_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn5n6_c20220101__20221231_zbEnPpTinKy4" title="Increase in valuation allowance"&gt;0.7&lt;/span&gt; million from the year ended December 31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys total deferred tax asset
as of December 31, 2023 and 2022 is as follows:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zrljI3KGPBS3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BA_z2cs9igmOMBi" style="display: none"&gt;Schedule of deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_497_20231231_z66W0nzoAKL1" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_499_20221231_zKM9Qd3Py0Z7" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_maDTANz27H_zHTYRCYpD6gl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;5,291,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;5,991,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz27H_zL0ZZbaTFdq8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,291,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,991,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_d0_mtDTANz27H_zk21ssa0xXWf" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
  <cardifflexington.com:MezzanineEquity id="f1010" decimals="0" contextRef="c67" unitRef="usd">5454979.0</cardifflexington.com:MezzanineEquity>
  <cardifflexington.com:DebtConversionConvertedSharesIssued id="f1011" decimals="INF" contextRef="c222" unitRef="shares">375000.0</cardifflexington.com:DebtConversionConvertedSharesIssued>
  <cardifflexington.com:PropertyPlantAndEquipmentEstimatedUsefulLives1 id="f1012" contextRef="c223">10 years or lease term, if shorter</cardifflexington.com:PropertyPlantAndEquipmentEstimatedUsefulLives1>
  <us-gaap:DebtCurrent id="f1013" decimals="0" contextRef="c224" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:Dividends id="f1014" decimals="0" contextRef="c214" unitRef="usd">336650.0</us-gaap:Dividends>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="f1015" contextRef="c12">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zf2PZqB9AXu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82C_zM7c654OQsQh"&gt;CAPITAL STOCK&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Preferred Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has designated multiple series of
preferred stock, including &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbZ5Cpmv74H" title="Preferred stock, shares authorized"&gt;2&lt;/span&gt; shares of series A preferred stock, &lt;span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zBH6aQa4jjV" title="Preferred stock, shares authorized"&gt;3,000,000&lt;/span&gt; shares of series B preferred stock, &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z36pa7UIejK" title="Preferred stock, shares authorized"&gt;500&lt;/span&gt; shares of series C
preferred stock, &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_ztArGQeCx1xj" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; shares of series E preferred stock, &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesF1PreferredStockMember_zWweC7rUN9Ng" title="Preferred stock shares authorized"&gt;50,000&lt;/span&gt; shares of series F-1 preferred stock, &lt;span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zXaJc6JIF14e" title="Preferred stock, shares authorized"&gt;15,000,000&lt;/span&gt; shares of series
I preferred stock, &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zrF9fqp3G9k9" title="Preferred stock, shares authorized"&gt;2,000,000&lt;/span&gt; shares of series J preferred stock, &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zzbZDaxBDSIj" title="Preferred stock, shares authorized"&gt;400,000&lt;/span&gt; shares of series L preferred stock, &lt;span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesNSeniorConvertiblePreferredStockMember_zWmr9QGFzZP6" title="Preferred stock, shares authorized"&gt;3,000,000&lt;/span&gt; shares of series
N senior convertible preferred stock, &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesRPreferredStockMember_zQ5fQCr0sAn6" title="Preferred stock, shares authorized"&gt;5,000&lt;/span&gt; shares of series R convertible preferred stock and &lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesXPreferredStockMember_z6PbWoKLkMxk" title="Preferred stock, shares authorized"&gt;5,000,000&lt;/span&gt; shares of series X senior convertible
preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a description of the rights and
preferences of each series of preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Redeemable Preferred Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognized the series N senior convertible
preferred stock, series R convertible preferred stock and series X senior convertible preferred stock as mezzanine equity in accordance
with ASC 480, Distinguishing Liabilities from Equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series N Senior Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series N senior convertible
preferred stock ranks, with respect to the payment of dividends and the distribution of assets upon liquidation, (i) senior to all common
stock and each other class or series that is not expressly made senior to or on parity with the series N senior convertible preferred
stock; (ii) on parity with each class or series that is not expressly subordinated or made senior to the series N senior convertible preferred
stock; and (iii) junior to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company
and each class or series that is expressly made senior to the series N senior convertible preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; Holders of series N senior
convertible preferred stock are entitled to dividends at a rate per annum of 12.0% of the stated value ($4.00 per share); provided that
upon an event of default (as defined in the certificate of designation for the series N senior convertible preferred stock), such rate
shall increase by 8% per annum. Dividends shall accrue from day to day, whether or not declared, and shall be cumulative. Dividends shall
be payable quarterly in arrears on each dividend payment date in cash or common stock at the Companys discretion. Dividends payable
in common stock shall be calculated based on a price equal to eighty percent (80%) of the volume weighted average price for the common
stock on the Companys principal trading market (the VWAP) during the five (5) trading days immediately prior to the
applicable dividend payment date. At December 31, 2023, cumulative dividends on Series N Preferred Stock were $&lt;span id="xdx_904_eus-gaap--DividendsPreferredStock_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesNSeniorConvertiblePreferredStockMember_zHURa21iI9af" title="Dividends payment"&gt;766,437&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights. &lt;/i&gt;Subject to the rights
of creditors and the holders of any senior securities or parity securities (in each case, as defined in the certificate of designation),
upon any liquidation of the Company or its subsidiaries, before any payment or distribution of the assets of the Company (whether capital
or surplus) shall be made to or set apart for the holders of junior securities (as defined in the certificate of designation), including
the common stock, each holder of outstanding series N senior convertible preferred stock shall be entitled to receive an amount of cash
equal to 115% of the stated value of $4.00 per share, plus an amount of cash equal to all accumulated accrued and unpaid dividends thereon
(whether or not declared) to, but not including the date of final distribution to such holders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. Holders of series N senior
convertible preferred stock do not have any voting rights; provided that, so long as any shares of series N senior convertible preferred
stock are outstanding, the affirmative vote of holders of a majority of the series N senior convertible preferred stock, which majority
must include SILAC Insurance Company so long as it holds any shares of series N senior convertible preferred stock, voting as a separate
class, shall be necessary for approving, effecting or validating any amendment, alteration or repeal of any of the provisions of the certificate
of designation or prior to the Companys (or Novas) creation or issuance of any parity securities or new indebtedness (as
defined in the certificate of designation); provided that the foregoing shall not apply to any financing transaction the use of proceeds
of which will be used to redeem the series N senior convertible preferred stock and the warrants issued in connection therewith. In addition,
the affirmative vote of holders of 66% of the series N senior convertible preferred stock, voting as a separate class, is required prior
to the Companys (or Novas) creation or issuance of any senior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each shares of series
N senior convertible preferred stock, plus all accrued and unpaid dividends thereon, shall be convertible, at the option of the holder
thereof, at any time and from time to time, into such number of fully paid and nonassessable shares of common stock determined by dividing
the stated value ($4.00 per share), plus the value of the accrued, but unpaid, dividends thereon, by a conversion price of $900 per share
(subject to standard adjustments in the event of any stock splits, stock combinations, stock reclassifications, dividends paid in common
stock, sales of substantially all assets, mergers, consolidations or similar transactions); provided that in no event shall the holder
of any series N senior convertible preferred stock be entitled to convert any number of shares that upon conversion the sum of (i) the
number of shares of common stock beneficially owned by the holder and its affiliates and (ii) the number of shares of common stock issuable
upon the conversion of the series N senior convertible preferred stock with respect to which the determination of this proviso is being
made, would result in beneficial ownership by the holder and its affiliates of more than 4.99% of the then outstanding common stock. This
limitation may be waived (up to a maximum of 9.99%) by the holder and in its sole discretion, upon not less than sixty-one (61) days
prior notice to the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. The Company may redeem
the series N senior convertible preferred stock at any time by paying in cash therefore a sum equal to 115% of the stated value of $4.00
per share, plus the amount of accrued and unpaid dividends and any other amounts due pursuant to the terms of the certificate of designation.
In addition, any holder may require the Company to redeem some or all of its shares of series N senior convertible preferred stock on
the same terms after a period of twelve months from the date of issuance; provided, however, that such redemption right shall only be
exercisable if the Company raises at least $5,000,000 or the common stock is trading on the Nasdaq Stock Market or the New York Stock
Exchange.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series R Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series R convertible preferred
stock ranks, with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock, series
B preferred stock, series C preferred stock, series E preferred stock, series F-1 preferred stock, series I preferred stock, series J
preferred stock, series L preferred stock and to each other class or series that is not expressly made senior to or on parity with the
series R convertible preferred stock; (ii) on parity with each class or series that is not expressly subordinated or made senior to the
series R convertible preferred stock; and (iii) junior to the series N senior convertible preferred stock, series X senior convertible
preferred stock and to each other series of preferred stock and each class or series that is expressly made senior to the series R convertible
preferred stock, as well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
R convertible preferred stock are entitled to receive cumulative dividends in the amount of twelve percent (12%) per annum, payable quarterly.
In addition, holders of series R convertible preferred stock are entitled to receive dividends equal (on an as converted to common stock
basis) to and in the same form as dividends actually paid on shares of common stock when, as and if such dividends are paid on shares
of common stock. Any dividends that are not paid when due shall continue to accrue and shall entail a late fee, which must be paid in
cash, at the rate of 18% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the missed
payment date through and including the date of actual payment in full. At December 31, 2023, cumulative dividends on Series R Preferred
Stock were $&lt;span id="xdx_909_eus-gaap--DividendsPreferredStock_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesRPreferredStockMember_z1tny2oK9cWg" title="Dividends payment"&gt;109,980&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series R convertible preferred stock shall
be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the stated value ($1,200), plus
any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing, for each share of series R convertible
preferred stock before any distribution or payment shall be made to the holders of any junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. The holders of series R
convertible preferred stock will vote together with the common stock on an as-converted basis. However, as long as any shares of series
R convertible preferred stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the
then outstanding shares of the series R convertible preferred stock, directly and/or indirectly (i) alter or change adversely the powers,
preferences or rights given to the series R convertible preferred stock or alter or amend the certificate of designation, (ii) authorize
or create any class of stock ranking as to redemption or distribution of assets upon a liquidation senior to, or otherwise &lt;i&gt;pari passu&lt;/i&gt;
with, the series R convertible preferred stock, or authorize or create any class of stock ranking as to dividends senior to, or otherwise
&lt;i&gt;pari passu&lt;/i&gt; with, the series R convertible preferred stock, (iii) amend its articles of incorporation or other charter documents
in any manner that adversely affects any rights of the holders of the series R convertible preferred stock, (iv) increase the number of
authorized shares of series R convertible preferred stock, or (v) enter into any agreement with respect to any of the foregoing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each shares of series
R convertible preferred stock shall be convertible, at the option of the holder thereof, at any time and from time to time, into such
number of fully paid and nonassessable shares of common stock determined by dividing the stated value ($1,200 per share) by a conversion
price equal to the lower of (i) $75.0 and (ii) the lowest daily VWAP during the twenty (20) trading days immediately prior to the applicable
conversion date. Notwithstanding the foregoing, the Company shall not effect any conversion of the series R convertible preferred stock,
and a holder shall not have the right to convert any portion of the series R convertible preferred stock, to the extent that, after giving
effect to the conversion, such holder (together with such holders affiliates, and any persons acting as a group together with such
holder or any of such holders affiliates) would beneficially own in excess of 4.99% of the then outstanding common stock. The conversion
price is subject to adjustment for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately
decreases or increases the common stock, as well as for mergers, business combinations and certain other fundamental transactions. In
addition, subject to certain exceptions, upon any issuance by the Company or any of its subsidiaries of common stock or common stock equivalents
for cash consideration, indebtedness or a combination of units thereof (a Subsequent Financing), the holder may elect, in
its sole discretion, to exchange (in lieu of conversion), if applicable, all or some of the shares of series R convertible preferred stock
then held for any securities or units issued in a Subsequent Financing on a $1.00 for $1.00 basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Participation Rights&lt;/i&gt;. Subject to certain
exceptions, upon a Subsequent Financing, a holder of at least 100 shares of series R convertible preferred stock shall have the right
to participate in up to an amount of the Subsequent Financing equal to 100% of the Subsequent Financing on the same terms, conditions
and price provided for in the Subsequent Financing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Company Redemption Rights&lt;/i&gt;. The Company
has the right to redeem all (but not less than all), shares of the series R convertible preferred stock issued and outstanding at any
time upon three (3) business days notice, at a redemption price per share equal to the product of (i) the Premium Rate multiplied
by (ii) the sum of (x) the stated value ($1,200), (y) all accrued but unpaid dividends, and (z) all other amounts due to the holder. Premium
Rate means (a) 1.1 if all of the series R convertible preferred stock is redeemed within ninety (90) calendar days from the issuance
date thereof; (b) 1.2 if all of the series R convertible preferred stock is redeemed after ninety (90) calendar days and within one hundred
twenty (120) calendar days from the issuance date thereof; (c) 1.3 if all of the series R convertible preferred stock is redeemed after
one hundred twenty (120) calendar days and within one hundred eighty (180) calendar days from the issuance date thereof; and (iv) 1.0
if all of the series R convertible preferred stock is redeemed after one hundred eighty (180) calendar days.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Upon Triggering Events&lt;/i&gt;. Upon
the occurrence of a Triggering Event (as defined below), each holder of series R convertible preferred stock shall (in addition to all
other rights it may have) have the right, exercisable at the sole option of such holder, to require the Company to (A) redeem all of the
series R convertible preferred stock then held by such holder for a redemption price, in cash, equal to the Triggering Redemption Amount
(as defined below), or (B) at the option of each holder either (i) redeem all of the series R convertible preferred stock then held by
such holder though the issuance to such holder of such number of shares of common stock equal to the quotient of (x) the Triggering Redemption
Amount, divided by (y) the lowest of (1) the conversion price, and (2) 75% of the average of the 10 VWAPs immediately prior to the date
of election, or (ii) increase the dividend rate on all of the outstanding series R convertible preferred stock held by such holder retroactively
to the initial issuance date to 18% per annum thereafter. Triggering Redemption Amount means, for each share of series R
convertible preferred stock, the sum of (a) the greater of (i) 130% of the stated value and (ii) the product of (y) the VWAP on the trading
day immediately preceding the date of the Triggering Event, multiplied by (z) the stated value divided by the then applicable conversion
price, (b) all accrued but unpaid dividends thereon and (c) all liquidated damages, late fees and other costs, expenses or amounts due
in respect of the series R convertible preferred stock including, but not limited to legal fees and expenses of legal counsel to the holder
in connection with, related to and/or arising out of a Triggering Event. A Triggering Event means any of the following events
(whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant
to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the Company shall fail to deliver the shares of common stock issuable upon a conversion prior to the fifth
(5&lt;sup&gt;th&lt;/sup&gt;) trading day after such shares are required to be delivered, or the Company shall provide written notice to any holder,
including by way of public announcement, at any time, of its intention not to comply with requests for conversion of any shares of series
R convertible preferred stock in accordance with the terms of the certificate of designation;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the Company shall fail for any reason to pay in full the amount of cash due pursuant to a Buy-In (as defined
in the certificate of designation) within five (5) trading days after notice therefor is delivered;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the Company shall fail to have available a sufficient number of authorized and unreserved shares of common
stock to issue to such holder upon a conversion;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;unless specifically addressed elsewhere in the certificate of designation as a Triggering Event, the Company
shall fail to observe or perform any other covenant, agreement or warranty contained in, or otherwise commit any breach of the Transaction
Documents (as defined in the certificate of designation), and such failure or breach shall not, if subject to the possibility of a cure
by the Company, have been cured within five (5) calendar days after the date on which written notice of such failure or breach shall have
been delivered;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the Company shall redeem junior securities or &lt;i&gt;pari passu&lt;/i&gt; securities;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the Company shall be party to a Change of Control Transaction (as defined in the certificate of designation);&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;there shall have occurred a Bankruptcy Event (as defined in the certificate
of designation);&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;any monetary judgment, writ or similar final process shall be entered or filed against the Company, any
subsidiary or any of their respective property or other assets for more than $50,000 (provided that amounts covered by the Companys
insurance policies are not counted toward this $50,000 threshold), and such judgment, writ or similar final process shall remain unvacated,
unbonded or unstayed for a period of thirty (30) trading days;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the electronic transfer by the Company of shares of common stock through the Depository Trust Company
or another established clearing corporation once established subsequent to the date of the certificate of designation is no longer available
or is subject to a freeze and/or chill; or&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;any Event of Default, as defined in the Purchase Agreement (as defined in the certificate
of designation).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series X Senior Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series X senior convertible
preferred stock ranks, with respect to the payment of dividends and the distribution of assets upon liquidation, (i) senior to all common
stock and each other class or series that is not expressly made senior to or on parity with the series X senior convertible preferred
stock; (ii) on parity with each class or series that is not expressly subordinated or made senior to the series X senior convertible preferred
stock; and (iii) junior to the series N senior convertible preferred stock, all indebtedness and other liabilities with respect to assets
available to satisfy claims against the Company and each class or series that is expressly made senior to the series X senior convertible
preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; Holders of series X senior
convertible preferred stock are entitled to dividends at a rate per annum of 10.0% of the stated value ($4.00 per share); provided that
upon an event of default (as defined in the certificate of designation for the series X senior convertible preferred stock), such rate
shall increase by 5% per annum. Dividends shall accrue from day to day, whether or not declared, and shall be cumulative. Dividends shall
be payable quarterly in arrears on each dividend payment date. At December 31, 2023, cumulative dividends on Series X Preferred Stock
were $&lt;span id="xdx_90D_eus-gaap--DividendsPreferredStock_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesXPreferredStockMember_zLFYkmOXwFei" title="Dividends payment"&gt;190,685&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights. &lt;/i&gt;Subject to the rights
of creditors and the holders of any senior securities, including the series N senior convertible preferred stock, or parity securities
(in each case, as defined in the certificate of designation), upon any liquidation of the Company or its subsidiaries, before any payment
or distribution of the assets of the Company (whether capital or surplus) shall be made to or set apart for the holders of junior securities
(as defined in the certificate of designation), including the common stock, each holder of outstanding series N senior convertible preferred
stock shall be entitled to receive an amount of cash equal to 100% of the stated value of $4.00 per share, plus an amount of cash equal
to all accumulated accrued and unpaid dividends thereon (whether or not declared) to, but not including the date of final distribution
to such holders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. Holders of series X senior
convertible preferred stock do not have any voting rights; provided that, so long as any shares of series X senior convertible preferred
stock are outstanding, the affirmative vote of holders of a majority of the series X senior convertible preferred stock, which majority
must include Leonite Capital LLC so long as it holds any shares of series X senior convertible preferred stock, voting as a separate class,
shall be necessary for approving, effecting or validating any amendment, alteration or repeal of any of the provisions of the certificate
of designation or prior to the creation or issuance of any parity securities or new indebtedness (as defined in the certificate of designation);
provided that the foregoing shall not apply to any financing transaction the use of proceeds of which will be used to redeem the series
X senior convertible preferred stock and the warrants issued in connection therewith. In addition, the affirmative vote of holders of
66% of the series X senior convertible preferred stock, voting as a separate class, is required prior to the creation or issuance of any
senior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each shares of series
X senior convertible preferred stock, plus all accrued and unpaid dividends thereon, shall be convertible, at the option of the holder
thereof, at any time and from time to time, into such number of fully paid and nonassessable shares of common stock determined by dividing
the stated value ($4.00 per share), plus the value of the accrued, but unpaid, dividends thereon, by a conversion price equal to the lower
of (i) the lowest VWAP during the five (5) trading days immediately prior to the applicable conversion date and (ii) the price per share
paid in any subsequent financing (the Fixed Price). The Fixed Price is subject to standard adjustments in the event of any
stock splits, stock combinations, stock reclassifications, dividends paid in common stock, sales of substantially all assets, mergers,
consolidations or similar transactions, as well as a price based antidilution adjustment, pursuant to which, subject to certain exceptions,
if the Company issues common stock at a price lower than the Fixed Price, the Fixed Price shall decrease to such lower price. Notwithstanding
the foregoing, in no event shall the holder of any series X senior convertible preferred stock be entitled to convert any number of shares
that upon conversion the sum of (i) the number of shares of common stock beneficially owned by the holder and its affiliates and (ii)
the number of shares of common stock issuable upon the conversion of the series X senior convertible preferred stock with respect to which
the determination of this proviso is being made, would result in beneficial ownership by the holder and its affiliates of more than 4.99%
of the then outstanding common stock. This limitation may be waived (up to a maximum of 9.99%) by the holder and in its sole discretion,
upon not less than sixty-one (61) days prior notice to the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. Commencing on September
22, 2023, any holder may require the Company to redeem its shares by the payment in cash therefore of a sum equal to 100% of the stated
value of $4.00 per share, plus the amount of accrued and unpaid dividends and any other amounts due pursuant to the terms of the certificate
of designation; provided however, that in the event that the Company completes a public offering prior to the redemption date, then any
holder may only cause the Company to redeem any outstanding series X senior convertible preferred stock by paying such redemption price
in twelve (12) equal monthly installments with the first such payment due on the date that is six (6) months following the date that the
Company completes such public offering.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Non-redeemable Preferred Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series A preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock and each other class or series that is not
expressly made senior to or on parity with the series A preferred stock; (ii) on parity with each class or series that is not expressly
subordinated or made senior to the series A preferred stock; and (iii) junior to the series B preferred stock, series C preferred stock,
series E preferred stock, series F-1 preferred stock, series I preferred stock, series J preferred stock, series L preferred stock, series
N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock and each other
series of preferred stock and each class or series that is expressly made senior to the series A preferred stock, as well as to all indebtedness
and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The series A preferred
stock is not entitled to participate in any distributions or payments to the holders of common stock or any other class of stock and shall
have no economic interest in the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. In the event of any
liquidation, dissolution or winding up of the Company, either voluntarily or involuntarily, a merger or consolidation of our company wherein
the Company is not the surviving entity, or a sale of all or substantially all of the assets of the Company, the holders of each share
of series A preferred stock shall be entitled to receive from any distribution of any of the assets or surplus funds of the Company, before
and in preference of any holder of shares of common stock, an amount equal to the stated value of $250. Once the holders receive the foregoing
from any such liquidation, dissolution or winding up, the holders shall not participate with the common stock or any other class of stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. Each share of series A preferred
stock shall have a number of votes at any time equal to (i) 25% of the number of votes then held or entitled to be made by all other equity
securities of the Company, including, without limitation, the common stock, plus (ii) one (1). The series A preferred stock shall vote
on any matter submitted to the holders of the common stock, or any other class of voting securities, for a vote, and shall vote together
with the common stock, or any class of voting securities, as applicable, on such matter for as long as the shares of series A preferred
stock are issued and outstanding. Notwithstanding the foregoing, the series A preferred stock shall not have the right to vote on any
matter as to which solely another series of preferred stock is entitled to vote pursuant to the Companys amended and restated articles
of incorporation or a certificate of designation of such other series of preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Transfer&lt;/i&gt;. Upon transfer of any share of
series A preferred stock, except for a transfer by the holder to an affiliate, whether such transfer is voluntary or involuntary, such
share of series A preferred stock shall automatically, and without any action being required by the Company or the holder, be converted
into one (1) share of common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Other Rights&lt;/i&gt;. Holders of series A preferred
stock do not have any conversion (except as set forth above) or redemption rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series B preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock and to each other
class or series that is not expressly made senior to or on parity with the series B preferred stock; (ii) on parity with the series C
preferred stock, series E preferred stock, series F-1 preferred stock, series J preferred stock, series L preferred stock and each other
class or series that is not expressly subordinated or made senior to the series B preferred stock; and (iii) junior to the series I preferred
stock, series N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock
and to each other series of preferred stock and each class or series that is expressly made senior to the series B preferred stock, as
well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
B preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series B preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series B preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series B preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
B preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. On any matter presented
to stockholders for their action or consideration, each holder of series B preferred stock shall be entitled to cast one (1) vote per
share of series B preferred stock held. Except as provided by law, the holders of series B preferred stock shall vote together with the
holders of shares of common stock as a single class. However, as long as any shares of series B preferred stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of outstanding series B preferred stock, (a) alter or change adversely
the powers, preferences or rights given to the series B preferred stock or alter or amend the certificate of designation for the series
B preferred stock, or (b) amend the Companys amended and restated articles of incorporation or other charter documents in any manner
that adversely affects any rights of the holders of series B preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
B preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares of
common stock as is determined as follows: (i) if the closing market price of the common stock on the principal trading market on which
the common stock is then traded or quoted is less than $4.00 per share, then each share of series B preferred stock shall be convertible
into a number of shares of common stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price
on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of series
B preferred stock shall be convertible into two (2) shares of common stock. In addition, upon the earlier to occur of: (a) the closing
of the sale of shares of common stock to the public at a price of at least $3.00 per share in a public offering pursuant to an effective
registration statement or offering statement under the Securities Act resulting in at least $3,000,000 of gross proceeds to the Company,
(b) the date on which the shares of common stock of the Company are listed on a national stock exchange, including without limitation
the New York Stock Exchange, NYSE American or the Nasdaq Stock Market (any tier), or (c) the date and time, or the occurrence of an event,
specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series B preferred stock, voting
together as a single class, each share of series B preferred stock shall be automatically converted into such number of shares of common
stock as is determined in accordance with the provisions above. Such conversion price is subject to standard adjustments in the event
of any stock dividends, stock reclassifications and similar events (but not for reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. Holders of series B
preferred stock do not have any redemption rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series C Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series C preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock and to each other
class or series that is not expressly made senior to or on parity with the series C preferred stock; (ii) on parity with the series B
preferred stock, series E preferred stock, series F-1 preferred stock, series J preferred stock, series L preferred stock and each other
class or series that is not expressly subordinated or made senior to the series C preferred stock; and (iii) junior to the series I preferred
stock, series N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock
and to each other series of preferred stock and each class or series that is expressly made senior to the series C preferred stock, as
well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
C preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series C preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series C preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series C preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
C preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. On any matter presented
to stockholders for their action or consideration, each holder of series C preferred stock shall be entitled to cast one (1) vote per
share of series C preferred stock held. Except as provided by law, the holders of series C preferred stock shall vote together with the
holders of shares of common stock as a single class. However, as long as any shares of series C preferred stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of outstanding series C preferred stock, (a) alter or change adversely
the powers, preferences or rights given to the series C preferred stock or alter or amend the certificate of designation for the series
C preferred stock, or (b) amend the Companys amended and restated articles of incorporation or other charter documents in any manner
that adversely affects any rights of the holders of series C preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
C preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares of
common stock as is determined by dividing the stated value ($4.00 per share) by a conversion price of $0.00004. In addition, on the date
on which the shares of common stock are listed on a national stock exchange, including without limitation the New York Stock Exchange,
NYSE American or the Nasdaq Stock Market (any tier) (a Listing Event), all outstanding shares of series C preferred stock
shall be automatically converted into such number of shares of common stock as is determined by dividing $50,000 by the highest traded
or closing price on such date, which such shares of common stock shall be issued pro rata among the holders of the outstanding series
C preferred stock. Finally, upon the earlier to occur of: (a) the closing of the sale of shares of common stock to the public at a price
of at least $3.00 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar
recapitalization with respect to the common stock) in a public offering pursuant to an effective registration statement or offering statement
under the Securities Act resulting in at least $3,000,000 of gross proceeds to the Company or (b) the date and time, or the occurrence
of an event, specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series C preferred
stock, voting together as a single class, each share of series C preferred stock shall be automatically converted into such number of
shares of common stock as is determined by dividing the stated value ($4.00 per share) by a conversion price of $0.00004. Such conversion
price is subject to standard adjustments in the event of any stock dividends, stock reclassifications and similar events (but not for
reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. If there is a Listing
Event, the Company shall have the right (but not the obligation) to redeem shares of series C preferred stock at a price per share of
$50,000.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series E Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series E preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock and to each other
class or series that is not expressly made senior to or on parity with the series E preferred stock; (ii) on parity with the series B
preferred stock, series C preferred stock, series F-1 preferred stock, series J preferred stock, series L preferred stock and each other
class or series that is not expressly subordinated or made senior to the series E preferred stock; and (iii) junior to the series I preferred
stock, series N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock
and to each other series of preferred stock and each class or series that is expressly made senior to the series E preferred stock, as
well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
E preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series E preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series E preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series E preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
E preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. On any matter presented
to stockholders for their action or consideration, each holder of series E preferred stock shall be entitled to cast one (1) vote per
share of series E preferred stock held. Except as provided by law, the holders of series E preferred stock shall vote together with the
holders of shares of common stock as a single class. However, as long as any shares of series E preferred stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of outstanding series E preferred stock, (a) alter or change adversely
the powers, preferences or rights given to the series E preferred stock or alter or amend the certificate of designation for the series
E preferred stock, or (b) amend the Companys amended and restated articles of incorporation or other charter documents in any manner
that adversely affects any rights of the holders of series E preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
E preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares of
common stock as is determined as follows: (i) if the closing market price of the common stock on the principal trading market on which
the common stock is then traded or quoted is less than $4.00 per share, then each share of series E preferred stock shall be convertible
into a number of shares of common stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price
on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of series
E preferred stock shall be convertible into two (2) shares of common stock. In addition, upon the earlier to occur of: (a) the closing
of the sale of shares of common stock to the public at a price of at least $3.00 per share in a public offering pursuant to an effective
registration statement or offering statement under the Securities Act resulting in at least $3,000,000 of gross proceeds to the Company,
(b) the date on which the shares of common stock of the Company are listed on a national stock exchange, including without limitation
the New York Stock Exchange, NYSE American or the Nasdaq Stock Market (any tier), or (c) the date and time, or the occurrence of an event,
specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series E preferred stock, voting
together as a single class, each share of series E preferred stock shall be automatically converted into such number of shares of common
stock as is determined in accordance with the provisions above. Such conversion price is subject to standard adjustments in the event
of any stock dividends, stock reclassifications and similar events (but not for reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series F-1 Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series F-1 preferred stock
ranks, with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock and to each
other class or series that is not expressly made senior to or on parity with the series F-1 preferred stock; (ii) on parity with the series
B preferred stock, series C preferred stock, series E preferred stock, series J preferred stock, series L preferred stock and each other
class or series that is not expressly subordinated or made senior to the series F-1 preferred stock; and (iii) junior to the series I
preferred stock, series N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred
stock and to each other series of preferred stock and each class or series that is expressly made senior to the series F-1 preferred stock,
as well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
F-1 preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series F-1 preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series F-1 preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series F-1 preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
F-1 preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. Except as provided by law,
the holders of series F-1 preferred stock shall have no voting rights. However, as long as any shares of series F-1 preferred stock are
outstanding, the Company shall not, without the affirmative vote of the holders of a majority of outstanding series F-1 preferred stock,
(a) alter or change adversely the powers, preferences or rights given to the series F-1 preferred stock or alter or amend the certificate
of designation for the series F-1 preferred stock, or (b) amend the Companys amended and restated articles of incorporation or
other charter documents in any manner that adversely affects any rights of the holders of series F-1 preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
F-1 preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares
of common stock as is determined as follows: (i) if the closing market price of the common stock on the principal trading market on which
the common stock is then traded or quoted is less than $4.00 per share, then each share of series F-1 preferred stock shall be convertible
into a number of shares of common stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price
on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of series
F-1 preferred stock shall be convertible into two (2) shares of common stock. In addition, upon the earlier to occur of: (a) the closing
of the sale of shares of common stock to the public at a price of at least $3.00 per share in a public offering pursuant to an effective
registration statement or offering statement under the Securities Act resulting in at least $3,000,000 of gross proceeds to the Company,
(b) the date on which the shares of common stock of the Company are listed on a national stock exchange, including without limitation
the New York Stock Exchange, NYSE American or the Nasdaq Stock Market (any tier), or (c) the date and time, or the occurrence of an event,
specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series F-1 preferred stock, voting
together as a single class, each share of series F-1 preferred stock shall be automatically converted into such number of shares of common
stock as is determined in accordance with the provisions above. Such conversion price is subject to standard adjustments in the event
of any stock dividends, stock reclassifications and similar events (but not for reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. Holders of series F-1
preferred stock do not have any redemption rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series I Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series I preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock, series B preferred
stock, series C preferred stock, series E preferred stock, series F-1 preferred stock, series J preferred stock, series L preferred stock
and to each other class or series that is not expressly made senior to or on parity with the series I preferred stock; (ii) on parity
with each class or series that is not expressly subordinated or made senior to the series I preferred stock; and (iii) junior to the series
N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock and to each other
series of preferred stock and each class or series that is expressly made senior to the series I preferred stock, as well as to all indebtedness
and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
I preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series I preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series I preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series I preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
I preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. On any matter presented
to stockholders for their action or consideration, each holder of series I preferred stock shall be entitled to cast five (5) votes per
share of series I preferred stock held. Except as provided by law, the holders of series I preferred stock shall vote together with the
holders of shares of common stock as a single class. However, as long as any shares of series I preferred stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of outstanding series I preferred stock, (a) alter or change adversely
the powers, preferences or rights given to the series I preferred stock or alter or amend the certificate of designation for the series
I preferred stock, or (b) amend the Companys amended and restated articles of incorporation or other charter documents in any manner
that adversely affects any rights of the holders of series I preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
I preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares of
common stock as is determined as follows: (i) if the closing market price of the common stock on the principal trading market on which
the common stock is then traded or quoted is less than $4.00 per share, then each share of series I preferred stock shall be convertible
into a number of shares of common stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price
on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of series
I preferred stock shall be convertible into two (2) shares of common stock. In addition, upon the earlier to occur of: (a) the closing
of the sale of shares of common stock to the public at a price of at least $3.00 per share in a public offering pursuant to an effective
registration statement or offering statement under the Securities Act resulting in at least $10,000,000 of gross proceeds to the Company,
(b) the date on which the shares of common stock of the Company are listed on a national stock exchange, including without limitation
the New York Stock Exchange, NYSE American or the Nasdaq Stock Market (any tier), or (c) the date and time, or the occurrence of an event,
specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series I preferred stock, voting
together as a single class, each share of series I preferred stock shall be automatically converted into such number of shares of common
stock as is determined in accordance with the provisions above. Such conversion price is subject to standard adjustments in the event
of any stock dividends, stock reclassifications and similar events (but not for reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. Holders of series I
preferred stock do not have any redemption rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series J Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series J preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock and to each other
class or series that is not expressly made senior to or on parity with the series J preferred stock; (ii) on parity with the series B
preferred stock, series C preferred stock, series E preferred stock, series F-1 preferred stock, series L preferred stock and each other
class or series that is not expressly subordinated or made senior to the series J preferred stock; and (iii) junior to the series I preferred
stock, series N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock
and to each other series of preferred stock and each class or series that is expressly made senior to the series J preferred stock, as
well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
J preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series J preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series J preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series J preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
J preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. On any matter presented
to stockholders for their action or consideration, each holder of series J preferred stock shall be entitled to cast one (1) vote per
share of series J preferred stock held. Except as provided by law, the holders of series J preferred stock shall vote together with the
holders of shares of common stock as a single class. However, as long as any shares of series J preferred stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of outstanding series J preferred stock, (a) alter or change adversely
the powers, preferences or rights given to the series J preferred stock or alter or amend the certificate of designation for the series
J preferred stock, or (b) amend the Companys amended and restated articles of incorporation or other charter documents in any manner
that adversely affects any rights of the holders of series J preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
J preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares of
common stock as is determined as follows: (i) if the closing market price of the common stock on the principal trading market on which
the common stock is then traded or quoted is less than $4.00 per share, then each share of series J preferred stock shall be convertible
into a number of shares of common stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price
on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of series
J preferred stock shall be convertible into two (2) shares of common stock. In addition, upon the earlier to occur of: (a) the closing
of the sale of shares of common stock to the public at a price of at least $3.00 per share in a public offering pursuant to an effective
registration statement or offering statement under the Securities Act resulting in at least $3,000,000 of gross proceeds to the Company,
(b) the date on which the shares of common stock of the Company are listed on a national stock exchange, including without limitation
the New York Stock Exchange, NYSE American or the Nasdaq Stock Market (any tier), or (c) the date and time, or the occurrence of an event,
specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series J preferred stock, voting
together as a single class, each share of series J preferred stock shall be automatically converted into such number of shares of common
stock as is determined in accordance with the provisions above. Such conversion price is subject to standard adjustments in the event
of any stock dividends, stock reclassifications and similar events (but not for reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. Holders of series J
preferred stock do not have any redemption rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series L Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Ranking. &lt;/i&gt;The series L preferred stock ranks,
with respect to the distribution of assets upon liquidation, (i) senior to all common stock, series A preferred stock and to each other
class or series that is not expressly made senior to or on parity with the series L preferred stock; (ii) on parity with the series B
preferred stock, series C preferred stock, series E preferred stock, series F-1 preferred stock, series J preferred stock and each other
class or series that is not expressly subordinated or made senior to the series L preferred stock; and (iii) junior to the series I preferred
stock, series N senior convertible preferred stock, series R convertible preferred stock, series X senior convertible preferred stock
and to each other series of preferred stock and each class or series that is expressly made senior to the series L preferred stock, as
well as to all indebtedness and other liabilities with respect to assets available to satisfy claims against the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Dividend Rights.&lt;/i&gt; The holders of series
L preferred stock are entitled to receive dividends equal (on an as converted to common stock basis) to and in the same form as dividends
actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be
paid on shares of series L preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Liquidation Rights&lt;/i&gt;. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of series L preferred stock shall be entitled
to receive out of the assets of the Company the same amount that a holder of common stock would receive if the shares of series L preferred
stock were fully converted to common stock immediately prior to such liquidation, which amount shall be paid to the holders of series
L preferred stock &lt;i&gt;pari passu&lt;/i&gt; with all holders of parity securities and in preference to the holders of junior securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;. On any matter presented
to stockholders for their action or consideration, each holder of series L preferred stock shall be entitled to cast one (1) vote per
share of series L preferred stock held. Except as provided by law, the holders of series L preferred stock shall vote together with the
holders of shares of common stock as a single class. However, as long as any shares of series L preferred stock are outstanding, the Company
shall not, without the affirmative vote of the holders of a majority of outstanding series L preferred stock, (a) alter or change adversely
the powers, preferences or rights given to the series J preferred stock or alter or amend the certificate of designation for the series
L preferred stock, or (b) amend the Companys amended and restated articles of incorporation or other charter documents in any manner
that adversely affects any rights of the holders of series L preferred stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conversion Rights&lt;/i&gt;. Each share of series
L preferred stock is convertible, at any time and from time to time at the option of the holder thereof, into such number of shares of
common stock as is determined as follows: (i) if the closing market price of the common stock on the principal trading market on which
the common stock is then traded or quoted is less than $4.00 per share, then each share of series L preferred stock shall be convertible
into a number of shares of common stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price
on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of series
L preferred stock shall be convertible into two (2) shares of common stock. In addition, upon the earlier to occur of: (a) the closing
of the sale of shares of common stock to the public at a price of at least $3.00 per share in a public offering pursuant to an effective
registration statement or offering statement under the Securities Act resulting in at least $3,000,000 of gross proceeds to the Company,
(b) the date on which the shares of common stock of the Company are listed on a national stock exchange, including without limitation
the New York Stock Exchange, NYSE American or the Nasdaq Stock Market (any tier), or (c) the date and time, or the occurrence of an event,
specified by vote or written consent of the holders of at least 67% of the then outstanding shares of series L preferred stock, voting
together as a single class, each share of series L preferred stock shall be automatically converted into such number of shares of common
stock as is determined in accordance with the provisions above. Such conversion price is subject to standard adjustments in the event
of any stock dividends, stock reclassifications and similar events (but not for reverse stock splits).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Redemption Rights&lt;/i&gt;. Holders of series L
preferred stock do not have any redemption rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred Stock Transactions&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2023, the Company
executed the following transactions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On May 25, 2023, the Company issued&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230524__20230525__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__custom--ChiefAccountingOfficerMember_z5zBH0PPHlze" title="Stock issued new, shares"&gt; 3,150&lt;/span&gt; shares of series B preferred stock to Zia Choe, Chief Accounting
Officer, for $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueOther_c20230524__20230525__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--TitleOfIndividualAxis__custom--ChiefAccountingOfficerMember_zora5rDXNG07" title="Stock issued new, value"&gt;25,000&lt;/span&gt;.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On July 24, 2023, the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230723__20230724__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember__srt--CounterpartyNameAxis__custom--PropertyManagerOfEdgeViewMember_zxIuLjj6rUXj" title="Stock issued for compensation, shares"&gt;5,000&lt;/span&gt; shares of series E preferred stock as compensation for the
property manager of Edge View in exchange for a bonus of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20230723__20230724__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember__srt--CounterpartyNameAxis__custom--PropertyManagerOfEdgeViewMember_zk2KsDnf6lRl" title="Stock issued for compensation, value"&gt;5,000&lt;/span&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2022, the Company
executed the following transactions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;In the second quarter of 2022, &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--SeriesDIntoSeriesBPreferredStockMember_z32Xep4TU9Xc" title="Conversion of stock, shares converted"&gt;37,500&lt;/span&gt; shares of series D preferred stock were cancelled and exchanged
for &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesIssued1_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--SeriesDIntoSeriesBPreferredStockMember_z2Iz5UwLJ4J4" title="Conversion of stock, shares issued"&gt;37,500&lt;/span&gt; shares of series B preferred stock and &lt;span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--SeriesHIntoSeriesBPreferredStockMember_zehUBb9DAC1i" title="Conversion of stock, shares converted"&gt;37,500&lt;/span&gt; shares of series H preferred stock were cancelled and exchanged for &lt;span id="xdx_907_eus-gaap--ConversionOfStockSharesIssued1_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--SeriesHIntoSeriesBPreferredStockMember_zFIlSHkJxB6l" title="Conversion of stock, shares issued"&gt;37,500&lt;/span&gt; shares
of series B preferred stock.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On September 7, 2022, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220906__20220907__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--NovaMember_zVs67r4RxoK8" title="Stock issued for acquisition, shares"&gt;818,750&lt;/span&gt; shares of series J preferred stock in connection with
the acquisition of Nova.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On September 12, 2022, the Company issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220911__20220912__us-gaap--StatementClassOfStockAxis__custom--SeriesXPreferredStockMember_zRm8qjGHqZ38" title="Stock issued new, shares"&gt;375,000&lt;/span&gt; shares of series X senior convertible preferred stock
for $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueOther_c20220911__20220912__us-gaap--StatementClassOfStockAxis__custom--SeriesXPreferredStockMember_z1jr7ifys9Yk" title="Stock issued new, value"&gt;1,500,000&lt;/span&gt;. See Note 9 for further discussion.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October 10, 2022, the Chief Operating Officer received &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20221009__20221010__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TransactionTypeAxis__custom--SettlementOfEmploymentMember_zhKlCVbhNVta" title="Stock issued for compensation, shares"&gt;18,750&lt;/span&gt; shares of series B preferred stock in
exchange for the settlement of employment at the fair value of $1 per share.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October 31, 2022, the Company entered into a buyback agreement, pursuant to which the managers of AHI
purchased back AHI and returned &lt;span id="xdx_906_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20221030__20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember__srt--CounterpartyNameAxis__custom--ManagersOfAHIMember_zKHjy8Z03xif" title="Stock returned to treasury, shares"&gt;175,045&lt;/span&gt; shares of series F preferred stock issued to them, which were remitted to treasury, in exchange
for &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221030__20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--CounterpartyNameAxis__custom--ManagersOfAHIMember_zsKhLPVY3xTb" title="Stock issued new, shares"&gt;67,500&lt;/span&gt; shares of series B preferred stock. There was a loss on disposal in the amount of $&lt;span id="xdx_90A_ecustom--GainLossOnDisposalOfStock_iN_di_c20221030__20221031__srt--CounterpartyNameAxis__custom--ManagersOfAHIMember_znbQy0rJ6Ubf" title="Loss on disposal of stock"&gt;217,769&lt;/span&gt; which represented net assets and
liabilities at the time of sale back.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;






















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 11, 2022, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221101__20221111__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--CounterpartyNameAxis__custom--ThirdPartyMember_zy0AoXQeXNfi" title="Stock issued new, shares"&gt;15,000&lt;/span&gt; shares of series B preferred stock to a third party in
exchange for $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20221101__20221111__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--CounterpartyNameAxis__custom--ThirdPartyMember_z9v8VxR3GLVe" title="Proceeds from issuance of preferred stock"&gt;15,000&lt;/span&gt; at the fair value of $1 per share.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On December 15, 2022, the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221214__20221215__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--CounterpartyNameAxis__custom--ThirdPartyMember_zleVlfbyGvag" title="Stock issued new, shares"&gt;10,000&lt;/span&gt; shares of series B preferred stock to a third party in
exchange for $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20221214__20221215__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--CounterpartyNameAxis__custom--ThirdPartyMember_zQ55rNokF1d9" title="Proceeds from issuance of preferred stock"&gt;10,000&lt;/span&gt; at the fair value of $1 per share.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2023, the Company
issued &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zkogXIloaa7" title="Debt converted, shares issued"&gt;13,068&lt;/span&gt; shares of common stock upon the conversion of certain convertible notes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2022, as part
of the Red Rock settlement, the Company issued &lt;span id="xdx_909_ecustom--StockIssuedForSettlement_c20220101__20221231__srt--CounterpartyNameAxis__custom--RedRockMember_zy9xraM0lFof" title="Stock issued for settlement, shares"&gt;8,782&lt;/span&gt; shares of common stock. The settlement also required the previous owners to relinquish
3,500 shares of common stock before a 1 for 75,000 reverse split resulting in a gain to the Company of $35,097. The Red Rock settlement
also required the previous owners to relinquish warrants for 25,000 shares of common stock. See also Note 10.&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:CostOfRevenue id="f1016" decimals="0" contextRef="c112" unitRef="usd">0.0</us-gaap:CostOfRevenue>
  <cardifflexington.com:AccruedInterest id="f1017" decimals="0" contextRef="c84" unitRef="usd">7506.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockSharesIssued id="f1018" decimals="INF" contextRef="c225" unitRef="shares">14885000.0</us-gaap:PreferredStockSharesIssued>
  <cardifflexington.com:AccruedInterest id="f1019" decimals="0" contextRef="c185" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1020" decimals="INF" contextRef="c217" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:EarningsPerShareBasic id="f1021" decimals="INF" contextRef="c73" unitRef="usd1">55.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:PreferredStockValue id="f1022" decimals="0" contextRef="c222" unitRef="usd">1500000.0</us-gaap:PreferredStockValue>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy id="f1023" contextRef="c12">&lt;p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zhnQFPExdSlj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zciSHIJA7fW2"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill and indefinite-lived assets are not amortized
but are evaluated for impairment annually or when indicators of a potential impairment are present. The Companys impairment testing
of goodwill is performed separately from its impairment testing of indefinite-lived intangibles. The Company reviews goodwill for impairment
on a reporting unit basis annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be
recoverable. Goodwill is tested first for impairment based on qualitative factors on an annual basis or in between if an event occurs
or circumstances change that indicate the fair value may be below its carrying amount, otherwise known as a triggering event.
An assessment is made of these qualitative factors as such to determine whether it is more likely than not the fair value is less than
the carry amount, including goodwill. The annual evaluation for impairment of indefinite-lived intangibles and, if then needed after the
first step, Goodwill, is based on valuation models that incorporate assumptions and internal projections of expected future cash flows
and operating plans. The Company believes such assumptions are also comparable to those that would be used by other marketplace participants.
For the year ended December 31, 2023, the Company determined there to be &lt;span id="xdx_909_eus-gaap--GoodwillImpairmentLossNetOfTax_do_c20230101__20231231_zwahgm8qvjAi" title="Goodwill impairment amount"&gt;no&lt;/span&gt; impairment. For the year ended December 31, 2022, the Company
recognized goodwill impairment in the amount of $&lt;span id="xdx_904_eus-gaap--GoodwillImpairmentLossNetOfTax_do_c20220101__20221231_ztK44OXP6Ttd" title="Goodwill impairment amount"&gt;2,092,048&lt;/span&gt; in its former financial services segment, which is now reflected in discontinued
operations. The Company based this decision on impairment testing of the underlying assets, expected cash flows, decreased asset value
and other factors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:IncreaseDecreaseInDueFromRelatedParties id="f1024" decimals="0" contextRef="c44" unitRef="usd">-36988.0</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
  <us-gaap:PreferredStockSharesOutstanding id="f1025" decimals="INF" contextRef="c225" unitRef="shares">14885000.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1026" decimals="INF" contextRef="c220" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ConvertibleNotesPayable id="f1027" decimals="0" contextRef="c8" unitRef="usd">3807030.0</us-gaap:ConvertibleNotesPayable>
  <cardifflexington.com:LossOnFinancePenaltiesAndFees id="f1028" decimals="0" contextRef="c12" unitRef="usd">0.0</cardifflexington.com:LossOnFinancePenaltiesAndFees>
  <us-gaap:PreferredStockSharesIssued id="f1029" decimals="INF" contextRef="c226" unitRef="shares">14885000.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:NotesPayable id="f1030" decimals="0" contextRef="c8" unitRef="usd">2280743.0</us-gaap:NotesPayable>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1031" decimals="0" contextRef="c196" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:PreferredStockSharesOutstanding id="f1032" decimals="INF" contextRef="c226" unitRef="shares">14885000.0</us-gaap:PreferredStockSharesOutstanding>
  <dei:EntityFileNumber id="f1033" contextRef="c12">000-49709</dei:EntityFileNumber>
  <us-gaap:CommonStockValue id="f1034" decimals="0" contextRef="c8" unitRef="usd">1804799.0</us-gaap:CommonStockValue>
  <us-gaap:ConvertibleNotesPayable id="f1035" decimals="0" contextRef="c227" unitRef="usd">4791099.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:CommonStockParOrStatedValuePerShare id="f1036" decimals="INF" contextRef="c8" unitRef="usd1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f1037" decimals="INF" contextRef="c228" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:CostOfRevenue id="f1038" decimals="0" contextRef="c104" unitRef="usd">4060034.0</us-gaap:CostOfRevenue>
  <cardifflexington.com:RepaymentsToDirectorsAndOfficers id="f1039" decimals="0" contextRef="c44" unitRef="usd">3573.0</cardifflexington.com:RepaymentsToDirectorsAndOfficers>
  <us-gaap:PreferredStockSharesIssued id="f1040" decimals="INF" contextRef="c217" unitRef="shares">155750.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:Depreciation id="f1041" decimals="0" contextRef="c12" unitRef="usd">20777.0</us-gaap:Depreciation>
  <us-gaap:ConvertibleNotesPayable id="f1042" decimals="0" contextRef="c229" unitRef="usd">3840448.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:IncomeLossFromContinuingOperations id="f1043" decimals="0" contextRef="c230" unitRef="usd">-2941123.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:DebtInstrumentMaturityDate id="f1044" contextRef="c183">2020-11-08</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:PreferredStockSharesOutstanding id="f1045" decimals="INF" contextRef="c217" unitRef="shares">155750.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:NetIncomeLoss id="f1046" decimals="0" contextRef="c52" unitRef="usd">816078.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:AccruedProfessionalFees id="f1047" decimals="0" contextRef="c21" unitRef="usd">573040.0</cardifflexington.com:AccruedProfessionalFees>
  <cardifflexington.com:MinimumAnnualAmount id="f1048" decimals="-6" contextRef="c231" unitRef="usd">8000000.0</cardifflexington.com:MinimumAnnualAmount>
  <us-gaap:ProceedsFromConvertibleDebt id="f1049" decimals="0" contextRef="c79" unitRef="usd">90166.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ConvertibleNotesPayable id="f1050" decimals="0" contextRef="c232" unitRef="usd">950651.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:PreferredStockValue id="f1051" decimals="0" contextRef="c225" unitRef="usd">59540000.0</us-gaap:PreferredStockValue>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1052" decimals="0" contextRef="c91" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:ConversionOfStockSharesConverted1 id="f1053" decimals="INF" contextRef="c233" unitRef="shares">37500.0</us-gaap:ConversionOfStockSharesConverted1>
  <cardifflexington.com:CancellationOfSeriesKPreferredStockShares id="f1054" decimals="INF" contextRef="c175" unitRef="shares">-8200562.0</cardifflexington.com:CancellationOfSeriesKPreferredStockShares>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f1055" decimals="0" contextRef="c191" unitRef="usd">12400.0</cardifflexington.com:IssuanceOfPreferredStockSeriesB>
  <us-gaap:NotesPayable id="f1056" decimals="0" contextRef="c21" unitRef="usd">155598.0</us-gaap:NotesPayable>
  <us-gaap:PreferredStockSharesIssued id="f1057" decimals="INF" contextRef="c220" unitRef="shares">150750.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1058" decimals="0" contextRef="c84" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:GainsLossesOnConsolidationOfDebt id="f1059" decimals="0" contextRef="c234" unitRef="usd">1397271.0</cardifflexington.com:GainsLossesOnConsolidationOfDebt>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1060" decimals="0" contextRef="c185" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:AnnualCashBonus id="f1061" decimals="0" contextRef="c231" unitRef="usd">420000.0</cardifflexington.com:AnnualCashBonus>
  <cardifflexington.com:CommonStockIssuedUponConversionOfNotesPayable id="f1062" decimals="0" contextRef="c12" unitRef="usd">199889.0</cardifflexington.com:CommonStockIssuedUponConversionOfNotesPayable>
  <us-gaap:PreferredStockSharesOutstanding id="f1063" decimals="INF" contextRef="c220" unitRef="shares">150750.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ConversionOfStockSharesIssued1 id="f1064" decimals="INF" contextRef="c235" unitRef="shares">37500.0</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:IncreaseDecreaseInAccruedSalaries id="f1065" decimals="0" contextRef="c12" unitRef="usd">982500.0</us-gaap:IncreaseDecreaseInAccruedSalaries>
  <us-gaap:EarningsPerShareDiluted id="f1066" decimals="INF" contextRef="c52" unitRef="usd1">-21.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1067" decimals="0" contextRef="c149" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:IncomeLossFromContinuingOperations id="f1068" decimals="0" contextRef="c236" unitRef="usd">-5485056.0</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:ConvertibleDebt id="f1069" decimals="0" contextRef="c237" unitRef="usd">36604.0</us-gaap:ConvertibleDebt>
  <us-gaap:GoodwillImpairmentLossNetOfTax id="f1070" decimals="0" contextRef="c44" unitRef="usd">2092048.0</us-gaap:GoodwillImpairmentLossNetOfTax>
  <us-gaap:ConversionOfStockSharesConverted1 id="f1071" decimals="INF" contextRef="c238" unitRef="shares">37500.0</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:NetIncomeLoss id="f1072" decimals="0" contextRef="c117" unitRef="usd">-5429521.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="f1073" decimals="0" contextRef="c12" unitRef="usd">-1721467.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ConvertibleDebt id="f1074" decimals="0" contextRef="c228" unitRef="usd">139166.0</us-gaap:ConvertibleDebt>
  <dei:EntityRegistrantName id="f1075" contextRef="c12">CARDIFF LEXINGTON CORPORATION</dei:EntityRegistrantName>
  <us-gaap:PreferredStockValue id="f1076" decimals="0" contextRef="c226" unitRef="usd">59540000.0</us-gaap:PreferredStockValue>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f1077" decimals="INF" contextRef="c224" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f1078" contextRef="c202">2022-11-04</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:ConversionOfStockSharesIssued1 id="f1079" decimals="INF" contextRef="c239" unitRef="shares">37500.0</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:PreferredStockValue id="f1080" decimals="0" contextRef="c217" unitRef="usd">623000.0</us-gaap:PreferredStockValue>
  <cardifflexington.com:CancellationOfSeriesKPreferredStock id="f1081" decimals="0" contextRef="c175" unitRef="usd">8201.0</cardifflexington.com:CancellationOfSeriesKPreferredStock>
  <cardifflexington.com:BonusStockToBeIssuedShares id="f1082" decimals="INF" contextRef="c240" unitRef="shares">210000.0</cardifflexington.com:BonusStockToBeIssuedShares>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStockShares id="f1083" decimals="INF" contextRef="c83" unitRef="shares">5000.0</cardifflexington.com:IssuanceOfSeriesEPreferredStockShares>
  <us-gaap:SharesOutstanding id="f1084" decimals="INF" contextRef="c241" unitRef="shares">24065.0</us-gaap:SharesOutstanding>
  <us-gaap:DebtCurrent id="f1085" decimals="0" contextRef="c242" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:LegalMattersAndContingenciesTextBlock id="f1086" contextRef="c12">&lt;p id="xdx_804_eus-gaap--LegalMattersAndContingenciesTextBlock_zWBkzdCmvdZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 27.35pt"&gt;&lt;b&gt;14.&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_826_zdey7uNvmxz5"&gt;LEGAL PROCEEDINGS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From time to time, the Company may become involved
in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties,
and an adverse result in these or other matters may arise from time to time that may harm the Companys business. Management is
not currently aware of any such legal proceedings or claims that it believes will have a material adverse effect on the Companys
business, financial condition, or operating results.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:LegalMattersAndContingenciesTextBlock>
  <us-gaap:IncreaseDecreaseInAccruedSalaries id="f1087" decimals="0" contextRef="c44" unitRef="usd">873506.0</us-gaap:IncreaseDecreaseInAccruedSalaries>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1088" decimals="0" contextRef="c242" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:NotesAndLoansPayableCurrent id="f1089" decimals="0" contextRef="c8" unitRef="usd">2136077.0</us-gaap:NotesAndLoansPayableCurrent>
  <us-gaap:CommonStockSharesAuthorized id="f1090" decimals="INF" contextRef="c21" unitRef="shares">7500000000.0</us-gaap:CommonStockSharesAuthorized>
  <cardifflexington.com:MedicalEquipment id="f1091" decimals="0" contextRef="c8" unitRef="usd">96532.0</cardifflexington.com:MedicalEquipment>
  <us-gaap:EarningsPerShareDiluted id="f1092" decimals="INF" contextRef="c34" unitRef="usd1">26.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:NetIncomeLoss id="f1093" decimals="0" contextRef="c214" unitRef="usd">-5429521.0</us-gaap:NetIncomeLoss>
  <dei:EntityPublicFloat id="f1094" decimals="0" contextRef="c243" unitRef="usd">868776.0</dei:EntityPublicFloat>
  <us-gaap:NetIncomeLoss id="f1095" decimals="0" contextRef="c101" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent id="f1096" decimals="0" contextRef="c21" unitRef="usd">46797.0</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="f1097" decimals="INF" contextRef="c44" unitRef="shares">5822.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:ConvertibleDebt id="f1098" decimals="0" contextRef="c166" unitRef="usd">21167.0</us-gaap:ConvertibleDebt>
  <us-gaap:PreferredStockValue id="f1099" decimals="0" contextRef="c220" unitRef="usd">603000.0</us-gaap:PreferredStockValue>
  <cardifflexington.com:IssuanceOfSeriesJPreferredStock id="f1100" decimals="0" contextRef="c44" unitRef="usd">3275000.0</cardifflexington.com:IssuanceOfSeriesJPreferredStock>
  <us-gaap:ProceedsFromConvertibleDebt id="f1101" decimals="0" contextRef="c183" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:PreferredStockSharesAuthorized id="f1102" decimals="INF" contextRef="c244" unitRef="shares">2.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f1103" contextRef="c75">2022-12-21</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:PreferredStockSharesAuthorized id="f1104" decimals="INF" contextRef="c245" unitRef="shares">2000000.0</us-gaap:PreferredStockSharesAuthorized>
  <cardifflexington.com:IssuanceOfSeriesEPreferredStock id="f1105" decimals="0" contextRef="c83" unitRef="usd">20000.0</cardifflexington.com:IssuanceOfSeriesEPreferredStock>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f1106" contextRef="c208">2016-09-12</us-gaap:DebtInstrumentIssuanceDate1>
  <us-gaap:GainsLossesOnRestructuringOfDebt id="f1107" decimals="0" contextRef="c12" unitRef="usd">-0.0</us-gaap:GainsLossesOnRestructuringOfDebt>
  <us-gaap:DeferredTaxAssetsGross id="f1108" decimals="0" contextRef="c8" unitRef="usd">5291000.0</us-gaap:DeferredTaxAssetsGross>
  <cardifflexington.com:IssuanceOfPreferredStockSeriesB id="f1109" decimals="0" contextRef="c12" unitRef="usd">25000.0</cardifflexington.com:IssuanceOfPreferredStockSeriesB>
  <us-gaap:DebtInstrumentMaturityDate id="f1110" contextRef="c202">2024-09-22</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:PreferredStockSharesAuthorized id="f1111" decimals="INF" contextRef="c246" unitRef="shares">2000000.0</us-gaap:PreferredStockSharesAuthorized>
  <cardifflexington.com:AccruedInterest id="f1112" decimals="0" contextRef="c247" unitRef="usd">0.0</cardifflexington.com:AccruedInterest>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f1113" decimals="0" contextRef="c8" unitRef="usd">2047131.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:ConvertibleDebt id="f1114" decimals="0" contextRef="c224" unitRef="usd">113167.0</us-gaap:ConvertibleDebt>
  <us-gaap:CommonStockSharesAuthorized id="f1115" decimals="INF" contextRef="c8" unitRef="shares">7500000000.0</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:DeferredTaxAssetsGross id="f1116" decimals="0" contextRef="c21" unitRef="usd">5991000.0</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:NotesAndLoansPayableCurrent id="f1117" decimals="0" contextRef="c21" unitRef="usd">15809.0</us-gaap:NotesAndLoansPayableCurrent>
  <us-gaap:ConvertibleDebt id="f1118" decimals="0" contextRef="c247" unitRef="usd">0.0</us-gaap:ConvertibleDebt>
  <cardifflexington.com:MedicalEquipment id="f1119" decimals="0" contextRef="c21" unitRef="usd">96532.0</cardifflexington.com:MedicalEquipment>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1120" decimals="0" contextRef="c79" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:EarningsPerShareDiluted id="f1121" decimals="INF" contextRef="c101" unitRef="usd1">-5.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ProceedsFromConvertibleDebt id="f1122" decimals="0" contextRef="c201" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:CommonStockSharesOutstanding id="f1123" decimals="INF" contextRef="c21" unitRef="shares">10997.0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1124" decimals="INF" contextRef="c245" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:NetIncomeLoss id="f1125" decimals="0" contextRef="c68" unitRef="usd">-5429521.0</us-gaap:NetIncomeLoss>
  <us-gaap:IncreaseDecreaseInInterestPayableNet id="f1126" decimals="0" contextRef="c12" unitRef="usd">486165.0</us-gaap:IncreaseDecreaseInInterestPayableNet>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="f1127" decimals="0" contextRef="c8" unitRef="usd">5291000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:EarningsPerShareDiluted id="f1128" decimals="INF" contextRef="c73" unitRef="usd1">5.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1129" decimals="INF" contextRef="c246" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive id="f1130" decimals="0" contextRef="c8" unitRef="usd">4989.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
  <cardifflexington.com:MezzanineEquity id="f1131" decimals="0" contextRef="c145" unitRef="usd">5740096.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:StockholdersEquity id="f1132" decimals="0" contextRef="c57" unitRef="usd">-1632373.0</us-gaap:StockholdersEquity>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1133" decimals="0" contextRef="c131" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="f1134" decimals="INF" contextRef="c12" unitRef="usd1">156.0</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="f1135" decimals="0" contextRef="c21" unitRef="usd">5991000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:ConvertibleDebt id="f1136" decimals="0" contextRef="c190" unitRef="usd">68666.0</us-gaap:ConvertibleDebt>
  <us-gaap:PreferredStockSharesAuthorized id="f1137" decimals="INF" contextRef="c248" unitRef="shares">50000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:DebtInstrumentMaturityDate id="f1138" contextRef="c75">2024-09-22</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentMaturityDate id="f1139" contextRef="c208">2017-09-12</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f1140" decimals="INF" contextRef="c249" unitRef="shares">818750.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f1141" decimals="0" contextRef="c21" unitRef="usd">1915920.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="f1142" decimals="INF" contextRef="c250" unitRef="shares">50000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CostOfRevenue id="f1143" decimals="0" contextRef="c99" unitRef="usd">3560624.0</us-gaap:CostOfRevenue>
  <us-gaap:EarningsPerShareBasic id="f1144" decimals="INF" contextRef="c101" unitRef="usd1">-5.0</us-gaap:EarningsPerShareBasic>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravelShares id="f1145" decimals="INF" contextRef="c82" unitRef="shares">8782.0</cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravelShares>
  <us-gaap:DebtCurrent id="f1146" decimals="0" contextRef="c193" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="f1147" decimals="-5" contextRef="c44" unitRef="usd">700000.0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:AssetsNet id="f1148" decimals="0" contextRef="c251" unitRef="usd">18955991.0</us-gaap:AssetsNet>
  <us-gaap:ProceedsFromConvertibleDebt id="f1149" decimals="0" contextRef="c70" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:EarningsPerShareDiluted id="f1150" decimals="INF" contextRef="c39" unitRef="usd1">20.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommonStockSharesIssued id="f1151" decimals="INF" contextRef="c21" unitRef="shares">10997.0</us-gaap:CommonStockSharesIssued>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f1152" decimals="INF" contextRef="c242" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:InterestExpenseDebt id="f1153" decimals="0" contextRef="c216" unitRef="usd">10671.0</us-gaap:InterestExpenseDebt>
  <us-gaap:ConvertibleDebtCurrent id="f1154" decimals="0" contextRef="c21" unitRef="usd">3515752.0</us-gaap:ConvertibleDebtCurrent>
  <us-gaap:IncreaseDecreaseInInterestPayableNet id="f1155" decimals="0" contextRef="c44" unitRef="usd">379428.0</us-gaap:IncreaseDecreaseInInterestPayableNet>
  <us-gaap:PreferredStockSharesIssued id="f1156" decimals="INF" contextRef="c245" unitRef="shares">1713584.0</us-gaap:PreferredStockSharesIssued>
  <cardifflexington.com:AccruedInterest id="f1157" decimals="0" contextRef="c105" unitRef="usd">27510.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1158" decimals="INF" contextRef="c248" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <cardifflexington.com:LiabilitiesCurrent1 id="f1159" decimals="0" contextRef="c146" unitRef="usd">11672952.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:LongTermNotesAndLoans id="f1160" decimals="0" contextRef="c8" unitRef="usd">144666.0</us-gaap:LongTermNotesAndLoans>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1161" decimals="0" contextRef="c140" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:PreferredStockSharesOutstanding id="f1162" decimals="INF" contextRef="c245" unitRef="shares">1713584.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:MachineryAndEquipmentGross id="f1163" decimals="0" contextRef="c8" unitRef="usd">9189.0</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="f1164" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zrljI3KGPBS3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BA_z2cs9igmOMBi" style="display: none"&gt;Schedule of deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_497_20231231_z66W0nzoAKL1" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_499_20221231_zKM9Qd3Py0Z7" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_maDTANz27H_zHTYRCYpD6gl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;5,291,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;5,991,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANz27H_zL0ZZbaTFdq8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,291,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,991,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_d0_mtDTANz27H_zk21ssa0xXWf" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1165" decimals="INF" contextRef="c250" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:StockholdersEquity id="f1166" decimals="0" contextRef="c69" unitRef="usd">-283118.0</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockSharesIssued id="f1167" decimals="INF" contextRef="c246" unitRef="shares">1713584.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="f1168" decimals="INF" contextRef="c44" unitRef="usd1">-999.0</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:SharesOutstanding id="f1169" decimals="INF" contextRef="c252" unitRef="shares">10997.0</us-gaap:SharesOutstanding>
  <us-gaap:DividendsPreferredStock id="f1170" decimals="0" contextRef="c117" unitRef="usd">307188.0</us-gaap:DividendsPreferredStock>
  <us-gaap:PreferredStockSharesOutstanding id="f1171" decimals="INF" contextRef="c246" unitRef="shares">1713584.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ConvertibleDebt id="f1172" decimals="0" contextRef="c56" unitRef="usd">68667.0</us-gaap:ConvertibleDebt>
  <us-gaap:ConvertibleDebt id="f1173" decimals="0" contextRef="c199" unitRef="usd">50080.0</us-gaap:ConvertibleDebt>
  <dei:EntityTaxIdentificationNumber id="f1174" contextRef="c12">84-1044583</dei:EntityTaxIdentificationNumber>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f1175" decimals="0" contextRef="c82" unitRef="usd">622275.0</cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel>
  <us-gaap:Assets id="f1176" decimals="0" contextRef="c126" unitRef="usd">18518727.0</us-gaap:Assets>
  <us-gaap:AssetsNet id="f1177" decimals="0" contextRef="c253" unitRef="usd">12692531.0</us-gaap:AssetsNet>
  <us-gaap:ProceedsFromConvertibleDebt id="f1178" decimals="0" contextRef="c202" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <cardifflexington.com:AccruedExpensesRelatedParties id="f1179" decimals="0" contextRef="c8" unitRef="usd">4733057.0</cardifflexington.com:AccruedExpensesRelatedParties>
  <us-gaap:GoodwillImpairmentLoss id="f1180" decimals="0" contextRef="c44" unitRef="usd">2092048.0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:EarningsPerShareBasic id="f1181" decimals="INF" contextRef="c68" unitRef="usd1">-999.0</us-gaap:EarningsPerShareBasic>
  <us-gaap:DebtInstrumentMaturityDate id="f1182" contextRef="c132">2024-08-25</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1183" decimals="0" contextRef="c183" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:LongTermNotesAndLoans id="f1184" decimals="0" contextRef="c21" unitRef="usd">139789.0</us-gaap:LongTermNotesAndLoans>
  <us-gaap:PreferredStockValue id="f1185" decimals="0" contextRef="c245" unitRef="usd">6854336.0</us-gaap:PreferredStockValue>
  <us-gaap:EarningsPerShareDiluted id="f1186" decimals="INF" contextRef="c68" unitRef="usd1">-999.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:PreferredStockSharesAuthorized id="f1187" decimals="INF" contextRef="c254" unitRef="shares">5000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="f1188" decimals="INF" contextRef="c248" unitRef="shares">35752.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:MachineryAndEquipmentGross id="f1189" decimals="0" contextRef="c21" unitRef="usd">9189.0</us-gaap:MachineryAndEquipmentGross>
  <dei:EntityShellCompany id="f1190" contextRef="c12">false</dei:EntityShellCompany>
  <us-gaap:StockholdersEquity id="f1191" decimals="0" contextRef="c67" unitRef="usd">-1915491.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertibleDebt id="f1192" decimals="0" contextRef="c242" unitRef="usd">90166.0</us-gaap:ConvertibleDebt>
  <us-gaap:StockholdersEquity id="f1193" decimals="0" contextRef="c252" unitRef="usd">824793.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:AccruedInterest id="f1194" decimals="0" contextRef="c228" unitRef="usd">10671.0</cardifflexington.com:AccruedInterest>
  <us-gaap:PreferredStockSharesOutstanding id="f1195" decimals="INF" contextRef="c248" unitRef="shares">35752.0</us-gaap:PreferredStockSharesOutstanding>
  <cardifflexington.com:IncreaseDecreaseRightOfUseLiabilities id="f1196" decimals="0" contextRef="c12" unitRef="usd">49547.0</cardifflexington.com:IncreaseDecreaseRightOfUseLiabilities>
  <us-gaap:PreferredStockSharesIssued id="f1197" decimals="INF" contextRef="c250" unitRef="shares">35752.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:InterestExpenseDebt id="f1198" decimals="0" contextRef="c91" unitRef="usd">19417.0</us-gaap:InterestExpenseDebt>
  <us-gaap:PreferredStockSharesAuthorized id="f1199" decimals="INF" contextRef="c255" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding id="f1200" decimals="INF" contextRef="c250" unitRef="shares">35752.0</us-gaap:PreferredStockSharesOutstanding>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f1201" decimals="0" contextRef="c94" unitRef="usd">-406485.0</cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel>
  <us-gaap:Assets id="f1202" decimals="0" contextRef="c55" unitRef="usd">0.0</us-gaap:Assets>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare id="f1203" decimals="INF" contextRef="c12" unitRef="usd1">-6.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="f1204" decimals="INF" contextRef="c256" unitRef="shares">375000.0</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:ProceedsFromConvertibleDebt id="f1205" decimals="0" contextRef="c75" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock id="f1206" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_z5gYPfcvmrB9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES AND LOANS PAYABLE (Details - Long term debt maturity)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BD_z0P4v9VUBir6" style="display: none"&gt;Schedule of maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_49B_20231231_z0K9Q7H2ZMja" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_z6CNyV1yjgPg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,136,077&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_zgH9ThDBJvHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_zJZv8F7jrCP7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_zFBy7iPT7tFd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_zkV0g5hdnpkg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_zfadzjwexIG6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;124,710&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebt_iI_pp0p0_zmQgOXdQuUZ2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,280,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <us-gaap:ProceedsFromConvertibleDebt id="f1207" decimals="0" contextRef="c208" unitRef="usd">0.0</us-gaap:ProceedsFromConvertibleDebt>
  <cardifflexington.com:AccruedExpensesRelatedParties id="f1208" decimals="0" contextRef="c21" unitRef="usd">3750557.0</cardifflexington.com:AccruedExpensesRelatedParties>
  <us-gaap:StockholdersEquity id="f1209" decimals="0" contextRef="c241" unitRef="usd">1804799.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f1210" decimals="INF" contextRef="c193" unitRef="shares">2867.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:AssetsNet id="f1211" decimals="0" contextRef="c257" unitRef="usd">587456.0</us-gaap:AssetsNet>
  <us-gaap:PreferredStockValue id="f1212" decimals="0" contextRef="c246" unitRef="usd">6854336.0</us-gaap:PreferredStockValue>
  <us-gaap:StockIssuedDuringPeriodValueOther id="f1213" decimals="0" contextRef="c256" unitRef="usd">1500000.0</us-gaap:StockIssuedDuringPeriodValueOther>
  <cardifflexington.com:LossOnFinancePenaltiesAndFees id="f1214" decimals="0" contextRef="c44" unitRef="usd">2063916.0</cardifflexington.com:LossOnFinancePenaltiesAndFees>
  <us-gaap:DebtCurrent id="f1215" decimals="0" contextRef="c181" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:PreferredStockValue id="f1216" decimals="0" contextRef="c248" unitRef="usd">143008.0</us-gaap:PreferredStockValue>
  <us-gaap:StockholdersEquity id="f1217" decimals="0" contextRef="c258" unitRef="usd">-8581265.0</us-gaap:StockholdersEquity>
  <cardifflexington.com:IncreaseDecreaseRightOfUseLiabilities id="f1218" decimals="0" contextRef="c44" unitRef="usd">-71371.0</cardifflexington.com:IncreaseDecreaseRightOfUseLiabilities>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="f1219" decimals="INF" contextRef="c12" unitRef="shares">14444.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:AssetsNet id="f1220" decimals="0" contextRef="c259" unitRef="usd">59691.0</us-gaap:AssetsNet>
  <us-gaap:CommonStockSharesOutstanding id="f1221" decimals="INF" contextRef="c8" unitRef="shares">24065.0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Assets id="f1222" decimals="0" contextRef="c145" unitRef="usd">18518727.0</us-gaap:Assets>
  <us-gaap:FurnitureAndFixturesGross id="f1223" decimals="0" contextRef="c8" unitRef="usd">15079.0</us-gaap:FurnitureAndFixturesGross>
  <cardifflexington.com:AccruedInterest id="f1224" decimals="0" contextRef="c197" unitRef="usd">26474.0</cardifflexington.com:AccruedInterest>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare id="f1225" decimals="INF" contextRef="c44" unitRef="usd1">-374.0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1226" decimals="0" contextRef="c228" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <cardifflexington.com:AccruedInterest id="f1227" decimals="0" contextRef="c224" unitRef="usd">63594.0</cardifflexington.com:AccruedInterest>
  <us-gaap:StockholdersEquity id="f1228" decimals="0" contextRef="c260" unitRef="usd">-9365982.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertibleDebtTableTextBlock id="f1229" contextRef="c12">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ConvertibleDebtTableTextBlock_zBoRQ91qs6kk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details - Convertible notes)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B5_zdeEaq14krfi" style="display: none"&gt;Schedule of convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;&lt;td id="xdx_49E_20231231_zwdufDlBFb7g" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_496_20221231_zYJWGmTepJVb" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Convertible notes payable&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ConvertibleNotesPayableGross_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayablesMember_zuwhVflcG4Di" style="width: 13%; text-align: right" title="Convertible notes payable"&gt;3,831,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ConvertibleNotesPayableGross_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayablesMember_zsrrw00cK3f2" style="width: 13%; text-align: right" title="Convertible notes payable"&gt;3,562,550&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscountNoncurrent_iNI_pp0p0_di_zmK28Ob4SMs2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Discounts on convertible notes payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,820&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(46,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total convertible debt less debt discount&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,807,030&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,515,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ConvertibleDebtCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,807,030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,515,752&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_zQjwcMnDyw61" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long-term portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
  <us-gaap:ProceedsFromConvertibleDebt id="f1230" decimals="0" contextRef="c216" unitRef="usd">139166.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:DebtCurrent id="f1231" decimals="0" contextRef="c166" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:AssetsNet id="f1232" decimals="0" contextRef="c261" unitRef="usd">592557.0</us-gaap:AssetsNet>
  <us-gaap:DebtInstrumentMaturityDate id="f1233" contextRef="c216">2024-09-22</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:CommonStockSharesIssued id="f1234" decimals="INF" contextRef="c8" unitRef="shares">24065.0</us-gaap:CommonStockSharesIssued>
  <us-gaap:StockholdersEquity id="f1235" decimals="0" contextRef="c145" unitRef="usd">675689.0</us-gaap:StockholdersEquity>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock id="f1236" contextRef="c12">&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zm4v7KxK1oy5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z75Aq0Qks1ze"&gt;Valuation of Long-lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with the provisions of Accounting
Standards Codification (ASC) Topic 360-10-5, Impairment or Disposal of Long-Lived Assets, all long-lived assets
such as plant and equipment and construction in progress held and used by the Company are reviewed for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is
evaluated by a comparison of the carrying amount of assets to estimated cash flows expected to be generated by the assets. If such assets
are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed
the fair value of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:PreferredStockValue id="f1237" decimals="0" contextRef="c250" unitRef="usd">143008.0</us-gaap:PreferredStockValue>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="f1238" decimals="0" contextRef="c44" unitRef="usd">-51216.0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:StockholdersEquity id="f1239" decimals="0" contextRef="c262" unitRef="usd">-70932435.0</us-gaap:StockholdersEquity>
  <us-gaap:DebtCurrent id="f1240" decimals="0" contextRef="c4" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="f1241" decimals="INF" contextRef="c182" unitRef="shares">400000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:NetIncomeLoss id="f1242" decimals="0" contextRef="c34" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:DebtCurrent id="f1243" decimals="0" contextRef="c178" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:InterestPayableCurrent id="f1244" decimals="0" contextRef="c8" unitRef="usd">620963.0</us-gaap:InterestPayableCurrent>
  <cardifflexington.com:MezzanineEquity id="f1245" decimals="0" contextRef="c55" unitRef="usd">299662.0</cardifflexington.com:MezzanineEquity>
  <us-gaap:ConvertibleDebt id="f1246" decimals="0" contextRef="c193" unitRef="usd">36604.0</us-gaap:ConvertibleDebt>
  <us-gaap:PreferredStockSharesAuthorized id="f1247" decimals="INF" contextRef="c263" unitRef="shares">400000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:FurnitureAndFixturesGross id="f1248" decimals="0" contextRef="c21" unitRef="usd">20212.0</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f1249" decimals="INF" contextRef="c166" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1250" decimals="0" contextRef="c202" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel id="f1251" decimals="0" contextRef="c44" unitRef="usd">215790.0</cardifflexington.com:IssuanceOfCommonStockForSettlementOfRedRockTravel>
  <us-gaap:NetIncomeLoss id="f1252" decimals="0" contextRef="c128" unitRef="usd">-15991.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="f1253" decimals="0" contextRef="c12" unitRef="usd">-1807987.0</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:StockholdersEquity id="f1254" decimals="0" contextRef="c264" unitRef="usd">-68684115.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLoss id="f1255" decimals="0" contextRef="c73" unitRef="usd">816078.0</us-gaap:NetIncomeLoss>
  <cardifflexington.com:AccruedInterest id="f1256" decimals="0" contextRef="c242" unitRef="usd">8284.0</cardifflexington.com:AccruedInterest>
  <dei:EntityAddressAddressLine1 id="f1257" contextRef="c12">3753 Howard Hughes Parkway</dei:EntityAddressAddressLine1>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1258" decimals="INF" contextRef="c182" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1259" decimals="INF" contextRef="c263" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ConvertibleDebtCurrent id="f1260" decimals="0" contextRef="c8" unitRef="usd">3807030.0</us-gaap:ConvertibleDebtCurrent>
  <dei:EntityAddressAddressLine2 id="f1261" contextRef="c12">Suite 200</dei:EntityAddressAddressLine2>
  <cardifflexington.com:LiabilitiesCurrent1 id="f1262" decimals="0" contextRef="c138" unitRef="usd">0.0</cardifflexington.com:LiabilitiesCurrent1>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="f1263" decimals="0" contextRef="c224" unitRef="usd">0.0</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:InterestPayableCurrent id="f1264" decimals="0" contextRef="c21" unitRef="usd">350267.0</us-gaap:InterestPayableCurrent>
  <us-gaap:DebtCurrent id="f1265" decimals="0" contextRef="c228" unitRef="usd">-0.0</us-gaap:DebtCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="f1266" decimals="INF" contextRef="c225" unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
  <cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesFShares id="f1267" decimals="INF" contextRef="c74" unitRef="shares">67500.0</cardifflexington.com:IssuanceOfSeriesBPreferredStockInExchangeForSeriesFShares>
  <us-gaap:AssetsNet id="f1268" decimals="0" contextRef="c265" unitRef="usd">1202364.0</us-gaap:AssetsNet>
  <us-gaap:EarningsPerShareDiluted id="f1269" decimals="INF" contextRef="c15" unitRef="usd1">-16.0</us-gaap:EarningsPerShareDiluted>
  <us-gaap:DebtInstrumentIssuanceDate1 id="f1270" contextRef="c180">2023-06-05</us-gaap:DebtInstrumentIssuanceDate1>
  <dei:EntityAddressCityOrTown id="f1271" contextRef="c12">Las Vegas</dei:EntityAddressCityOrTown>
  <us-gaap:PreferredStockSharesAuthorized id="f1272" decimals="INF" contextRef="c226" unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:Dividends id="f1273" decimals="0" contextRef="c44" unitRef="usd">336650.0</us-gaap:Dividends>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="f1274" contextRef="c12">&lt;p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zKyyZknwr8Tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zGUnkCSJsP0k"&gt;Revenue Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys primary source of revenue
is its healthcare subsidiary, which records revenues from providing licensed and/or certified orthopedic procedures. Revenue is recognized
at a point in time in accordance with ASC 606. The Companys healthcare subsidiary does not have contract liabilities or deferred
revenue as there are no amounts prepaid for services. The Company applies the following five-step ASC 606 model to determine revenue recognition:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of a contract with a customer&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification of the performance obligations in the contact&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Determination of the transaction price&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Allocation of the transaction price to the separate performance obligations&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognition of revenue when performance obligations are satisfied.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company applies the five-step model when it
is probable that the Company will collect the consideration it is entitled to in exchange for thegoodsor services it transfers
to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses services
promised within each contract and determines those that are a performance obligation and assesses whether each promised service is distinct.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Companys contracts for both its contract
and service fees each contain a single performance obligation (providing orthopedic services), as the promise to transfer the individual
services is not separately identifiable from other promises in the contracts and, therefore, not distinct, as a result, the entire transaction
price is allocated to this single performance obligation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, the Company recognizes revenues (net)
when the patient receives orthopedic care services. The Companys patient service contracts generally have performance obligations
which are satisfied at a point in time. The performance obligation is for onsite or off-site care provided. Patient service contracts
are generally fixed-price, and the transaction price is in the contract. Revenue is recognized when obligations under the terms of the
contract with our patients are satisfied; generally, at the time of patient care.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Established billing rates are not the same as
actual amounts recovered for the Companys healthcare subsidiary.They generally do not reflect what the Company is ultimately
paid by the customer, insurance carriers and other payors, and therefore are not reported in the consolidated financial statements at
that rate. The Company is typically paid amounts based on established charges per procedure with guidance from the annually
updated Current Procedural Terminology (CPT) guidelines (a code set maintained by the American Medical Association through
the CPT Editorial Panel), that designates relative value units and a suggested range of charges for each procedure which is then assigned
a CPT code.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This fee is discounted to reflect the percentage
paid to the Company using a modifier recognized by each insurance carrier for services, less deductible, co-pay, and contractual
adjustments which are deducted from the calculated fee. The net revenue is recorded at the time the services are rendered.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="f1275" decimals="INF" contextRef="c181" unitRef="shares">0.0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="f1276" decimals="INF" contextRef="c38" unitRef="shares">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ProceedsFromRepaymentsOfDebt id="f1277" decimals="0" contextRef="c75" unitRef="usd">0.0</us-gaap:ProceedsFromRepaymentsOfDebt>
  <us-gaap:NetIncomeLoss id="f1278" decimals="0" contextRef="c136" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockValue id="f1279" decimals="0" contextRef="c263" unitRef="usd">1277972.0</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue id="f1280" decimals="0" contextRef="c64" unitRef="usd">8537912.0</us-gaap:PreferredStockValue>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="f1281" decimals="0" contextRef="c44" unitRef="usd">-1099461.0</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <cardifflexington.com:AccruedInterest id="f1282" decimals="0" contextRef="c237" unitRef="usd">20160.0</cardifflexington.com:AccruedInterest>
  <dei:EntityAddressStateOrProvince id="f1283" contextRef="c12">NV</dei:EntityAddressStateOrProvince>
  <us-gaap:GoodwillImpairmentLoss id="f1284" decimals="0" contextRef="c12" unitRef="usd">0.0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:LeaseholdImprovementsGross id="f1285" decimals="0" contextRef="c8" unitRef="usd">15950.0</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f1286" decimals="INF" contextRef="c266" unitRef="shares">15000.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PreferredStockSharesIssued id="f1287" decimals="INF" contextRef="c182" unitRef="shares">319493.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ConvertibleDebt id="f1288" decimals="0" contextRef="c211" unitRef="usd">68667.0</us-gaap:ConvertibleDebt>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1289" decimals="INF" contextRef="c225" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour id="f1290" decimals="0" contextRef="c8" unitRef="usd">4989.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:PreferredStockSharesOutstanding id="f1291" decimals="INF" contextRef="c182" unitRef="shares">319493.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f1292" decimals="INF" contextRef="c226" unitRef="usd1">4.0</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesIssued id="f1293" decimals="INF" contextRef="c263" unitRef="shares">319493.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="f1294" decimals="0" contextRef="c266" unitRef="usd">15000.0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:PreferredStockSharesOutstanding id="f1295" decimals="INF" contextRef="c263" unitRef="shares">319493.0</us-gaap:PreferredStockSharesOutstanding>
</xbrli:xbrl>
